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B cells recognise antigens on micro-organisms through their B cell receptor (BCR) and via 
Toll-like receptors (TLRs), and thus respond in both innate and adaptive manners during the 
subsequent immune response.  Innate recognition through TLRs has the potential to alter the 
behaviour of whole B cell populations.  I show, here, that MyD88-dependent activation of B 
cells via TLR2 or TLR9 causes the rapid loss of expression of CD62L, by metalloproteinase-
dependent shedding, resulting in the exclusion of these cells from lymph nodes and Peyer’s 
patches, but not the spleen.  Moreover, systemic infection with Salmonella typhimurium 
causes shedding of CD62L and the subsequent focussing of B cell migration to the spleen.  I 
reveal that splenic B cells undergo further changes during S. typhimurium infection, 
including TLR-dependent differentiation of marginal zone B cells into IgM-secreting plasma 
cells.  Together, these TLR-mediated alterations to B cells are likely to influence the 
development of immunity to pathogens carrying the appropriate ligands. 
 
In addition to these innate responses of B cells, endocytosis of cognate antigen through their 
BCR allows antigen presentation.  This, together with their ability to secrete cytokines, 
means they have the potential to drive T helper cell responses.  I investigate the role of B 
cells in such CD4+ T cell responses by following antigen-specific T cells in vivo, using both 
a peptide immunisation strategy and the S. typhimurium infection model.  I use anti-CD20 B 
cell depletion antibodies to deplete B cells at various stages of the immune response, and 
analyse the effects on T follicular helper and memory cell populations.  I show that both the 
generation and maintenance of T follicular helper cells is dependent on the presence of B 
cells.  Furthermore, I demonstrate that B cells are necessary very early in immune responses, 
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CHAPTER 1:  Introduction 
 
 
Overview of immune responses 
The immune system functions continuously to fight off invading pathogens, whilst 
regulating itself to prevent both autoimmunity and immunopathology.  Due to the vast array 
of pathogenic organisms and the need to also recognise hazardous tumour cells, the immune 
system has evolved in mammals to be incredibly complex.  Importantly, the distinction 
between self and non-self is an essential component of immune activation [1].  Cells 
specialised in immuno-surveillance monitor the body for pathogens, and transport fragments 
of any foreign material they encounter back to lymphoid organs.  The subsequent activation 
of the innate and adaptive arms of the immune system is a complex process, involving 
multiple cell types and cellular interactions, within various tissues of the body.  Ultimately, 
the clearance of the pathogenic micro-organism requires the immune cells to work together 
to perform their effector functions efficiently and rapidly, in order to prevent pathogen-
mediated damage.  The understanding of the mechanisms of immune cell activation, and the 
processes required for pathogen clearance and generation of protective immunity, is essential 
for the development of vaccines and therapeutic treatments. 
 
While the innate arm of the immune system is activated rapidly and non-specifically in 
response to pathogen encounter, the adaptive cells (that is to say B and T lymphocytes) are 
slower to respond and require the recognition of cognate antigen.  These two arms of 
immune defence are often thought of as distinct and separate, whereas, in reality, there is 
great overlap between the two, with cells from each phase having the ability to influence 
each other in an intricate network of interactions.  Thus, while innate cells induce activation 
of adaptive cells, such adaptive cells in turn can feedback to enhance (or regulate) the 
functions of innate cells.  Moreover, the rapid ‘innate’ responses of so-called adaptive 
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Spleen structure 
Following the development of B and T cells in the bone marrow and thymus, respectively, 
mature lymphocytes migrate to the periphery, where they congregate in secondary lymphoid 
tissues.  These organs are structured in a highly organised manner, which allows the innate 
and adaptive arms of the immune system to come together for efficient activation, in 
response to pathogen stimulation.  One of the largest lymphoid structures within the body, 
and the major site of B cell localisation, is the spleen (figure 1.1A).  Within the spleen, B and 
T cells are found predominantly in the white pulp, which surrounds the central arteriole, and 
is separated from the red pulp by the marginal zone [2].  The importance of the spleen in 
immune activation was demonstrated as early as 1976 by the observation that, following 
splenectomy in human patients, severe systemic bacterial infection (i.e. sepsis) occurred at 
high frequencies [3].  In addition to its vital role in immune activation, the spleen functions 
to filter the blood of dying erythrocytes and foreign particulate antigen. 
 
- The red pulp 
The spleen acts as a filter of the blood, removing dead and dying erythrocytes from the 
bloodstream, as well as foreign particles that have become systemic.  The blood flows 
directly into the spleen through the splenic artery, which separates into vessels and 
subsequently arterioles.  Specialised stress fibres in the red pulp region filter the blood, and 
any old erythrocytes with stiffening membranes bind to the cords and are subsequently 
phagocytosed by nearby macrophages [2].  Another important task of these red pulp 
macrophages is the recycling of iron from the erythrocytes they encounter.  Iron from 
phagocytosed erythrocytes can either be released from the red pulp macrophages as a low 
molecular weight product, or stored within them as an insoluble complex [2].  Filtered blood 
then collects in the venous sinuses, and exits the spleen via the collecting vein. 
 
- The white pulp 
Lymphocytes are located within the white pulp and marginal zone regions of the spleen.  In 
the white pulp, stromal cells form a network within the T cell zone, where T cells and 
dendritic cells are located.  These stromal cells, called fibroblastic reticular cells [4], secrete 
chemokines, namely CCL19 and CCL21, which bind to their receptor, CCR7, and attract T 
cells and dendritic cells to the region [5,6].  CCL19 is also expressed by high endothelial 
venules (HEV) to encourage extravasation of CCR7+ cells into the lymph nodes [5,7].  
Meanwhile, follicular dendritic cells situated in the follicles secrete CXCL13, which attracts 
CXCR5+ B cells to these sites (see figure 1.1C) [8].  The importance of the chemokine 
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receptors CCR7 and CXCR5 in organising lymphocytes within secondary lymphoid organs 
has been demonstrated, using CXCR5-/- CCR7-/- mice.  These mice have severely disrupted 
organisation of the spleen, with poorly defined B and T cell zones, and they lack peripheral 
lymph nodes [6].  Within the host, lymphocytes regulate their expression of the chemokine 
receptors CCR7 and CXCR5 as a means of altering their homing patterns.  For example, 
activated T cells downregulate CCR7, and concurrently upregulate CXCR5, to migrate to the 
follicular boundary, where they interact with B cells and provide ‘help’ for the induction of 
the germinal centre (GC) response [9,10].  Additionally, some CXCR5+ T cells, known as T 
follicular helper cells (TFH cells), permanently reside in the follicles and function in aiding B 
cell responses [11], as described in more detail below. 
 
- The marginal zone 
Surrounding the white pulp is the marginal zone (figure 1.1A), where some arterial branches 
terminate.  Lymphocytes entering the spleen are thought to do so via the marginal zone, 
before migrating to the white pulp in response to the chemokine signals identified above.  
The resident cell populations within the marginal zone are the marginal zone B cells and two 
types of macrophage: the marginal zone macrophages, and the marginal zone metallophilic 
macrophages.  The outer ring of marginal zone macrophages is located between the marginal 
zone and the red pulp regions, and is characterised by expression of the scavenger receptor, 
MACRO, and the C-type lectin, SIGNR1 [2].  The maintenance of the marginal zone 
macrophage population at its site in the marginal zone has been described to be dependent on 
chemokine signalling, namely through the chemokine ligands CCL19 and CCL21 [12].  
Marginal zone metallophilic macrophages, on the other hand, are found at the inner region of 
the marginal zone, adjacent to the white pulp, and express the adhesion molecule SIGLEC1 
[2].  These marginal zone metallophilic macrophages can be visualised using anti-MOMA-1 
antibodies, which do not bind marginal zone macrophages [13].  The presence of the 
marginal zone B cells between these two populations of macrophages appears dependent on 
an interaction with the macrophages in this region [14], while the presence of such 
populations of macrophages have also been shown to require marginal zone B cells [15], 
highlighting a role for cellular interactions in marginal zone maintenance. 
 
Marginal zone B cells, identified by their IgMhiIgDloCD21hiCD23int-lo phenotype (whereas 
follicular B cells are IgMloIgDhiCD21int-hiCD23hi) [16], have been shown to be functionally 
distinct from follicular B cells [17].  The population of marginal zone B cells plays roles in 
both T cell-independent and T cell-dependent responses [18], although their rapid response 
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time in a T cell-independent process has led to their description as innate cells.  These 
marginal zone B cells, in contrast to follicular B cells, are non-circulatory and apparently 
long-lived [19].  The specificities of marginal zone B cell receptors (BCRs) has been shown 
to be diverse, although the IgM they produce in response to T cell-independent antigen is of 
low affinity, as they have not undergone affinity maturation [16,20].  Due to the location of 
the marginal zone adjacent to the marginal sinuses, cells in this region are among the first to 
access systemic antigen, allowing for the rapid production of antibody by marginal zone B 
cells in response to systemic antigen [18].  Their positioning in this region with ready access 
to antigen may also offer a possible explanation for the theory that marginal zone B cells are 
better than follicular B cells at antigen presentation to T cells [21].  This matter of antigen 
uptake in the marginal zone is discussed more fully later. 
 
- Architecture of other lymphoid tissues 
Although the spleen is the major site of B cell localisation and vital for immune activation, 
other secondary lymphoid organs, including lymph nodes (see figure 1.1B) and Peyer’s 
patches, are also involved in the efficient function of the immune system.  Peyer’s patches, 
situated in the intestinal wall, possess large proportions of B cells, which are involved in the 
production of IgA and the maintenance of mucosal immunity within the gut [22].  Cells 
within the Peyer’s patches are also involved in tolerance to oral antigen, as Peyer’s patch-
null mice lack this ability to tolerate such antigens [22].  In the lymph nodes, B cell 
proportions are reduced compared to in the spleen, and only follicular, not marginal zone, B 
cells are present.  Conversely, T cell proportions are increased in the lymph nodes.  
Specifically, naïve CD4+ T cells are found in large numbers in these peripheral lymphoid 
organs, highlighting the importance of the lymph nodes for T cell priming [23].  
Furthermore, many mutations have been described, which result in the lack of lymph nodes 
in mice, all of which are associated with impaired immune responses.  Such mutations 
include aly (Alymphoplasia) [24] and lymphotoxin-! [25], although these mutations may 
also affect the development and/or function of immune cells.  Together these other lymphoid 
tissues described here are also important in immune cell activation, and maintaining 
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Activation of CD4+ helper T cells 
The activation of the CD4+ T ‘helper’ cell population occurs in the secondary lymphoid 
tissues, and requires multiple signals to be received by the T cell from an initiating antigen-
presenting cell (APC).  The professional APC that is highly efficient at inducing T cell 
activation is the dendritic cell, although other cells, including B cells and macrophages, can 
also present antigen to T cells.  Conventional myeloid dendritic cells are found in an 
immature state in tissues throughout the body, such as Langerhan’s cells in the skin, and are 
characterised by their large capacity for phagocytosis.  They also express a series of innate 
receptors for pathogen recognition, such as Toll-like receptors (TLRs) and C-type lectin 
receptors, and are activated by signalling through such receptors, mediated by pathogen 
molecules (pathogen-associated molecular patterns, PAMPs) or host distress molecules (e.g. 
heat-shock proteins) [26,27].  Signalling of dendritic cells through these innate receptors 
induces their maturation and migration to lymphoid tissues, such as the draining lymph node 
[28], although dendritic cells can also be activated by other means including via signals from 
other innate cells [29].  Such activated or mature dendritic cells present antigen via MHC 
class II, together with high levels of co-stimulatory molecules [28], and are very efficient at 
inducing naïve T cell activation, hence the term professional APC.  Once in the spleen or 
lymph node, mature dendritic cells migrate specifically to the T cell zone, due to their 
expression of the chemokine receptor CCR7 [27], where they interact with T cells. 
 
Naïve T cells also congregate in the T cell zones of secondary lymphoid organs due to their 
CCR7+ phenotype.  Migration of activated dendritic cells directly to this site allows T cells 
to then ‘meet’ the dendritic cells and scan them for cognate antigen [30].  The subsequent 
activation of naïve T cells requires 3 defined signals from the initiating APC.  The first 
signal is received through the T cell receptor (TCR) following binding to the relevant 
antigen/MHC class II complexes presented by dendritic cells, referred to as signal 1 [27].  
Thereafter, co-stimulatory molecules, such as binding of CD28 on T cells to CD80 or CD86 
on dendritic cells, deliver signal 2 to T cells [27].  Cytokine release by the APC constitutes 
signal 3, and directs the polarisation of the T cell response [27].  When T cells receive a 
signal through their TCR that is not accompanied by signals 2 or 3, the cell is likely to 
become anergic, which may lead to tolerance, in order to prevent immune reactions against 
self antigens that are presented in the absence of inflammatory signals [27,31]. 
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T helper cell subset differentiation 
Following receipt of the 3 signals identified above, T cells become activated, and 
differentiate into one of several subsets of effector cells, depending on the cytokine signals 
from the initiating APC and/or the surrounding environment.  The resulting T helper cell 
subsets are characterised by the expression of particular transcription factors, and the 
secretion of specific cytokines.  Each subset is tailored for specific types of infection and 
specialises in particular functions, such as driving production of specific antibody isotypes 
by B cells, subject to the requirements of the immune response at the time.  A summary of 
the cytokine signals that drive T cell subset differentiation, their associated transcription 
factors, cytokines they produce, and immune responses in which they are involved, are 
presented in figure 1.2. 
 
- Phenotype and functions of effector T helper cells 
Briefly, Th1 cell differentiation is induced by IL-12 production by dendritic cells in an IFN!-
rich environment, and functions during intracellular bacterial and viral infections.  This cell 
type typically expresses the transcription factor Tbet, and secretes large amounts IFN", as 
well as IL-2 [32].  IFN! has diverse effects on immune cells, including the activation of 
macrophages, while IL-2 induces further T cell division.  T cell help for B cells under Th1 
conditions results in the secretion of IgG isotypes, specifically IgG2a/c, IgG2b and IgG3.  
Th2 cells, on the other hand, differentiate in response to IL-4 signalling, express the 
transcription factor GATA3, and secrete IL-4, IL-5 and IL-13 as their signature cytokines 
[32].  The original source of this IL-4 that drives Th2 cell differentiation is not thought to be 
dendritic cells, but may instead be basophils [33].  Th2 responses generate IgG1 and IgE 
production by B cells [34], and play roles in helminth infection, as well as allergic reactions.  
The cytokines produced by Th2 cells, namely IL-4, IL-5 and IL-13, have a range of effects 
on both immune and non-immune cells, including the activation of mast cells, eosinophils 
and basophils, generation of alternatively activated macrophages, contraction of smooth 
muscle and increased mucus production by goblet cells [35]. 
 
For many years the Th1 and Th2 cell subsets dominated the field until, recently, several 
more T cell subsets were discovered, namely Th17 cells and regulatory T cells (Treg cells).  
Th17 cells are characterised by their expression of Ror"t and secretion of IL-17 (A and F) 
and IL-22, and are thought to function in immune responses to extracellular bacteria and 
fungi, especially at the mucosal sites [32].  Their differentiation occurs in response to 
transforming growth factor-" (TGF#) together with IL-6 production by APCs, while IL-23 
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may also be involved in their generation and/or maintenance [36].  Interestingly, TGF# 
production alone or in conjunction with IL-2 gives rise to a further subset of T cells, the 
inducible regulatory T cells (iTreg cells) [37].  These cells, unlike the natural regulatory T 
cell population that develops in the thymus, are capable of differentiation in the periphery.  
Both natural and inducible Treg cells are thought to express the transcription factor FoxP3, 
while a proportion of them also appear IL-25+ (IL-2R#+) [37].  Regulatory T cells perform a 
critical function in regulating immune responses, a role demonstrated by the severe and 
lethal autoimmune disease that develops in FoxP3-null mice [38]. 
 
Meanwhile, controversy surrounds the latest T cell ‘subset’ of IL-9 producing Th9 cells, also 
involved in immunity to intestinal helminths.  These cells are thought to develop either from 
Th2 cells following TGF" signalling, or directly from early activated T cells when 
stimulated with IL-4 plus TGF" [39].  Although the authors describe these Th9 cells as 
distinct from either Th1, Th2, or Th17 cells in vitro [39], whether or not this cell type really 
is a separate lineage of T helper cells remains a topic of debate [37].  For this reason, I have 
excluded Th9 cells from figure 1.2.  Finally, a further subset of T helper cells is the TFH cells, 
which differentiate in response to IL-21 and IL-6 [40], and are located in the B cell follicles.  
These cells, which express the transcription factor Bcl-6 (B cell lymphoma-6) [41,42] and 
are specialised at providing help for B cells, are discussed in greater detail later. 
 
- The role of TGF! in T cell regulation and differentiation 
As mentioned above, one of the cytokines involved in determining the phenotype of the T 
cell response is TGF#.  TGF# alone or with IL-2 leads to iTreg cell differentiation, while 
TGF# plus IL-6 results in Th17 cell generation, or with IL-4 results in Th9 cells [37,39].  
The TGF# family consists of 3 related cytokines, TGF#1, TGF#2, and TGF#3, which show 
high levels of homology [43].  Members of the TGF# family of cytokines are widely 
distributed throughout the mammalian body, and are capable of influencing the functions of 
a large variety of cell types.  TGF#1, the main TGF# family member expressed in the 
immune system, is synthesised in an inactive form [44].  Secreted TGF#, in a complex with 
other proteins, requires a low pH, proteolysis and binding to cell surface proteins for 
activation [45].  Activated TGF# then binds its receptor (TGF"R), which consists of the 
ALK5 subunit together with the TGF#RII subunit [44].  Treg cells secrete TGF", in 
conjunction with other cytokines (see figure 1.2), which can impact on cells in both the 
innate and adaptive immune system. 
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Multiple cell types within the immune system express the TGF# receptor and thus can be 
regulated by this cytokine.  These include macrophages, dendritic cells, natural killer cells, 
and B and T cells [45].  TGF#1-mediated suppression of immune cells is a vital part in the 
control of inflammation, and without it death occurs around 4 weeks of age as a result of 
multifocal inflammation, leading to multiple organ failure [46].  Similarly, disruption of the 
TGF# receptor signalling pathway (TGF#R-/-) in an inducible system led to death following 
excessive inflammation [47].  These studies highlight the essential role of the TGF# family 
members in the wholesale regulation of immune cells.  However, the specific function of 
TGF#-mediated regulation of the T cell compartment is not addressed in these reports. 
 
More recently, a mouse strain has been generated, in which T cells express a mutant form of 
the TGF# receptor, and thus cannot respond to TGF# signals [43].  Specifically, these mice 
express a dominant-negative form of the TGF# receptor type II under the control of the CD4 
promoter (CD4-dnTGF#RII mice).  This receptor, similar to its wild type counterpart, is 
capable of binding all 3 isoforms of TGF#, however, due to the truncated nature of its 
intracellular domain, signal transduction within the cell is interrupted [48].  The lack of the 
CD8 silencer in this particular strain of mice allows the expression of the mutant form of the 
TGF#RII on all CD4+ and CD8+ T cells [43].  Studies in these mice have revealed the 
importance of TGF#-mediated regulation of the T cell population, as these CD4-dnTGF"RII 
mice develop spontaneous autoimmune disease.  Disease onset occurrs around 3-4 months of 
age, and is characterised by severe inflammatory bowel disease, infiltration of lymphocytes 
into multiple organs, and the presence of auto-reactive serum antibodies [43].  Therefore, 
similar to TGF#1-/- and TGF#R-/- mice, in mice in which T cells alone cannot respond to 
TGF#, excessive inflammation ultimately leads to death, albeit with delayed kinetics.  
Therefore, the inability of the T cell populations, alone, to respond to TGF" signalling was 
enough to break self-tolerance and induce fatal autoimmunity, emphasizing the need for the 
TGF"-producing Treg cell population and/or TGF"-mediated suppression. 
 
Interestingly, the generation of these CD4-dnTGF"RII mice has provided conflicting 
evidence as to the role of TGF# in the development of Treg cells.  While previous studies 
reveal TGF# to be essential for the generation of Treg cells [49], others have shown in 
TGF#1-/- mice that Treg cells develop normally in the absence of TGF# [50].  Some data 
suggested that natural Treg cells could develop, but were poorly maintained in the periphery, 
in the absence of TGF# [51].  Importantly, use of the transgenic CD4-dnTFG#RII mice 
revealed Treg cell numbers to be normal [52].  Thus, it seems likely that the development of 
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natural Treg cells in the thymus may be possible in the absence of TGF#.  However, the 
possibility remains that the maintenance of Treg cells in the periphery, and the generation of 
inducible Treg cells, may be more reliant on this cytokine [44].  Thus, although some Treg 
cells exist in the CD4-dnTGF"RII mice, the lack of TGF"-mediated control of T cells 
resulted in the loss of tolerance to self-antigens, emphasizing the importance of TGF" as a 
regulatory cytokine in the T cell compartment under steady-state conditions. 
 
Furthermore, due to the reliance of Th17 cell (and possibly Th9 cell) differentiation on 
TGF", such responses are likely impaired in the CD4-dnTGF"RII mice.  Indeed, such mice 
have been shown to lack Th17 cells, and do not develop Experimental Autoimmune 
Encephalomyelitis (EAE), a disease mediated by self-reactive Th17 cells [53].  Due to the 
novel nature of Th9 cells, they have not, as far as I am aware, been studied in these CD4-
dnTGF"RII mice.  Indeed, the use of these mice may be informative as to the need for TGF" 
for IL-9 production, and provide information as to the distinctiveness of the Th9 cell lineage.  
The generation of these CD4-dnTGF"RII mice has, therefore, proven a useful tool in 
evaluating the specific roles of TGF" signalling in T cells in immunity and regulation, and 
will continue to do so. 
 
- T follicular helper cells (TFH cells) 
As stated above, a further subset of T cells is the TFH cell population that, as their name 
suggests, resides within the follicles of secondary lymphoid organs and provides help for B 
cells.  Specifically, TFH cells function in aiding adaptive B cell responses, by driving the GC 
reaction, class switching of immunoglobulin, and plasma and memory cell differentiation 
[54], and indeed such responses of B cells are absolutely dependent on the presence of T 
helper cells [55,56].  The transcription factor Bcl-6 has been shown to be involved in the 
differentiation of TFH cells, which occurs in response to IL-21 and IL-6 signalling [40,41,42], 
as outlined in figure 1.2.  Without Bcl-6 expression in T cells, the development of TFH cells 
is severely reduced [41], highlighting the importance of this transcription factor in their 
differentiation.  Conversely, over-expression of Bcl-6 leads to the upregulation of the 
hallmark TFH cell molecules, CXCR5 and PD-1, and thus an increase in the total number of 
cells with the TFH cell phenotype [42]. 
 
Such TFH cells are situated within the follicles due to their expression of the chemokine 
receptor CXCR5, while they do not express CCR7, and thus they migrate towards CXCL13 
secreted by follicular dendritic cells [11].  TFH cells can therefore be identified by flow 
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cytometry by this CXCR5+ phenotype, as well as expression of either ICOS (inducible co-
stimulator) or PD-1 (programmed death-1) [54].  By immunohistology of splenic tissue 
sections, CD4+ TFH cells can be seen clearly within the follicles, in close association with 
follicular B cells.  Their expression of ICOS, a co-stimulatory molecule belonging to the 
CD28 family, is involved in the positive regulation of B cells during the GC reaction, as well 
as in the maintenance of the TFH cell population [11].  Specifically, a B-T cell interaction in 
the follicular region, involving ICOSL and ICOS interaction, is required for the maintenance 
of cells with the TFH cell phenotype [40], highlighting the vital role of B cells.  In the 
absence of ICOSL expression by B cells, TFH cell numbers are significantly reduced [40].  In 
addition to ICOS expression, TFH cells can be identified by their high expression levels of the 
inhibitory molecule PD-1.  PD-1 signalling appears to be involved in maintaining the 
function of TFH cells, as in the absence of PD-1, although TFH cell numbers were actually 
enhanced (for reasons unknown), their function in terms of cytokine production and help for 
B cells was diminished [57].  TFH cells also express high levels of CD40 ligand, a co-
stimulatory molecule for B cells, which together with ICOS and PD-1 are involved in the 
positive regulation of B cells during and after the GC reaction, and impact B cell 
differentiation into plasma and memory cells [11,57].  The details of the requirement for TFH 
cells in the generation of B cell responses, including the roles of ICOS, PD-1 and CD40L, 
are discussed later, with reference to B cell activation and differentiation. 
 
As discussed above, T helper cell subsets can be further characterised by their unique 
cytokine secretion profile.  In the case of TFH cells, the typical cytokine that they produce is 
IL-21.  The optimal production of IL-21 by TFH cells has been shown to be dependent on 
their expression of ICOS [58], suggesting that signalling through ICOS, perhaps via 
interaction with ICOSL expressed by B cells, is a positive feedback mechanism of IL-21 
regulation.  Not only is IL-21 required for the differentiation of TFH cells [40], but this 
cytokine may also be involved in their maintenance.  This conclusion is drawn from the 
observation that TFH cells continue to express the IL-21 receptor, and thus IL-21 produced by 
TFH cells may act in an autocrine manner to ensure the maintenance of this population [58].  
However, more recent studies show that IL-21 is not required for the presence of T follicular 
helper cells in mice [59,60].  TFH cell-derived IL-21 also impacts on the B cell GC reaction 
and their subsequent differentiation into effector and memory cells, a concept that is 
discussed fully later in relation to B cell effector and memory cell development. 
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- Plasticity of T helper cell subsets 
Although the different lineages of T helper cell subsets, presented in figure 1.2, appear 
distinct, in reality the flexibility of effector cells to change phenotype from one to another 
remains a topic of dispute.  The current thinking is that, while some effector subsets are 
mutually exclusive and inhibit each other’s differentiation, others seem more flexible.  The 
plasticity of effector CD4+ T cells also appears dependent on their differentiation state: the 
further along the effector cell differentiation pathway, the less easy it is to alter effector 
phenotype.  In other words, terminally differentiated effector T cells appear unable to alter 
their effector phenotype, whereas soon after activation effector cells may alter their subset 
according to signals received through cytokine receptors [61,62]. 
 
Looking specifically at cells of the Th1 and Th2 subsets, cells primed in vitro in either Th1- 
or Th2-inducing conditions may be able to switch from IFN! to IL-4 production, or vice 
versa, at early stages of the culture.  During the transition phase, IFN!+ IL-4+ cells exist, 
before full differentiation under the new conditions [63].  These data comes to light, despite 
the observation that IFN! and IL-4 are co-inhibitory [37], due to mutual inhibition of the 
master regulators, Tbet and GATA3, at the gene transcription level as a result of changes to 
gene accessibility due the histone arrangement [64,65,66].  However, cells that have endured 
more than 1 week of culture under Th1 or Th2 conditions lose the ability to switch effector 
phenotype and cytokine production, as they become terminally differentiated [63].  One 
mechanism of this stability is that Tbet or GATA3 expression by Th1 and Th2 cells, 
respectively, promotes a self-reinforcing feedback loop, which stabilises differentiation [66].  
It should be noted, however, that Th1 and Th2 cells generated in vivo during infection may 
differ in their effector subset flexibility than those generated under strong polarising 
conditions in vitro, as has been suggested [32].  Moreover, Th17 cells appear much less rigid 
throughout the differentiation pathway, than Th1 and Th2 cells.  Due to the requirement for 
TGF", Th17 cells share a close lineage with iTreg cell differentiation, and also appear able 
to switch to a Th1 phenotype and secrete IFN!, thus have a close relationship with this 
subset [67].  In EAE, some activated autoimmune cells in the central nervous system secrete 
both IFN! and IL-17, confirming the flexibility of the Th17 cell subset [68].  Furthermore, 
the most recently identified T helper cell subset, the Th9 cells, also show great plasticity, in 
that they share a common lineage with Th2 cells and may secrete IL-4 [39].  This raises the 
issue as to whether these cells should truly be considered as a separate effector cell subset.  
Therefore, in many cases, categorising a T cell response according to the most prevalent 
cytokine is inaccurate, and does not reflect the heterogeneity of the T effector cells involved. 
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- The plasticity of T follicular helper cells 
The flexibility of the TFH cell population is also a subject of controversy.  Chtanova and 
colleagues describe the TFH cell lineage as entirely separate from the Th1 and Th2 subsets, 
due to their specific expression of the transcription factor, Bcl-6, and other genes in a highly 
distinctive profile [69].  Further research also shows TFH cells to be separate from the Th17 
cell lineage [40].  One of the studies that identified Bcl-6 as the transcription factor 
expressed by TFH cells showed that over-expression of this transcription factor resulted in the 
inhibition of other T helper effector cell lineages [41].  This repression of the Th1 and Th17 
lineages was found to be due to Bcl-6 binding to the promoters of the Th1 and Th17 master 
regulator transcription factors, Tbet and Ror!t, and repressing the production of the 
cytokines, IFN! and IL-17 [42].  Together, these data suggest that TFH cells are a distinct 
subset, unrelated to Th1 and Th17 cells. 
 
Furthermore, the transcription factors Bcl-6 and Blimp-1 are mutually exclusive in 
lymphocyte populations [70].  As Blimp-1 has been implicated in effector T helper cell 
development [71,72], this transcription factor may be a specific marker for effector Th cells, 
as is the case in both the B cell and CD8+ T cell compartments [71].  Conversely, as stated 
above, Bcl-6 is essential for TFH cell differentiation [40,41,42].  Therefore, again, these data 
on expression of the transcription factors Bcl-6 and Blimp-1 point to the TFH cell lineage as 
separate from other effector T helper cell subsets.  Indeed, Blimp-1+ effector T helper cells 
appear unable to provide B cell help, and thus cannot perform TFH cell functions [72]. 
 
However, a more recent review discusses the potential for TFH cells isolated during an 
immune response to resemble Th1, Th2 or Th17 effector cells [63].  Indeed, during helminth 
infection, GATA3+ Bcl-6+ cells have been isolated, which the authors called TFH cells due to 
their expression of CXCR5 and location in the follicles, highlighting the possibility either 
that effector Th2 cells can gain the TFH cell phenotype during infection, or vice versa 
[73,74].  These data is further supported by the observation that newly activated T helper 
cells upregulate CXCR5 and migrate into the follicles [75].  Therefore, the possibility 
remains that antigen-activated T helper cells found in follicles soon after 
immunisation/infection may differ in phenotype and function from true TFH cells that initiate 
B cell selection and differentiation post-GC, as has been suggested in a recent review [71].  
Thus, again, labelling T cells as ‘follicular helpers’ or ‘TFH cells’ due to their expression of 
CXCR5 may mask different types of TFH cells, and one should keep in mind the potential 
diversity in this subset when discussing TFH cells identified in this way. 




One of the defining characteristics of adaptive immune cells is their ability to generate 
memory.  This memory is the basis of immunity to disease and the reason that vaccines are 
effective in protecting the host from infection.  Such protective immunity is long-lived, 
although putting a numerical figure on the longevity of memory cells in humans is a difficult 
task.  However, the concept of immunological memory has long been accepted, and more 
recently the cellular basis has been determined.  While protective immunity by B cells 
consists of both memory cells and long-lived plasma cells, which maintain levels of serum 
antibodies, T cell memory consists only of memory cells, while long-lived effector cells are 
absent.  Thus, the longevity of immune memory is as a result of the development of 
specialised memory cells, with a lifespan of ~4-6 weeks [76], and the maintenance of these 
memory cell clones (perhaps for the life of the host?) by means of homeostatic turnover.  
Here, the development and characteristics of memory cells in the T cell population are 
discussed. 
 
During the initial phase of the T cell response, antigen-specific T cells rapidly expand in 
response to antigenic stimulation.  It is well documented that the clonal expansion of CD8+ T 
cells is greater than that of CD4+ T cells.  In other words, at the peak of the primary immune 
response, antigen-specific cytotoxic T cells account for a much larger proportion of the 
CD8+ T cell repertoire than effector T helper cells do of the CD4+ T cell repertoire [77].  In 
both cases, most of the antigen-specific T cells that are generated differentiate into short-
lived effector cells, and function in pathogen clearance.  In the case of CD4+ T cells, the 
effector cells will be of a specific subset phenotype, as described in figure 1.2, depending on 
the infectious agent and cytokine environment.  Most of these T cells found at the peak of 
the primary response that recognise antigen will undergo the cell death process during the 
contraction phase, the onset of which correlates with the disappearance of antigen due to 
pathogen clearance [77]. 
 
However, a proportion of activated antigen-specific T cells survive the contraction phase, 
and go on to form memory cells, although the identity of the survival signal(s) involved 
remains ill-defined.  The resulting memory cells differ from their naïve counterparts in terms 
of functional ability to respond to pathogens.  Specifically, memory cells mount an 
accelerated and enhanced response when antigen is encountered for a second time [76].  
Although the concept of immune memory has long been accepted, and the adaptive cell 
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types with a memory feature have been identified, dissecting the pathways and processes that 
lead to memory development, as well the phenotype of antigen-specific memory cells, has 
been a slow procedure. 
 
- CD4+ T cell memory characteristics 
The memory population of T helper lymphocytes generated after immune activation differs 
from naïve T cells in several characteristics.  Firstly, the frequency of antigen-specific 
memory cells retained after antigen exposure is greater than the frequency of naïve cells 
specific for that particular antigen [76].  Secondly, in addition to this quantitative difference 
in memory CD4+ T cells, they also differ qualitatively from naïve T cells.  In this respect, not 
only are memory cells longer lived than naïve cells, but they also differ in terms of their 
response to antigen. 
 
Specifically, memory T helper cells respond stronger and faster to antigen, and thus are 
likely to be more efficient at antigen clearance [78].  Some evidence suggests that memory T 
cells can respond to lower doses of antigen, and do not rely so heavily on co-stimulation 
from the initiating APC, thus explaining the faster response time [78,79].  Recent analysis of 
T cell-APC interactions using in vivo imaging suggests memory T cells are also more 
efficient at surveying antigen on APCs than naïve T cells, a trait that also promotes a faster 
response time [80].  Furthermore, memory T cells differ in their cytokine-producing ability, 
compared to naïve cells.  For example, memory cells are thought to produce significantly 
larger amounts of IL-2 in response to antigenic stimulation compared to naïve cells, 
increasing their potential for rapid division [79].  The explanation for this ability to rapidly 
secrete cytokines is due to the altered, more open, chromatin structure within memory cells 
[77].  Additionally, some studies report that memory CD4+ T cells secrete a broader range of 
cytokines, compared to naïve or primary effector cells, such that pathogen clearance will be 
efficient even under different inflammatory conditions, or when the pathogen enters via a 
different route [78].  This flexibility in memory cell cytokine secretion, and the lack of 
distinction between Th1/Th2/Th17 cell subset phenotypes in the memory phase, remains an 
important area of investigation. 
 
- The models of T helper cell memory differentiation 
The pathway leading to T helper cell memory generation, and the exact signals required for 
memory cell differentiation, remain elusive.  A diagram of the possible differentiation 
pathways of CD4+ T cell subsets is shown in figure 1.3 (adapted from [77]).  Several theories 
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exist as to the developmental relationship between effector and memory T helper cells: is it a 
linear pathway where effector cells further differentiate into memory cells (figure 1.3A)?  Or 
are these two pathways separate in a diverging model [81] (figure 1.3B)?  If the latter is the 
case, then this leaves us with questions regarding the initial choice between effector and 
memory cell differentiation: how does a newly activated T cell decide whether to become an 
effector cell or a memory cell? 
 
The discovery of central and effector memory cells in the CD4+ T cell population, which 
differ in their expression of surface markers and localisation within the host (discussed 
further below), complicates matters further [82] (figure 1.3C).  In humans, central memory T 
cells have a CCR7+ CD62L+ phenotype and therefore can enter the lymph nodes and home to 
the T cell zones, whereas effector memory T cells are CCR7- and heterogeneous for CD62L 
expression, but express other adhesion molecules and chemokine receptors that allow 
migration to inflamed tissues, but such cells are not attracted to the T cell zones of secondary 
lymphoid organs [83].  For a more detailed analysis and discussion of these effector and 
central memory cells, see below.  So-called ‘effector’ memory cells appear to have a more 
limited lifespan, and reduced proliferative capacity, when compared to ‘central’ memory 
cells [84].  This particular model (figure 1.3C) suggests that ‘early’ and ‘late’ effector cells 
vary in their memory-generating capacity.  However, the distinction between ‘early’ and 
‘late’ effector cells, as well as between effector and effector memory cells, in terms of 
surface markers and function is less clear.  Clearly, further research in this field is necessary 
to gain answers to these questions. 
 
- The difficulties in studying CD4+ T cell memory 
However, due to the low numbers of antigen-specific CD4+ T cells found during immune 
responses, it is difficult to study T helper cell memory generation in vivo.  In the past, 
transgenic T cell transfers have been used by as a tool for analysing antigen-specific CD4+ T 
cell responses following immunisation [85].  However, this system has several drawbacks, 
namely the vastly large and non-physiological numbers of responding T cells of the same 
clone.  Furthermore, the generation of a stable memory population in this system proved 
difficult ([85] and my unpublished data).  Indeed, work by Hataye et al showed that clonal 
abundance controls cell survival, and it is necessary to transfer low numbers of transgenic T 
cells (~1000) for a stable memory population to be generated after immunisation [86].  
Using this method of transferring low numbers of T cells, and detecting donor cells using an 
enrichment protocol, it was shown that, although T helper cell memory was long-lived, it 
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was not entirely stable, but declined steadily over time [86].  These data contrast to that from 
analysis of CD8+ T cell memory, in which the number of memory cells of a particular 
specificity is thought to be relatively consistent over long periods of time, due to homeostatic 
turnover [77]. 
 
Despite overcoming some of the problems of the transgenic T cell transfer model, this 
system of transferring low numbers of antigen-specific T cells is not ideal for studying 
memory generation, as it relies on measuring transferred rather than endogenous T cell 
responses, and thus does not truly reflect in vivo responses to antigen.  Recent advances in 
experimental methods, and the advent of MHC class II tetramers (see below), have resulted 
in the development of better techniques for the study of endogenous CD4+ T cell memory 
generation in vivo, in polyclonal systems.  Thus, the processes and differentiation pathways 
involved in T helper cell memory generation may be unravelled in the near future.  Indeed, 
this thesis uses such techniques to investigate the specific requirement for B cells in T helper 
cell memory generation.  In the meantime, lessons may be learnt from the understanding of 
CD8+ T cell memory development. 
 
- Studies of CD8+ T cell memory generation 
The larger numbers of antigen-specific CD8+ T cells during a primary immune response, and 
the success of MHC class I tetramers, make cytotoxic T cell differentiation pathways easier 
to study in vivo, without the need for transgenic T cell transfers.  Kaech and colleagues have 
gone some way to dissecting the differentiation of effector and memory cells in CD8+ T cells 
[87,88,89].  Joshi et al, for example, distinguished between terminally differentiated short-
lived effector cells (SLECs) and memory precursor effector cells (MPECs) using the cell 
surface markers as follows:  SLECs were identified as IL-7Rlo KLRG1hi, whereas MPECs, 
which had greater potential for memory generation, were defined as IL-7Rhi KLRG1lo [87].  
Additionally, the authors state that the relative levels of Tbet expression (which is also the 
Th1 master regulator in CD4+ T cells) regulate the generation of SLECs and MPECs in the 
CD8+ T cell population.  Specifically, high expression of Tbet leads to SLEC differentiation, 
whereas low levels of Tbet promotes MPEC development [87].  It would be interesting to 
determine if the expression levels of Tbet reflect the affinity of the TCR for antigen.  The 
authors, therefore, suggest a relatively divergent model of differentiation, with the cell fate 
decision being made early in the response [88].  Although both MPECs and SLECs have an 
effector cell phase, terminally differentiated SLECs appear unable to further differentiate 
into memory cells. 
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Meanwhile Rutishauser and colleagues revealed a role for the transcription factor Blimp-1 in 
determining the effector/memory fate of CD8+ T cells.  Blimp-1 was found to promote 
effector cell differentiation, and acted as a marker for effector cell identification, while the 
absence of this transcription factor led to an increased prevalence of memory precursor cells 
[89].  Conversely, the transcription factor Bcl-6 has been implicated in the generation of 
memory cytotoxic T cells [90].  These data, therefore, also point to a relatively divergent 
model of effector and memory cell differentiation, with cells becoming either Blimp-1-
expressing effectors or Bcl-6-expressing memory cells.  These ground-breaking studies have 
provided great insight into the differentiation model of CD8+ T cells.  These data also allow 
us to speculate on the potential parallels in CD4+ T cell memory generation. 
 
- Implications for CD4+ T cell memory generation 
The differentiation pathways of cytotoxic and helper T cells may (or may not) be similar.  
Certainly, some parallels between CD4+ and CD8+ T cell effector and memory phenotype 
have already been discovered.  For example, IL-7R# expression, reported above to be a 
CD8+ MPEC marker [87], has also been seen in memory cells of the CD4+ T cell population 
[91], and reflects the dependence on IL-7 signalling for homeostatic turnover of memory 
cells (see below).  Furthermore, Blimp-1 expression by effector cells is similar in CD8+ and 
CD4+ T cells [92], as well as in the B cell population [93].  Together, these data support the 
notion that the pathways of effector and memory cell differentiation may be similar in the 
cytotoxic and helper T cell compartments (as well as in B cells), and perhaps controlled by 
the transcription factors Bcl-6 and Blimp-1.  The identification of SLECs and MPECs in the 
CD4+ T cell population would be required to further support this theory. 
 
The potential role of Tbet expression in regulating cell fate between effector and memory 
differentiation is an interesting mechanism, which also requires future investigation in CD4+ 
T cells.  In addition to the roles of transcription factors, other observations have been made 
in relation to the effector/memory cell fate decision in T cells.  Firstly, the strength of the 
signal received through the TCR is thought to determine whether the cell differentiates into 
an effector or memory cell [94,95].  Factors that contribute to signal strength include antigen 
concentration, expression levels of MHC and co-stimulatory molecules on the APC, and the 
duration of the APC-T cell interaction.  For example, a sustained APC-T cell interaction may 
induce effector cell differentiation, while a transient but sufficient signal may result in 
memory generation [84].  Ahmed and co-workers suggest that antigen levels are important in 
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determining memory generation, with low levels driving the differentiation of cells into 
‘central’ memory cells, resulting in the accumulation of memory cells of this type [77].  This 
may be a mechanism to ensure T cell clones of the highest affinity enter the memory pool.  
Secondly, the size of the memory pool generated is directly proportional to the amount of 
expansion during the primary response, a process driven by OX40 signalling [96], 
suggesting that this co-stimulatory molecule plays a role in the cell fate decision.  Also, a 
direct role of B cells is essential for T helper memory cell differentiation, a requirement that 
is discussed in much greater detail below, with respect to B cell antigen presentation. 
 
- Identification of memory T helper cells using cell surface markers 
The use of cell surface markers to determine T helper cell activation status and subset 
phenotype has proved challenging.  Unfortunately, there do not appear to be any definitive 
markers for memory T helper cells.  However, some combinations of markers have been 
outlined for naïve, activated, or memory T cell distinction.  These markers are predominantly 
adhesion molecules and chemokine receptors, and thus memory cells are identified by their 
altered migration patterns in vivo.  Naïve T cells, for example, have been described as 
CD62Lhi CD44lo, while activated and memory T cells have a CD62Llo CD44hi phenotype 
[97] (figure 1.4A).  While CD62L mediates cell rolling on the endothelium and is involved 
in lymphocyte entry into the lymph nodes (see below), CD44 binds to Hyaluronan and 
mediates cell binding to the extracellular matrix and other cells [98]. 
 
With the discovery of central and effector memory populations within the CD4+ T cell 
compartment, these cells too were separated according to their expression of adhesion 
molecules and chemokine receptors.  Specifically, central memory cells are CCR7+ CD62Lhi, 
whereas effector memory cells have a CCR7- phenotype and were seen to be heterogeneous 
for CD62L expression [82], thus reflecting their altered migration to the T cell zones within 
secondary lymphoid organs (figure 1.4A).  These effector and memory T helper cell 
distinctions are discussed further in the next paragraph.  Meanwhile, the cytotoxic T cell 
memory population has its own identifying markers.  As mentioned above, the most recent 
studies reveal MPECs to have an IL-7Rhi KLRG1lo phenotype, whereas SLECs are IL-7Rlo 
KLRG1hi [87], although it remains to be seen whether or not these markers hold true in T 
helper cell memory populations.  Expression of IL-7R# seems an obvious choice for 
memory cell identification, due to the role of IL-7 in the maintenance of memory cells (see 
below).  However, the function of KLRG1 (killer-cell lectin-like receptor subfamily G1), 
shown to provide an inhibitory signal in natural killer cells, on T cells (specifically effector 
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cells) remains unknown [99].  Identifying these cell surface markers in the CD4+ T cell 
compartment would therefore go some way to determining if SLECs and MPECs exist in the 
T helper cell population, and may provide a useful method of distinguishing effector and 
memory cell populations. 
 
Recently, Ly6C, originally described as a marker for activated T cells, has been identified as 
a possible marker for the identification of memory CD4+ T cells [97].  In CD8+ T cells, 
Ly6C has been implicated to function in homing [100], and has been reported to be 
expressed exclusively by memory cells [101].  In CD4+ T cells, on the other hand, Ly6C may 
function in regulating cytokine production by Th1 and Th2 effector cells by initiating an 
inhibitory signal [102].  Whether this cell surface marker really is a novel method of 
identifying memory CD4+ T cells is investigated further in this thesis (see chapter 6). 
 
- Memory T helper cell migration patterns 
As mentioned, the identification of naïve and activated, as well as central memory and 
effector memory, CD4+ T cells is often performed on the basis of expression of particular 
cell surface molecules.  Many of these molecules are adhesion molecules and chemokine 
receptors, and their differential expression on T cell subsets reflects their altered migration 
patterns in vivo.  Specifically, naïve T cells are identified by their CD62L+ CCR7+ phenotype 
(figure 1.4A).  The expression of the selectin CD62L and the chemokine receptor CCR7 
result in naïve T cell migration across the high endothelial venules into the lymph nodes, and 
their subsequent accumulation in the T cell zone by attraction to the chemokines CCL19 and 
CCL21 [103].  Activated effector T cells, on the other hand, display a very different 
migration pattern.  Effector T cells tend not to express CCR7 or CD62L, and therefore do not 
migrate to lymph nodes, but instead express adhesion molecules such as LFA-1, VLA-4 and 
PSGL-1, together with chemokine receptors, including CXCR3, which allow the migration 
of effector T cells to sites of inflammation (figure 1.4A) [103,104].  Effector memory T cells 
appear to resemble effector T cells in terms of adhesion molecule and chemokine receptor 
expression, and similarly migrate preferentially to inflamed tissues rather than lymph nodes 
[83] (figure 1.4A).  Conversely, central memory T cells retain the ability to migrate to both 
inflamed tissues and lymph nodes, by expressing molecules required for both lymph node 
homing (CCR7 and CD62L) and tissue homing (CXCR3 and other adhesion molecules), as 
outlined in figure 1.4A [83]. 
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As mentioned, chemokine receptors such as CXCR3 enable effector and memory T cell 
populations to migrate to sites of inflammation within the body.  In addition to these 
inflammatory chemokine receptors, some sub-populations of memory cells express tissue-
specific adhesion molecules and chemokine receptors [104].  The best example of this tissue-
specific homing of memory T cells is to the gut.  As can be seen in figure 1.4B, lymphocyte 
migration to the gut requires expression of the integrin !4#7 and/or the selectin CD62L, 
which bind to MAdCAM-1, and the chemokine receptor CCR9, which recognises the gut-
associated chemokine CCL25 [103].  Expression of these molecules by a memory T cell 
would ensure migration to the gut.  Alternatively, skin-specific chemokine receptors include 
CCR10 and CCR4, which bind CCL27 and CCL17, respectively, in the skin tissue [104].  A 
more detailed description of the adhesion molecules and chemokine receptors required for T 
cell entry into specific tissues, such as the gut and skin, is given in figure 1.4B. 
 
Thus, the precise identification of memory T helper cells is a confusing process, with 
different research groups using varying combinations of cell surface markers.  Really, the 
only failsafe method of pinpointing memory cells directly ex vivo in a polyclonal system (i.e. 
without using cell transfers) is to look for antigen-specific T cells that survive after antigen 
clearance. 
 
- Maintenance of memory T helper cells 
The signals required for memory cell differentiation might be distinct from those required 
for memory cell survival and long-term maintenance, although dissecting the requirements 
for memory cell generation versus maintenance is a difficult task.  It appears that, although 
memory cells are long-lived (~4-6 weeks or more [76]), they require signals to survive and 
maintain their numbers over long periods of time, by homeostatic turnover.  The specific 
requirements for T helper memory cell survival have been investigated in vivo. 
 
One signal that has dominated this area of research is the role of antigen, and presentation by 
APCs, in the maintenance of memory T helper cells.  The requirement for antigen has 
proved difficult to study in vivo, as it is necessary to ensure complete antigen clearance in 
order to investigate the longevity of memory cells.  In many instances, antigen persists for 
long periods of time, such as in persistent viral infections, or can form antigen depots, such 
as on follicular dendritic cells.  Therefore, many studies made use of cell transfers from 
primed mice into either mice incapable of antigen presentation (MHC-deficient) or into mice 
with a different MHC haplotype that donor cells do not recognise.  Some studies concluded 
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that, in the complete absence of antigen presentation, T helper cell memory was short-lived 
[105], suggesting antigen presentation is essential in memory maintenance [106].  However, 
a more recent report suggested T helper cell memory to survive independently of MHC class 
II [107].  Furthermore, the transfer of memory T helper cells into MHC class II-deficient 
hosts resulted in the loss of function of memory T cells over time [108,109], suggesting TCR 
signalling is involved in the long-term maintenance of memory cells, or their function, in this 
system.  Despite these discrepancies in results, presumably due to the vastly different 
systems used, the current thinking is that, although antigen may not be essential in situations 
where competition is absent (such as in experiments using immuno-deficient mice, which 
possess unlimited niches for memory cells to inhabit), the presence of antigen is likely to 
increase the likelihood of memory cell survival [110].  Thus, if we think of a limited number 
of memory cell niches within the host, competition exists between cells for survival.  In such 
a setting, cells that receive antigenic stimulation through the TCR are, therefore, likely to be 
favoured over those that do not receive such signals [110].  However, whether or not there is 
an absolute requirement for antigen presence remains a controversial topic. 
 
In addition to TCR signalling, cytokine signals also appear essential for the maintenance of 
memory T helper cells.  Namely, IL-7 promotes the survival and homeostatic turnover of the 
memory helper and cytotoxic T cell populations [111], hence the use of IL-7R# expression 
as a means of identifying memory T cells.  The role of IL-15, which is also necessary in 
maintaining CD8+ T cell memory [112], in T helper cell memory maintenance remains 
disputed, but appears less essential [113].  This opinion is supported by the observation that 
memory CD4+ T cells express lower levels of the IL-15 receptor than memory CD8+ T cells, 
indicating that T helper cell memory maintenance is less dependent on IL-15 [114].  Thus, 
signals through both the TCR and IL-7R appear to be vital in the maintenance of T helper 
memory cells in vivo [115]. 
 
Furthermore, some studies also highlight the potential involvement of B cells in the 
maintenance of T helper cell memory [106,116], as well as in their generation (see below).  
The maintenance of memory CD4+ T cells appears to be dependent on B cells, although their 
antigen presentation seems to not be essential [116].  Therefore, B cells may be providing a 
signal other than the MHC class II/TCR interaction for the survival of memory T cells.  
Thus, many questions remain unanswered in reference to both the development and 
maintenance of CD4+ T cell memory, and specifically the need for B cells continues to be an 
area of active research. 
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Overview of B cell functions 
The B cell population consists of several different subsets, which differ in their phenotype 
and function.  As mentioned above, marginal zone and follicular B cells are found within the 
spleen.  A further subset of B cells, the B1 cells, are located primarily in the peritoneal 
cavity, although small numbers of these cells are also detectable in the spleen.  These B1 
cells, identified by their B220int CD5int phenotype, are one of the main producers of cross-
reactive ‘natural’ antibody, involved in the early stages of immune defence [117].  In the 
past, the focus of B cell function has been on the GC reaction, and the subsequent generation 
of plasma cells and memory.  Thus, the diversity of B cell functions is often overlooked. 
 
B cells have both innate and adaptive roles in immune defence, and are therefore at the 
interface of these two arms of the immune system.  Traditionally, B cells are thought of as 
members of the adaptive immune response, due to their roles as antigen presenters, their 
major function as producers of high affinity class-switched antibody, and their ability to 
generate memory cells.  However, B cells also respond rapidly to pathogen ligands through 
innate receptors, such as TLRs, resulting in the production of cytokines and cross-reactive 
antibody, and thus also function in the early innate immune response to pathogens. 
 
- Toll-like receptor (TLR) structure and signalling 
Toll was first identified in Drosophila, and found to have a role in host defence against 
fungal infection [118,119].  Since then, a mammalian homologue of Toll was discovered 
[120].  The family of mammalian proteins relating to Drosophila Toll were found to share 
conserved regions, and was thereafter named the Toll-like receptors (TLRs).  Similar to that 
in Drosophila, this family of proteins was also found to function in the immune system, and 
induce inflammation [121].  TLRs are a family of type 1 transmembrane proteins, found in 
both mice and humans, which are characterised by the presence of a leucine-rich repeat 
extracellular domain and a highly conserved Toll-IL-1 receptor (TIR) cytoplasmic domain 
[121].  These receptors are found on the cell surface and in the endosomal compartment, and 
recognise structurally conserved molecules of pathogens, called PAMPs.  Such pathogen 
ligands include LPS, foreign DNA and RNA, and flagellin, while host ‘danger’ factors, such 
as heat shock proteins, can also act as ligands [121].  Signalling through these TLRs results 
in activation of distinct yet overlapping signalling pathways, involving adaptor proteins such 
as MyD88 and TRIF.  An overview of TLR location, ligands, and signalling pathways is 
presented in figure 1.5 (adapted from [122]). 
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Ultimately, TLR signalling leads to the activation of transcription factors, including 
members of the NF$B family, and transcription of target genes (see figure 1.5B).  The target 
genes of NF$B are predominantly inflammatory molecules, and include cytokines (IL-1, IL-
6, IL-12, TNF!), adhesion molecules (ICAM, VCAM), inducible enzymes (inducible nitrous 
oxide, iNOS), MHC class II, and anti-microbial peptides (e.g. #-defensins), to name but a 
few [123].  The cytokines IL-1, IL-6 and TNF! initiate an inflammatory response and 
activate innate cells, while induction of iNOS and anti-microbial peptides are involved in 
direct pathogen killing.  In addition to this innate response that mediates pathogen killing, 
NF$B targets help to prime the adaptive immune response.  For example, the up-regulation 
of MHC class II molecules by cells such as dendritic cells and macrophages, which possess 
TLRs, allows antigen presentation to T cells and, in conjunction with IL-12, initiates Th1 
cell differentiation and subsequent IFN" production [123].  Thus the recognition of microbial 
compounds through TLRs is a vital mechanism in the efficient induction of immune 
responses.  However, it is not only innate cells that express these pattern recognition 
receptors, but B cells, too, express TLRs, and thus can respond to pathogen molecules 
directly. 
 
- Stimulation of B cell TLRs 
Murine B cells are known to express TLRs 1-9 at the mRNA level [124], although 
expression levels are thought to vary between subsets.  When stimulated through these TLRs 
in vitro, B cells are induced to proliferate and differentiate into antibody-secreting plasma 
cells in a T cell-independent manner.  Notably, plasma cell differentiation is most 
pronounced in marginal zone and B1 subsets of B cells, while TLR stimulation only 
marginally promotes plasma cell differentiation in follicular B cells [125].  IgM is the most 
dominant antibody isotype secreted by B cells in response to TLR stimulation, although both 
IgG and IgA can also be detected [125].  Likewise, in vivo responses to T-dependent 
antigens also require TLR signalling in B cells for optimal antibody production [126,127].  
Specifically, these studies found that B cell MyD88 signalling is required for IgM and 
IgG2a/c responses.  In addition to antibody production, TLR stimulation of B cells also 
induces upregulation of cell-surface MHC class II and co-stimulatory molecules [124], 
enhancing antigen-presenting capacity, and secretion of cytokines such as IL-6, IL-10 and 
IFN" [124], allowing the regulation of helper and regulatory T cell responses [128].  
Therefore, the rapid innate response of B cells to pathogens via TLR stimulation has a direct 
impact, not only on the developing adaptive B cell response, but also on the magnitude and 
phenotype of the helper T cell response. 
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Although TLR-induced activation of B cells is important for early plasma cell differentiation 
and for enhancing their antigen presenting capacity, this mechanism has been implicated in 
autoimmunity, as a means of breaking B cell tolerance by bypassing the requirement for T 
cells.  For example, TLR9 stimulation by CpG DNA has been implicated in Systemic Lupus 
Erythematosus (SLE) and Rheumatoid Arthritis (RA), diseases which are characterised by 
DNA-specific autoantibodies [129].  Class switched IgG2a and IgG2b autoantibodies in SLE 
are dependent on B cell signalling through TLR9 and MyD88 [130].  This TLR is therefore a 
potential therapeutic target to reduce disease severity.  Contradictory data, however, suggests 
B cell TLR9 stimulation as a means of IL-10 production, which functions in regulating 
autoimmunity [131,132].  Thus, individual TLRs have the potential to drive activation or 
regulation, and the involvement of TLR stimulation of B cells in the induction or 
exacerbation of autoimmune disease is a topic of interest, and a potential therapeutic target. 
 
- B cells as antigen-presenting cells 
Although TLR stimulation of B cells can induce plasma cell differentiation and cytokine 
production in a T cell-independent process, an interaction with T helper cells is required for 
several aspects of B cell function, namely GC formation, somatic hypermutation, class 
switching, and memory generation.  The initiation of this cognate interaction between B and 
T cells requires antigen presentation by B cells via MHC class II, the binding of antigen-
specific T cells, and the formation of an immunological synapse between the two cells. 
 
B cells recognise cognate antigen through their BCR, and subsequently internalise this 
antigen by BCR-mediated endocytosis.  This process is particularly efficient when antigen 
concentrations are low [133], as the BCR binds specific antigen with high affinity and can 
therefore concentrate very low levels of antigen for efficient presentation [134].  Particles are 
then broken down internally, and peptides presented via MHC class II.  The expression of 
HLA-DO, which modulates the function of HLA-DM, means that antigen internalised 
through the BCR is favoured for presentation via MHC class II molecules [135].  
Furthermore, cross-linking of the BCR as a result of antigen binding stimulates the up-
regulation of surface CD86, a key co-stimulatory molecule [136].  The presentation of 
antigen by B cells, together with the expression of co-stimulatory molecules, allows a direct 
interaction between B cells and T cells.  Both cell types benefit from the resulting dialogue, 
with B cells receiving T cell ‘help’, and T cells receiving co-stimulatory and cytokine signals 
Chapter 1:  Introduction 
! #&!
required for effector cell differentiation.  Therefore, not only do T cells influence the 
developing B cell response, but B cells also impact on the T cell response. 
 
- B cell influence on T helper cell differentiation 
The role of B cells as APCs in influencing T helper cell responses was considered minimal, 
when compared to that by dendritic cells.  While dendritic cells are efficient ‘professional’ 
APCs, B cells were thought to make only a minor contribution to T cell activation.  
However, the antigen-presenting capacity of B cells has been studied both in vitro and in 
vivo to determine the extent of their contribution to T helper cell responses. 
 
Initially, in vitro experiments showed that different B cell subsets might have varying 
capacities to present antigen.  Specifically, marginal zone, rather than follicular, B cells were 
found to be the main antigen presenters [21].  Whether or not this is true in vivo is difficult to 
determine.  If marginal zone B cells are better APCs in vivo, this may reflect their 
positioning in the marginal zone, where they have ready access to systemic antigen [2].  
Such in vitro studies expanded to in vivo models, with the generation of B cell-deficient mice 
by means of depletion antibodies.  Long-term B cell depletion was achieved by treatment 
with anti-µ-chain antibodies from the birth of the mice.  Data from these mice suggested B 
cells were an important APC in the lymph nodes [137,138].  Alternatively, some authors 
used lymphocyte transfers into immuno-deficient mice to determine the role of B cells as 
APCs.  Data from this system suggested a role for B cells as APCs in the activation of 
memory rather than naïve T cells [139]. 
 
However, both these model systems have their drawbacks.  Specifically, analysing cell 
function in vitro may not reflect their true in vivo function due to the simplicity of the 
culture, while the treatment of mice with depletion antibodies from birth results in 
unnaturally high levels of circulating antibody of a particular specificity as well as large 
amounts of cell death, which may impact on other immune cells.  Thus, it was only with the 
advent of B cell-deficient mice by genetic mutation that the function of B cells in driving T 
helper cell responses in vivo could be more fully dissected.  B cell-deficient µMT mice were 
generated by disrupting one of the membrane exons of the µ-chain constant region [140].  
Thereafter, another B cell-deficient strain, the JHD mice, were developed by deletion of the 
JH segments in the heavy chain [141].  Using these systems, B cells have since been shown 
to play an important role in the induction of T cell responses, although the exact part they 
play in T cell priming remains controversial.  While some data reports impaired T cell 
Chapter 1:  Introduction 
! #'!
priming and proliferation following immunisation [142,143,144], others state that B cells are 
dispensable for the primary response [145,146].  Constant et al reveal a role for B cells in the 
priming of T cells to protein, not peptide, antigen in vivo [147,148].  Further data suggests 
that antigen presentation by B cells results in a bias towards the induction of Th2 responses 
[149,150].  The latest report indicates a role for B cells in the development of early Th1 and 
Th17 responses, a process that is dependent on TLR-induced cytokine secretion by B cells 
rather than direct antigen presentation [151]. 
 
The studies investigating T cell memory responses in B cell-deficient mice are more 
conclusive.  T cell memory generation appears to be significantly impaired in the absence of 
B cells, a phenomenon shown in both viral [152,153] and bacterial [154,155] infection 
systems, as well as following protein antigen immunisation [156,157].  Chan and colleagues 
developed a mouse in which B cells are present but cannot secrete antibody, and therefore 
contain no circulating immunoglobulin [158].  These mice allowed the distinction between 
antibody production and antigen presentation by B cells, and their relative roles in T cell 
memory development.  The authors found T cell memory to be normal in these mice, 
suggesting that B cell antigen presentation is essential for T cell memory generation, whilst 
antibody production is dispensable [158].  CD4+ T cell memory is also severely impaired in 
bone marrow chimeras in which the B cell compartment is deficient in MHC class II [142], 
again indicating that B cell antigen presentation via MHC class II is required for the 
generation of T cell memory.  Furthermore, B cells might be required for the maintenance of 
the T helper cell memory population once it is generated, a mechanism that is independent of 
B cell antigen presentation (see above) [116]. 
 
- T cell-independent antibody production 
The B cell population as a whole has the ability to respond to pathogen stimulation in either 
a T cell-dependent or -independent manner, and subsequently differentiate into antibody-
secreting plasma cells.  In part, the dependence on T cells is determined by the subset of the 
B cell, and the nature of the stimulus.  Looking at B cell subset production of antibody, B1 
cells in the peritoneal cavity and splenic marginal zone B cells are primed for the rapid 
production of IgM in a T cell-independent manner, in response to innate signals such as 
through TLRs.  The prompt differentiation of marginal zone B cells into plasma cells in a T 
cell-independent manner usually occurs in the red pulp regions of the spleen, and is termed 
an extrafollicular plasma cell response, although such extrafollicular plasma cell responses 
can also occur in a T cell-dependent manner [159].  The signal strength of antigen 
Chapter 1:  Introduction 
! #(!
recognition is thought to regulate the choice between extrafollicular and GC responses [160].  
The resulting IgM generated in a T cell-independent process is of low affinity, as the cells 
have not undergone somatic hypermutation.  The plasma cells that develop in the absence of 
T cell help are short-lived [161], and do not form long-lived plasma cells that re-locate to the 
bone marrow.  This early IgM response likely impacts directly on both pathogen clearance 
and the developing adaptive immune response. 
 
- T cell-dependent GC formation and plasma/memory cell differentiation 
In addition to this early production of low affinity IgM by marginal zone and B1 cells, the 
secretion of high affinity class-switched antibody, mainly by follicular B cells, is a vital 
component of the adaptive arm of the immune response.  The differentiation of high affinity 
class-switched plasma cells, together with memory cells, is as a result of the GC reaction, 
and is essential for long-lived immunity to pathogens.  Such plasma cell and memory 
development are dependent on signals received from T helper cells [55,162]. 
 
Activated follicular B cells require a cognate interaction with CD4+ T cells, usually near the 
B-T cell boundary, to drive the GC reaction.  For this interaction to occur, antigen-activated 
B and T cells must regulate their chemokine receptor expression and alter their localisation.  
Activated T cells upregulate CXCR5 expression, and thus migrate towards the follicle [75], 
while B cells stimulated via the BCR upregulate CCR7 and migrate towards the T cell zone 
[163].  Some B cells that receive the necessary signals from the B-T cell interaction form a 
GC.  Both the development and maintenance of GCs is dependent on B cell expression of 
Bcl-6 [164], a transcription factor that TFH cells also depend on.  During the rapid B cell 
proliferation within the GC, the BCR undergoes affinity maturation, as a result of mutations 
in the variable regions of the immunoglobulin genes [55].  Rapidly dividing centroblasts in 
the dark zone undergo somatic hypermutation and class switch recombination, which is 
dependent on the enzyme activation-induced cytidine deaminase (AID), before re-expressing 
the BCR on the surface, as centrocytes in the light zone [55,165].  Thereafter, B cells are 
selected for by follicular dendritic cells in the light zone region, which possess antigen in the 
form of immune complexes on their surface.  This mechanism maintains B cell tolerance to 
self-antigens.  Any cells that do not receive survival signals, in the form of antigenic 
stimulation through the BCR coupled with co-stimulatory signals from TFH cells, die by 
apoptosis in this region [55,166].  The transcription factor Blimp-1 then regulates B cell 
differentiation into plasma cells, which is accompanied by the downregulation of Bcl-6, 
although the exact signals that determine differentiation into plasma cells or memory cells is 
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unknown [93,166].  Thus the transcription factors Bcl-6 and Blimp-1 appear to regulate B 
cell differentiation into effector and memory cells [72].  The plasma cells generated 
following the GC reaction may be short-lived, and be dispatched to the inflammatory site, or 
long-lived cells that migrate to the bone marrow [167].  Whether such long-lived plasma 
cells have an inherently long lifespan, and/or whether they require replenishment from the 
memory B cell pool, remains unknown. 
 
As outlined above, TFH cells are vital in the efficient generation of B cell responses.  This 
was demonstrated by the observation that, in mice that lack Bcl-6 expression in T cells (and 
thus lack TFH cells), GCs and antibody production were significantly impaired [41].  Recent 
papers have shown specific TFH cell surface molecules to bind B cells and initiate their 
selection and survival post-GC.  For example, PD-1, expressed by TFH cells, binds its ligands 
PD-L1 and PD-L2, which are expressed at high levels on GC B cells, and initiates plasma 
cell differentiation.  In the absence of PD-1 or its ligands, there is a significant reduction in 
long-lived plasma cell numbers [57].  Furthermore, ICOS and CD40L on TFH cells bind 
ICOSL and CD40, respectively, on B cells to positively regulate their survival following B 
cell proliferation in the GC [11]. 
 
TFH cell-derived IL-21 also acts directly on B cells, playing a role in driving the GC reaction, 
for the induction of proliferation, affinity maturation and plasma cell differentiation 
[60,168].  Specifically, although B cell development and maturation occur independently of 
IL-21 signalling, IL-21 acts as a co-stimulator in conjunction with BCR stimulation to 
increase B cell proliferation [169].  Furthermore, IL-21 has important roles in class switch 
recombination, plasma cell differentiation and antibody production, functions illustrated by 
the severe defect in IgG production in IL-21R-/- mice, in both naïve and immunised animals 
[170].  While GCs developed in these IL-21R-/- mice, memory B cell generation was 
enhanced, whereas long-lived plasma cell numbers were significantly reduced [168].  
Similarly, in the absence of IL-21 production by T cells, GCs do not persist, and memory 
generation is accelerated, although such memory cells are of poor quality as they have not 
undergone efficient affinity maturation [60].  This study also implies that B cell memory 
generation is independent of TFH cell-derived IL-21, while plasma cell development shows a 
dependence on IL-21.  Thus, IL-21 signalling in B cells appears to be one of the mechanisms 
involved in determining the cell fate decision between memory and effector cell generation.  
Together, these data emphasize the requirement of TFH cells for optimal B cell responses. 
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Lymphocyte migration and CD62L 
Some immune cells continually migrate throughout the body, circulating between lymphoid 
organs, non-lymphoid tissues, and sites of inflammation [2].  In the case of lymphocytes, 
they migrate between such sites via the bloodstream and/or lymphatics, pausing a while in 
secondary lymphoid organs before moving on.  This circulation of lymphocytes is important 
for immune surveillance, while the pausing of cells in the spleen and lymph nodes allows for 
cellular interactions, necessary for priming.  While lymphocyte access to the spleen is 
uninhibited due to the direct flow of blood into this organ, the main route of lymphocyte 
entry into the lymph nodes from the bloodstream is across specialised structures called high 
endothelial venules (HEVs).  One of the key molecules necessary for the transmigration 
process is CD62L (L-selectin). 
 
CD62L is an adhesion molecule belonging to the C-type lectin family, and is composed of a 
calcium-dependent lectin domain, an epidermal growth factor-like domain, and 2-9 short 
consensus repeat units [171].  A schematic showing the structure of CD62L is shown in 
figure 1.6A.  Calmodulin constitutively binds the cytoplasmic tail of CD62L, maintaining its 
expression at the cell surface [172].  CD62L binds carbohydrate ligands such as those 
induced on inflamed endothelium and those constitutively expressed at HEVs [171].  More 
specifically, CD62L ligands include sulphated carbohydrates of glycosylation-dependent cell 
adhesion molecule-1 (GlyCAM-1) at lymph node HEVs [173], mucosal addressin cell 
adhesion molecule-1 (MAdCAM-1) at Peyer’s patch HEVs, and CD34 at HEVs and 
inflamed endothelium [174].  Binding of lymphocyte CD62L to its ligand(s) on endothelium 
occurs early in the lymphocyte-endothelium interaction, and initiates tethering and rolling of 
cells [175,176].  Thereafter, firm adhesion occurs, which is mediated by lymphocyte 
integrins, such as LFA-1, binding to ICAM-1 on the endothelial layer, allowing the 
subsequent transmigration from the bloodstream into tissues or lymph nodes. 
 
CD62L is essential for lymphocyte entry into the lymph nodes across the HEVs, as blocking 
antibodies against CD62L have been shown to inhibit lymphcyte binding to HEVs both in 
vitro and in vivo [177].  Meanwhile CD62L-/- mice display a 70-90% reduction in lymph 
node size and cellularity, with the remaining lymphocytes thought to enter via the lymphatics 
[178].  Interestingly, these CD62L-/- mice display increased lymphocyte numbers in the 
spleen, indicating that CD62L is not required for entry into this lymphoid organ.  
Unsurprisingly, CD62L-/- mice have delayed or impaired immune responses, likely due to the 
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inability of lymphocytes to enter the lymph nodes, for efficient activation, and the inhibition 
of leukocyte entry into sites of inflammation to carry out their effector function [179,180]. 
 
- CD62L expression and shedding 
Naïve lymphocytes, including B cells, are CD62L+ and express varying levels of this 
molecule depending on the organ from which they are isolated.  Upon stimulation with 
cognate antigen or by phorbol esters such as PMA, CD62L undergoes an activation-induced 
conformational change, and is shed from the cell surface [181].  A diagram representing the 
shedding process is shown in figure 1.6B.  Upon cell stimulation, serine residues on the 
cytoplasmic tail of CD62L are phosphorylated by members of the protein kinase C (PKC) 
family [182].  This phosphorylation results in the dissociation of Calmodulin, which in turn 
allows a conformational change in CD62L [183].  This altered structure reveals the cleavage 
site in the extracellular domain, allowing binding by the protease, and shedding from the cell 
surface.  The enzyme responsible for shedding of surface CD62L is a zinc-containing 
membrane-associated metalloprotease, a disintegrin and metalloproteinase (ADAM) 17 (also 
known as TACE, TNF! converting enzyme), which is also responsible for the cleavage of 
TNF! [184].  This enzyme is thought to have relaxed sequence specificity, recognising 
instead the shape of the target molecule, while the distance of the cleavage site from the 
membrane appears particularly important [171]. 
 
Cleavage of CD62L from the cell surface by lymphocytes occurs rapidly, with 90% of 
lymph node cells shedding CD62L in response to PMA within 1 hour [185].  While shedding 
of CD62L is a short-term mechanism of expression regulation, full activation of 
lymphocytes also results in control of CD62L expression at the gene transcription level.  In 
addition to shedding induced by cognate antigen and PMA, lymphocytes are thought to shed 
CD62L following cross-linking by binding of CD62L to its ligands.  This would therefore 
imply that, following binding to HEVs, CD62L is shed during extravasation.  However, 
there are conflicting reports as to whether or not this is the case [181,186,187]. 
 
CD62L cleavage occurs immediately extracellular to the transmembrane region [187] (see 
figure 1.6B), leaving behind a 6kDa transmembrane fragment while the extracellular domain 
is released and can be readily detected in the bloodstream [188].  The released segment 
remains functionally active, binding HEVs and activated endothelium and acting as a 
‘buffer’ to moderate cell binding, and thus regulating leukocyte entry into inflamed sites 
[188].  It should be noted that, in addition to activation-induced shedding, CD62L also 
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undergoes cleavage during constitutive turnover, which is thought to be mediated by another, 
as yet unidentified, protease [189]. 
 
CD62L expression levels can be used as a method of determining lymphocyte subsets.  For 
example, as mentioned above, activated lymphocytes stimulated via the BCR or TCR are 
CD62L-.  Additionally, in the B cell population, immature transitional (T1) B cells, which 
migrate from the bone marrow to the spleen to complete the maturation process, are CD62L- 
[190].  This ensures they do not enter the lymph nodes or sites of inflammation, and is 
therefore a mechanism to prevent these cells from encountering antigen, which would result 
in their deletion, and therefore restrict the B cell repertoire [191,192].  CD62L has also been 
used as a means of identifying central and effector memory T cells, as was discussed above 
[82].  Generally speaking, T cells are consistently found to express greater levels of CD62L 
than B cells, which may explain why T cells preferentially migrate to the lymph nodes while 
B cells are found in greater numbers in the spleen [193]. 
 
- Role of CD62L in immune responses 
CD62L expression is important in the development of immune responses, as CD62L-
deficient mice have reduced leukocyte migration to inflamed sites and impaired delayed-type 
hypersensitivity responses [194], due to the inability of leukocytes to exit the blood and 
traffic to infected regions.   Primary T cell proliferation and cytokine production is also 
impaired in CD62L-/- mice [195], probably due to the lack of functional lymph nodes, which 
are involved in T cell priming.  Furthermore, the metalloprotease-mediated shedding of 
CD62L following lymphocyte activation is crucial, as mice expressing a mutant form of this 
molecule, that cannot be cleaved from the surface of T cells, exhibited impaired responses to 
viral infection and delayed viral clearance [181,196].  These data highlight that, not only is 
expression of CD62L necessary for efficient immune responses, but also its regulation by 
shedding is a vital process.  However, all of the work to date on CD62L has focussed on T 
cell populations, and little is known about B cell regulation of CD62L expression in altering 







Chapter 1:  Introduction 
! $#!
Systems utilised for investigating lymphocyte responses in vivo 
Clearly, when studying immune cells such as B cells to further investigate their roles in 
immune responses, it is essential to use in vivo systems as much as possible.  In this PhD, I 
investigate the innate and cognate functions of B cells, and their role in the induction of T 
cell differentiation and memory generation.  Therefore, I made use of in vivo models to study 
these topics.  Specifically, for studying the early innate responses of B cells, I used a murine 
infection model of Salmonella.  Furthermore, I wanted to follow CD4+ T cell responses in 
vivo, in order to determine the impact of B cells.  As mentioned above, analysing T helper 
cell differentiation pathways using mouse models is notoriously difficult in comparison to 
CD8+ T cells, due to the small numbers of antigen-specific cells generated.  Here, I made use 
of two systems for the detection of antigen-specific T helper cells ex vivo.  These two 
systems, the Salmonella infection model and the use of MHC class II tetramers, are 
introduced below. 
 
- Salmonella typhimurium infection model 
In order to study TLR-dependent B cell responses and follow antigen-specific effector and 
memory T cells in vivo, the murine infection model of typhoid fever, Salmonella enterica 
serovar Typhimurium (S. typhimurium), is used.  This intracellular Gram-negative bacterium 
enters the human host via the oral route, as a result of the intake of contaminated food or 
water.  In the gut, a proportion of bacteria survives the low pH of the stomach and enters the 
small intestine.  There, they use a type III secretion system to invade the epithelial cells and 
M-cells of the Peyer’s patches [197].  Bacterial-induction of macrophage apoptosis allows 
the evasion of destruction in the Peyer’s patches [197].  Thereafter, the bacteria are thought 
to gain entry, first, into the mesenteric lymph nodes, and subsequently enter the bloodstream, 
spleen and liver [198].  Once in these sites, the bacteria reside and multiply within 
macrophages.  The human disease, typhoid fever, continues to have a significant global 
burden on human health.  The potential for vaccine development as a means to prevent 
infection, instigated the development of the murine model of this infection. 
 
A non-virulent strain of S. typhimurium was generated, called aromatic-dependent (aroA-) or 
SL3261, which requires aromatic derivatives not present in mammalian tissues [199].  Use 
of this strain as a live attenuated vaccine in mice was shown to confer protection from future 
infection by a virulent strain [199].  It is this particular strain of S. typhimurium, SL3261, 
that I use to investigate B cell responses and T cell differentiation in this PhD.  Although the 
natural route of infection is via oral uptake, I use intravenous administration, here.  However, 
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as this bacterium naturally becomes rapidly systemic, I do not foresee the route of entry to be 
disadvantageous.  The immune response generated in response to the aroA- strain has been 
well characterised in the mouse model.  Systemic infection results in the development of 
strong Th1 and antibody responses [200,201].  Early in infection, the macrophage response 
is required to control the initial phase of bacterial growth [202], while specific Th1-
associated cytokines (IFN", TNF!, IL-12) are also crucial [203,204,205].  The peak of 
bacterial numbers in the spleen and liver is around day 7 of infection, and thereafter bacteria 
are reduced to very low levels by 4-6 weeks post-infection.  However, a few viable bacteria 
remain as far out as 12 weeks post-infection, suggesting chronic low-level infection of S. 
typhimurium is a possibility [206]. 
 
The necessity of TLR signalling for the generation of immune responses to Salmonella is 
well characterised using in vivo infection models.  C3HeJ mice, for example, which lack 
TLR4 expression and so cannot respond to LPS, are highly susceptible to Salmonella 
infection [207].  TLR4 is thought to be important early in infection for cytokine production 
and killing of bacteria during the exponential growth phase, whereas TLR2 (which 
recognises bacterial glycolipids and lipopeptides) plays a role later [208,209].  The lack of 
the MyD88 adaptor protein during the primary immune response to an attenuated strain of S. 
typhimurium results in significantly increased bacterial load during the initial few weeks of 
infection, but these mice are able to subsequently clear infection, albeit with delayed kinetics 
[151,210].  These mice that have an impairment in MyD88 signalling show reduced IL-12 
production and therefore diminished Th1 responses to infection [211].  Some data also 
suggests that MyD88-/- mice may, in fact, mount a skewed Th2 response [210].  This 
skewing towards a Th2 environment may be an outcome of the reduced Th1 response, and 
ultimately reflect the lack of dendritic cell-derived IL-12.  Together, the data from MyD88-/- 
mice emphasize the requirement for TLR signalling in both the early innate response by 
macrophages, and on the development of the adaptive response, in this infection model. 
 
- The involvement of B cells in S. typhimurium infection 
The specific role of B cells in the S. typhimurium infection model has also been studied 
[154,155,212].  B cells appear dispensable for the primary immune response to attenuated 
strains of Salmonella, with bacterial load at the peak of infection, and the primary T cell 
cytokine response, equivalent in B cell-deficient and wild type mice [155].  However, 
protective immunity is absolutely dependent on the presence of B cells, with B cell-deficient 
mice showing hugely impaired IL-2 and IFN" production by T cells after bacterial clearance, 
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and increased mortality during challenge [154], suggesting an absence of T cell memory 
[154,155,212].  Transfer of immune serum did not restore protection in B cell-deficient 
animals, suggesting one important role of B cells in this model is the presentation of antigen 
to T cells for the generation of memory, a function not influenced by the presence of 
antibody [154].  To transfer protection from immunised to naïve mice, both immune serum 
and T cells are required [213], indicating that protective immunity may be dependent on 
memory formation in both the B and T cell compartments. 
 
Recent work from our laboratory has addressed the specific role of B cell TLR stimulation in 
Salmonella infection [126].  Using mixed bone marrow chimeras, in which the B cell 
compartment alone is deficient in MyD88 (MyD88B-/-), reveals that primary T cell IFN! 
production during S. typhimurium infection is reduced, suggesting B cells play an important 
role as APCs in driving the early Th1 response [126].  Thus the early role of B cells in 
influencing T cell priming appears dependent on TLR stimulation of B cells.  Looking at 
antibody production, IgG2a/c is reduced in MyD88B-/- chimeric mice during S. typhimurium 
infection [126] and this correlates with the impairment of T cell production of IFN!.  The 
authors imply that the reduction in the early Th1 response is causing impaired help for B 
cells, and therefore, lower class-switched antibody responses [126].  Here, I want to expand 
on this data, and further investigate the early TLR-induced responses of B cells in this S. 
typhimurium infection model.  I also use this infection model for studying the generation of 
CD4+ T cell memory, and the involvement of B cells in this process. 
 
- The use of MHC class II tetramers 
Another method of following in vivo-generated endogenous antigen-specific CD4+ T cell 
responses over time is the use of MHC class II tetramers.  MHC class II tetramers are 
composed of the MHC class II ! and # chains with the peptide of interest covalently bound.  
This complex is labelled with biotin, and four of these molecules are then bound by 
Streptavidin PE.  For a diagram of MHC class II tetramer structure, see chapter 6 (figure 
6.1A, page 177).  The peptide used in all experiments shown here is the H19env peptide, 
which is the immuno-dominant peptide from the envelope protein of the Moloney murine 
leukaemia virus.  The tetramers containing this peptide, originally developed by 
Schumacher’s laboratory [214], have been used in conjunction with MHC class I tetramers 
to follow CD4+ and CD8+ T cell responses, respectively, in mice infected with the Moloney 
murine leukaemia virus [214].  The kinetics of antigen-specific CD4+ T cell expansion and 
decline following immunisation of mice with the H19env peptide have also been established 
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using these MHC class II tetramers [215].  Immunisation of peptide in Complete Freud’s 
Adjuvant (CFA) s.c. leads to a peak in primary T cell numbers on ~day 9.  Thereafter, 
antigen-specific T cell numbers decline, and a stable of pool of memory cells is generated.  
Importantly, these memory cells were detectable >150 days post-immunisation, indicating 
that this is a suitable system for investigating T cell memory populations. 
 
By using MHC class II tetramers, T helper cells can be directly visualised ex vivo by flow 
cytometry, allowing antigen-specific cells to be phenotyped, for example by expression of 
cell surface markers.  However, detecting cytokine production to determine their cell subset 
phenotype is more difficult, and is only possible in the Salmonella model.  Therefore, by 
using both the S. typhimurium infection model and the peptide immunisation system, it is 
hoped that the role of B cells in T cell memory generation can be fully investigated. 
 
- The use of anti-CD20-mediated B cell depletion 
Since the generation of B cell-deficient mice by means of gene disruption, the role of B cells 
in the generation of immune responses has been examined in various models and systems.  
However, the use of such B cell-deficient mice is not without its problems.  Firstly, B cell-
deficient µMT mice appear to have abnormal T helper cell compartment, in that CD4+ T 
cells isolated from B cell-deficient mice are strongly inhibitory towards B cells [216], and T 
cells primed in the absence of B cells are unable to provide B cell help [217].  Secondly, 
spleen and lymph node architecture are likely disrupted in B cell-deficient mice, as the 
normal development of these organs is dependent on B cells.  For example, follicular 
dendritic cells provide the network in the follicles and GCs, and are dependent on B cells for 
their differentiation [218].  Components of the marginal zone, too, are dependent on B cells 
for their generation and maintenance [15].  Thus, lymphoid tissue structure will no doubt be 
severely disrupted when developed in the absence of B cells, and so any impairment in 
immune responses in B cell-deficient mice may be attributed to defects in other cell 
compartments rather than the lack of B cells.  To overcome some of these identified issues, 
here, I make use of a B cell depletion system in order to investigate the role of B cells in the 
induction of T helper cell responses. 
 
The depletion of B cells in vivo using an antibody that targets the B cell-specific surface 
protein, CD20, has been approved for use in humans in the form of the drug Rituximab 
[219].  CD20 expression is restricted to B cells, with expression initiated around the time of 
immunoglobulin rearrangement in the pre-B cell population in the bone marrow, and 
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maintained throughout maturation to naïve B cell status.  Memory B cells, too, express this 
molecule, but expression is lost upon differentiation into plasmablasts and plasma cells 
[220].  CD20 functions as a calcium channel, and is thought to regulate cell cycle 
progression by altering calcium (Ca2+) flux [221].  The fact that CD20 is expressed only by 
B cells, is not shed from the cell surface, and is not internalised upon antibody binding 
makes it a perfect target for depletion antibodies [219].  Monoclonal depletion antibodies 
against CD20 have been developed for use in humans and mice, with several clones and 
design variations available.  Interestingly, there is no cross-reactivity between the human and 
mouse forms [222], so in this PhD the anti-human form of CD20 is used as a control in all 
experiments, and mice treated with this isotype control antibody reflect the non-depleted 
group.  Following injection of either mice or humans with anti-CD20 depletion antibodies 
intravenously, B cells are depleted by various mechanisms, including antibody-dependent 
cellular cytotoxicity, complement activation, and induction of apoptosis [222,223,224].  The 
phagocytic network appears vital in the depletion process [225,226]. 
 
- Anti-CD20 (Rituximab) clinical trials in humans 
A chimeric IgG1 antibody, consisting of mouse anti-human CD20 variable regions fused to 
human immunoglobulin constant regions, is available for use in humans, in the form of the 
drug Rituximab.  This drug was first approved for the treatment of B cell lymphoma, such as 
B cell non-Hodgkin lymphoma, in 1997, as >90% of B cell lymphoma were found to express 
CD20 [219].  Following approval for use in humans, McLaughlin et al conducted an 
influential phase III clinical trial in B cell lymphoma patients, using a 4-dose treatment 
programme [227].  The overall response rate, as defined by >50% reduction in disease for at 
least 28 days, was 50% of the 166 patients.  Of these, 6% were complete responders, who 
remained disease-free for >28 days following treatment.  By 13 months after treatment, 53 of 
the 76 responders had not yet relapsed.  Of the 50% of patients classed as non-responders, 
the majority (56 of 75) had a reduction in disease.  Notably, there were no reports of serious 
infections following treatment, however, there was no untreated control group for 
comparison.  Furthermore, some adverse side effects were reported following the first 
treatment, and there was one case of an immune response against the chimeric antibody 
[227].  This initial study therefore showed anti-CD20 B cell depletion therapy to be a 
promising treatment of lymphoma.  Since then, further clinical trials have taken place using 
Rituximab as treatment for autoimmune diseases (reviewed in [228,229,230]), including 
SLE [231,232], RA [233], and Multiple Sclerosis [234], among others.  The results from 
these trials are highly variable, and most lacked sufficient patient numbers to make results 
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significantly valid.  Interestingly, some success has been reported in SLE and RA where 
disease symptoms improved but autoantibody levels were not affected [229], suggesting that 
B cells may be having a pathogenic effect that is independent of antibody production, such 
as contributing to the anti-self T cell response via antigen presentation. 
 
Most clinical trials have focussed on the efficacy of Rituximab treatment, and there is little 
research on the global effects of depleting B cells on the host immune system or on 
mounting immune responses.  As B cells are an important cell type in both innate and 
adaptive immune responses, and are essential for the generation and/or maintenance of 
several other cell types, one might expect the depletion of these cells to have knock-on 
effects on the immune system as a whole.  One depletion study in humans reports T cell 
numbers and ex vivo proliferation responses to be normal [235], while another revealed no 
differences in absolute numbers of CD3+, CD4+, or CD8+ cells [227].  It is perhaps not 
surprising that no differences were seen in whole T cell populations, but T cell subsets such 
as memory cells and TFH cells, which are thought to require signals from B cells for their 
generation and/or maintenance, were not specifically analysed. 
 
It seems likely that the depletion of B cells will result in an immuno-compromised host.  
Indeed, a case study of 4 Rituximab-treated peritransplantation patients, out of a group of 62, 
revealed unusual serious viral infections, whereas there were no cases of viral infections in 
the non-Rituximab treated control group [236].  These 4 patients with viral infections all had 
impaired T cell responses, as measured by T cell number recovery.  Another study, 
comparing humoral responses to recall antigens before and after Rituximab treatment, 
reported significantly lower responses post-treatment [237].  The authors conclude that this 
loss of existing humoral immunity following treatment was because of reduced numbers of 
plasma cells, as a result of the inability of such cells to be replenished from the memory B 
cell pool due to their depletion.  Furthermore, antibody responses to neo-antigens were, 
rather unsurprisingly, significantly decreased in Rituximab-treated patients, suggesting that 
vaccines given during the period of depletion will be ineffective [238]. 
 
Together, these studies in humans provide only very minimal information on the global 
effects of B cell depletion on the immune system.  Further data is required on the effects of 
B cell depletion on other cell types, such as CD4+ T cell subsets.  A recent review 
summarising the data in this field reports B cell depletion to result in a reduction in T cell 
activation, due to abolishment of antigen presentation by B cells, and a possible increase in 
Chapter 1:  Introduction 
! $)!
numbers and function of Treg cells, although the mechanism for this remains unclear [239].  
Dissecting the knock-on effects of B cell depletion on other immune cells in humans is a 
difficult task, and studies in mice may provide further insight. 
 
- Anti-CD20-mediated B cell depletion in mice 
Although anti-CD20 has been extensively tested in humans, relatively few studies have been 
conducted in mice.  The studies that haven been performed in mice have done so in one of 
two systems.  Firstly, a transgenic mouse strain in which the B cell population expresses the 
human form of CD20 has been generated [240,241].  In these ‘humanised’ mice, B cell 
depletion is achieved using a form the human drug (clone 2h7) mirroring the clinical trial 
treatment strategy, and therefore closely resembles depletion in humans.  Secondly, an anti-
mouse CD20 IgG2a monoclonal antibody (clone 18B12), developed by immunising CD20-/- 
mice with CD20-transfected cell lines, is available for B cell depletion in mice [240].  The 
ability to deplete B cells in mice has provided insight into the likely kinetics of B cell 
depletion and repopulation, the study of which is impossible in humans. 
 
Studies using B cell depletion systems in mice have investigated the efficacy of B cell 
depletion in regular and autoimmune-prone mice [240,242], measuring variables such as B 
cell numbers in different lymphoid tissues.  In the mouse model of SLE, B cell depletion 
resulted in the amelioration of disease, and reduced levels of autoantibodies [240].  
However, the authors observed greater resistance to B cell depletion in autoimmune prone 
strains of mice compared to wild type mice [240].  This would suggest that, in humans, B 
cell depletion might be less efficient in patients with established autoimmune disease.  In 
another study using the mouse model of spontaneous autoimmune thyroiditis, depletion of B 
cells either before or after disease onset improved symptoms [242].  Again, the authors 
reported some resistance to depletion in certain subsets of B cells in these autoimmune mice, 
with anti-CD20 treatment depleting only 50-80% of splenic B cells [242].  It would be 
interesting to determine the mechanism(s) of resistance of these cells, as this too may be 
relevant to depletion in humans.  A further study, in the mouse model EAE, revealed B cell 
depletion to reduce the numbers of antigen-specific Th1 and Th17 cells in the central 
nervous system, pointing to a role of B cells in the priming of these T helper cells in this 
model of Multiple Sclerosis [243].  However, a conflicting study showed B cell depletion in 
EAE to exacerbate disease, due to the role of so-called regulatory B cells [244]. 
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Further studies in mice have determined the mechanism of action of anti-CD20 depletion, 
that is to say how are B cells depleted [225,241,245].  These reports indicate B cell depletion 
to occur by several mechanisms, including complement activation, Fc receptor-mediated 
phagocytosis and induction of apoptosis.  However, as far as I am aware, no studies have 
investigated the impact of B cell depletion on other cell types within the immune system in 
non-autoimmune animals.  Thus, the potential impact of anti-CD20-mediated B cell 
depletion on the immune system as a whole requires in-depth analysis, and may have 
significant implications on the ability of the host to fight infection and maintain protective 
immunity. 
 
Therefore, the clone of anti-mouse-CD20 for use in wild type mice (clone 18B12) is used 
here to further investigate the effects of depleting B cells on the T helper cell populations, 
specifically TFH cells and memory cells.  This method has several advantages over the use of 
B cell-deficient mice, such that it allows the control of the presence or absence of B cells 
during specific times of the immune response.  Thus, I use this anti-CD20-mediated B cell 
depletion system to identify the timing of the involvement of B cells in T helper cell 
responses in the in vivo models outlined above, namely Salmonella infection and peptide 
immunisation. 
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Aims of this PhD 
 
Generally speaking, the aim of this PhD is to further investigate the roles of B cells in both 
the innate and adaptive arms of the immune response.  Specifically, the first chapters focus 
on the so-called innate responses of B cells, following TLR stimulation.  I look at the 
changes to migration and the differentiation into plasma cells, and highlight the importance 
of these early B cell responses during infection.  Thereafter, I more fully investigate the role 
of B cells as APCs in the generation of T helper cell responses; using both the S. 
typhimurium infection model and a peptide immunisation system.  I ask questions as to the 
timing of the involvement of B cells, and discuss the possible model of memory generation 
and the specific function that B cells may be providing. 
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C57BL/6, MyD88-/- [246], TRIF-/- [247], TLR2-/- [248], TLR9-/- [249], Ly5.1+, CD4-
dnTGF#RII [43], µMT [140], and CD1d-/- [250] mice were bred and maintained at the 
School of Biological Sciences Animal Facility, University of Edinburgh, UK.  Bone marrow 
from CD62L(E) mice [181] was a kind gift from Professor Thomas F. Tedder (Duke 
University, NC, USA).  Details of the mouse strains and housing conditions can be found in 
table 2.1.  In all experiments, mice aged 6-10 weeks were used, and all genetically modified 
mice were backcrossed 6-10 generations to C57BL/6.  For experiments using CD4-
dnTGF"RII mice, only heterozygous mice were used.  Experiments were covered by a 
Project Licence granted by the UK Home Office under the Animals (Scientific Procedures) 
Act of 1986.  Locally, the University of Edinburgh Ethical Review Committee approved this 
licence. 
 
Generation of CD62L(E) bone marrow chimeras 
Mixed bone marrow chimeras were generated as previously described [75].  Briefly, B cell-
deficient µMT recipient mice were sub-lethally irradiated with 8Gy of gamma irradiation 
from a sealed source.  The following day, they were reconstituted with 2x106 CD90-depleted 
mixed inoculum bone marrow cells.  These inocula consisted of 50% µMT bone marrow and 
50% either wild type or CD62L(E) bone marrow.  Therefore, in the CD62L(E) chimeras, all 
B cells arose from the CD62L(E) cells, while all other hematopoietic cells arose from both 
the CD62L(E) and µMT cells.  Chimeras were left for 8-10 weeks to reconstitute before use 
in experiments. 
 
Anti-CD20 B cell depletion 
To deplete B cells, C57BL/6 mice were treated with a single dose of 250µg of anti-mouse 
CD20 [240] (clone 18B12, IgG2a isotype, Dr Marilyn Kehry, Biogen IDEC Inc., San Diego, 
CA) diluted in PBS.  As a control, some mice were treated with anti-human CD20 (clone 
2B8, Dr Marilyn Kehry, Biogen IDEC Inc.), which has no cross-reactivity with mouse 
CD20, so these mice are non-depleted controls.  The timing of anti-CD20 treatment is shown 
in each individual experiment. 
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Immunisations 
CpG DNA:  For CpG DNA immunisations, mice were immunised intravenously with 20µg 
of CpG DNA (InVivogen, Autogen Bioclear UK Ltd., Wiltshire, UK) diluted in PBS, or 
mock immunised with PBS alone.  Mice were bled pre-immunisation and at various times 
after immunisation, with blood samples prepared, as described below, for lymphocyte 
extraction. 
 
H19env peptide:  For studies using MHC class II tetramers, mice were immunised with the 
immuno-dominant peptide from the envelope protein of the Moloney murine leukaemia 
virus (H19env peptide), N-EPLTSLTPRCNTAWNRLKL-COOH (Cambridge Research 
Biochemicals, Billingham, Cleveland, UK).  Usually, for the primary immunisation, the 
peptide was emulsified in Complete Freud’s Adjuvant (CFA, Sigma, UK) using a sonicator.  
Subsequently, 200µg of peptide antigen was administered subcutaneously into the hind legs 
in a total volume of 200µL (100µL each back leg).  For boosting, 2x106 peptide-pulsed 
dendritic cells were prepared as detailed below, and injected intravenously in a volume of 
200µL.  In some experiments, for the boost immunisation 200µg of peptide was administered 
together with 10µg LPS (from E. coli, Sigma, UK) intraperitoneally and subcutaneously 
(100µl i.p. and 50µl in each back leg s.c.). 
 
DNP-KLH:  For immunisation with DNP-KLH/Alum, keyhole limpet hemocyanin (KLH) 
was coupled to dinitrophenyl (DNP, Sigma) as previously described [251].  200µg of DNP-
KLH precipitated in Alum was administered intraperitoneally for the primary injection in a 
total volume of 200µL, and both intraperitoneally and subcutaneously for the boost 
immunisation (100µl i.p. and 50µl in each back leg). 
 
In vivo B cell labelling 
For the in vivo labelling of B cells, mice were injected intravenously with 1µg anti-CD19 PE 
and/or 1µg anti-CD21 FITC (both from BD Biosciences, San Jose, CA) in a total volume of 
200µL as previously described [252].  Tissues were removed 20 minutes post-injection, and 
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Bone marrow-derived dendritic cell generation, activation and peptide pulsing 
Bone marrow-derived dendritic cells (BMDC) were generated by a modified version of the 
procedure developed by Inaba et al [253].  Briefly, femurs and tibia were extracted from 
mice and flushed with medium.  Bone marrow was broken down by passage through a 21-
gauge needle (BD Biosciences).  2x106 cells were cultured in 10mL medium, further 
supplemented with 20ng/mL granulocyte macrophage colony-stimulating factor (GM-CSF, 
Peprotech EC Ltd., London, UK).  Plates were incubated at 37°C in humidified 5% CO2 
atmosphere.  On day 3, 10mL of fresh medium containing GM-CSF was added to the plates.  
On days 6 and 8, 10mL medium was removed from the plates, and 10mL fresh medium 
containing GM-CSF was added.  On day 10, dendritic cells were harvested, and cultured at 
2x106 cells/mL with 0.1µg/mL LPS (InVivogen, Autogen Bioclear Ltd.) overnight (~16 
hours).  The following day, cells were harvested, washed, and cultured at 2x106 cells/mL 
with H19env peptide at 50µg/mL for 90 minutes.  BMDC were further washed with medium 
to remove peptide before transfer.  As mentioned above, 2x106 cells were injected i.v. in a 
total volume of 200µL. 
 
Salmonella enterica serovar Typhimurium infection 
The aroA- attenuated strain of S. typhimurium (SL3261) was used for all infections [199].  
Bacteria were grown as stationary-phase overnight (16 hour) cultures in Luria-Bertani (LB) 
broth (Difco Laboratories, Surrey, UK).  Animals were injected intravenously with ~1x106 
viable bacteria, diluted in PBS.  Infectious dose was determined by plating bacteria onto LB 
agar plates and culturing overnight at 37ºC, then counting the number of colony-forming 
units (CFU).  This was then multiplied up to determine the number of viable bacteria given 
per mouse.  Similarly, splenic bacterial load during infection was determined by taking part 
of the spleen of known weight, making a cell suspension in PBS, and plating it out onto LB 
agar plates.  The total number of bacteria, per spleen, was calculated by multiplying the 
number of CFU by dilution factor, dividing by the weight of the spleen section cultured, and 
finally multiplying by total spleen weight. 
 
Media 
For the generation of BMDC, Roswell Park Memorial Institute (RPMI) medium was used.  
This was supplemented with 10% foetal calf serum (FCS, Sigma), Penicillin/Streptomycin at 
100µg/mL and L-Glutamine at 2mM (Gibco, UK).  Medium was further supplemented with 
GM-CSF at 20ng/mL. 
 
Chapter 2:  Materials and Methods 
! &+!
For lymphocyte extraction and B cell cultures, Iscove’s modified Dulbecco’s media (IMDM) 
was used, supplemented with 5% FCS and Penicillin/Streptomycin as detailed above 
(complete IMDM).  For T cell cultures, complete IMDM was additionally supplemented 
with 50µM 2-Mercapto-ethanol (BDH Laboratory Supplies, Poole, UK). 
 
For tetramer staining, IMDM was supplemented with Penicillin/Streptomycin, as detailed 
above, and 10% FCS. 
 
Cell isolation 
Single cell suspensions were prepared from spleen, lymph nodes, and Peyer’s patches by 
manual disruption in complete IMDM.  Peritoneal washes were performed, by injecting 
medium into the intact peritoneal cavity, to isolate peritoneal cells.  Bones were flushed with 
medium as described above, to isolate bone marrow, and then broken down using a 21-gauge 
needle.  Where appropriate, samples were depleted of erythrocytes using red blood cell lysis 
buffer (Sigma). 
 
B/T cell purification 
Cells within single cell suspensions were labelled with anti-CD19 or anti-CD4 microbeads 
(Miltenyi Biotech, Bisley, UK) using 10µL beads plus 90µL medium per 107 cells.  After 
incubating for 30 minutes on ice, cells were washed and sorted over a single LS column, for 
the case of CD4+ T cells, or two consecutive LS columns, for the case of CD19+ B cells, 
according to the manufacturer’s instructions (Miltenyi Biotech).  B cell purity was in excess 
of 98% (data not shown). 
 
Lymphocyte isolation from the blood 
For lymphocyte extraction, blood samples were collected in heparin (LEO Laboratories Ltd., 
Bucks, UK).  PBS was added to dilute samples before loading onto lympholyte (Cedarlane 
Labs Ltd, Hornby, Canada) at an approximate ratio of 1:1.  Samples were spun at 1000xg for 
20 minutes at room temperature.  The lymphocyte layer was isolated, and washed 
extensively with PBS before staining or transfer, to remove all traces of lympholyte. 
 
In vitro TLR stimulation cultures 
For in vitro TLR stimulation cultures, splenocytes or purified B cells were cultured at 4x106 
cells/mL in complete IMDM in 6 or 24 well plates.  Endotoxin-free TLR ligands 
(InVivogen) were utilised at the following concentrations: the TLR2 ligands zymosan, 
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peptidoglycan and PAM3 CSK4 were used at 10, 10 and 0.2 µg/mL, respectively; the TLR3 
ligand polyI:C was utilised at 25 µg/mL; LPS (TLR4) from E. coli was used at 1 µg/mL; 
flagellin (TLR5) from S. typhimurium was used at 0.1 µg/mL; the TLR7 ligand loxoribine 
was used at 100 µM; the TLR9 ligand unmethylated CpG DNA (ODN 1826 5’-TCC ATG 
ACG TTC CTG ACG TT-3’) was used at 5 µg/mL.  PMA and ionomycin (Sigma) were used 
at 10 ng/mL and 1 µg/mL, respectively.  Schistosomal egg antigen (SEA) and heat-killed 
Propionibacterium acnes were kind gifts from Dr Andrew McDonald (University of 
Edinburgh, UK), and were used at various concentrations as described in the figures.  Where 
appropriate, the metalloprotease inhibitor Ro 31-9790 (Roche Research Products, Welwyn 
Garden City, UK) was used at 50 µg/mL.  Most TLR stimulation cultures were for 4 hours, 
or as otherwise stated in the figures.  For the recovery of CD62L expression, cells were 
harvested after 4 hours, washed, and plated out again at 4x106 cells/mL in fresh medium. 
 
Preparation of S. typhimurium antigens and in vitro cultures 
Bacterial antigens from Salmonella enterica serovar Typhimurium were prepared as 
previously described [254].  Briefly, overnight stationary phase cultures of the SL3261 
attenuated strain were heat-inactivated at 85ºC for 10 minutes.  Around 2.5x106 CFU 
bacteria that had undergone heat-inactivation were used for in vitro cultures with B cells to 
look at CD62L expression.  For B cell restimulation cultures, 10-fold dilutions of heat-killed 
bacteria starting at 1/5 were performed in triplicate and cultured together with sorted B cells 
at 2x106 cells/mL for 5 days.  Supernatants were collected and analysed for cytokines by 
ELISA as detailed below.   For B cell culture with live bacteria to analyse CD62L 
expression, around 2.5x106 CFU bacteria were used.  To prepare the crude sonicate, 
overnight-cultured bacteria (SL3261 strain) were sonicated, and debris removed by 
centrifugation.  To make the C5 antigen, overnight culture of the C5 virulent strain of S. 
typhimurium was EDTA-treated, sonicated, and centrifuged to remove cellular debris.  The 
supernatant was then alkali-treated with NaOH at 37°C for 3 hours, and subsequently 
neutralised with HCl.  Both the crude sonicate and C5 antigen were used at 20 µg/mL when 
analysing B cell CD62L expression. 
 
For T cell restimulation cultures, purified T cells at 1x106 cells/mL were cultured together 
with gamma-irradiated (30Gy) splenocytes (also at 1x106 cells/mL) to act as antigen 
presenting cells, and the C5 antigen added at 20, 10, 5, and 1 µg/mL.  Supernatants were 
collected at day 1 of culture for IL-2 detection, and day 3 of culture for IL-10, IL-17 and 
IFN" detection.  For T cell cultures, medium containing 2-Mercaptoethanol was utilised. 
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In vivo proliferation assay using BrdU 
In the Salmonella infection model:  Mice were injected with 2 mg bromodeoxyuridine 
(BrdU) intraperitoneally on days 2, 4 and 8 of S. typhimurium infection.  The following day 
(days 3, 5, and 9), spleens were removed and single cell suspensions prepared.   
 
In the peptide immunisation tetramer system:  Mice were injected with 2 mg BrdU i.p. for 3 
consecutive days before harvest.  Spleens were removed 6 weeks after immunisation, at the 
memory time-point, and on day 5 post-boost. 
 
BrdU staining:  Proliferation, as determined by BrdU incorporation, was measured using a 
FITC-BrdU Flow Kit (BD Biosciences) as described in the manufacturer’s instructions.   
Briefly, cells were surface stained with anti-CD19 PE and anti-CD4 APC, washed, then 
resuspended in fixation / permeabilization buffer overnight.  The following day, cells were 
washed and DNase treated for 1 hour at 37ºC, then stained with anti-BrdU FITC for 30 
minutes at room temperature in the dark.  Each sample had an isotype control counter-part.  
Cells were further washed before analysis. 
 
Cell transfers 
For cultured TLR-stimulated cell transfers: Purified B cells from Ly5.1+ donor mice were 
cultured with CpG DNA for 4 hours, as described above, or left unstimulated.  After 
harvesting, cells were washed extensively in PBS, and 5x106 cells injected intravenously into 
recipient C57BL/6 mice.  The CD62Llo phenotype of CpG-stimulated cells was confirmed 
by flow cytometry. 
 
For CD62Lhi cell transfer:  CD62Lhi lymphocytes were isolated from the blood as follows.  
Blood was collected into heparin from donor Ly5.2+ mice by cardiac puncture.  
Lymphocytes were extracted on lympholyte, as described above.  5x106 unsorted 
lymphocytes were injected intravenously into recipient Ly5.1+ uninfected or day 6 
Salmonella-infected mice.  Prior to transfer, the CD62Lhi phenotype of donor cells was 
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Flow cytometry 
Before staining, cells were washed in FACS buffer (PBS with 0.05% Sodium azide and 3% 
FCS).  The following antibodies were used for flow cytometry (all BD Biosciences unless 
otherwise stated): anti-CD19 PE, anti-CD4 APC, anti-B220 PerCP, anti-CD21 FITC (clone 
7G6), anti-CD21 PE-Cy7 (clone 7E9), anti-CD23 PE, anti-CD5 biotin (ebioscience, San 
Diego, CA), anti-Ly5.1 biotin, anti-CD62L FITC (Abcam, Cambridge, UK), rat IgG2a FITC 
isotype control (Abcam), anti-CD80 biotin, anti-CD86 biotin, anti-MHC class II FITC (clone 
M5114, in-house), anti-GL7 FITC, anti-IgD biotin (clone 1126C, in-house), anti-CD40 FITC 
(in-house), anti-CD20 PE, anti-CD138 APC, anti-CD44 FITC (in-house), anti-CD44 APC, 
anti-CD25 APC, anti-Ly6C FITC, anti-CD28 biotin, anti-CD40L FITC (clone MR1, in-
house), anti-KLRG1 PE-Cy7 (ebioscience), anti-IL-7R! FITC (ebioscience), Streptavidin-
PerCP, Streptavidin-APC.  For more details of the antibodies used for flow cytometry, see 
table 2.2.  Cells were stained for 20 minutes on ice and then washed 3 times in FACS buffer.  
Where appropriate, cells were further stained with Streptavidin for 20 minutes on ice, and 
washed again.  Samples were analysed on a FACSCalibur or LSR II flow cytometer (BD 
Biosciences) using CellQuest or FACS-Diva software, respectively, and data analysed using 
FlowJo software (Tree Star Inc, San Carlos, CA). 
 
MHC class II tetramer staining 
Two-three million cells isolated from the spleen, draining lymph nodes or bone marrow were 
added to 96 well round bottom plates.  In some cases, these had been sorted over a single 
column for CD4+ T cells, as described above, to enrich this population.  Cells were washed 
in IMDM containing 10% FCS.  PE-labelled MHC class II tetramers, containing the H19env 
peptide or tetramers containing an irrelevant peptide as a negative control (both from the 
NIH Tetramer Core Facility, Atlanta, GA), were diluted 1/100.  25µL of diluted tetramer or 
isotype control was added to each well, and incubated at 37°C for 3 % - 4 hours, agitating 
regularly to prevent cell clumping.  The following antibodies were then added without 
washing, and incubated at room temperature for 10-15 minutes:  anti-CD19 PerCP (BD 
Bioscience), anti-CD4 APC e-fluor 780 (ebioscience), and anti-F4-80 APC or PE-Cy7 (both 
ebioscience), together with T cell activation marker antibodies listed above and in table 2.2.  
Cells were then washed 3 times in FACS buffer, and resuspended in 100µL for acquisition.  
Before acquisition, 100µL of Propidium Iodide (PI, Sigma), diluted 1 in 200 in FACS buffer, 
was added to each sample.  Samples were analysed on a LSR II flow cytometer (BD 
Biosciences) using BD FACS-Diva software, and data analysed using FlowJo software (Tree 
Star Inc.). 
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T follicular helper cell staining 
Five million splenocytes were taken, washed twice in PBS, and stained with Live/Dead 
fixable aqua fluorescent stain (Invitrogen, Carlsbad, CA, diluted 1 in 500 dilution in cold 
PBS, 20µL per sample) for 20 minutes on ice.  After washing in FACS buffer, cells were 
stained with the following antibodies, in the presence of Fc receptor blocking antibody 
(clone 2.4G2, in-house):  anti-CXCR5 biotin (BD Bioscience), anti-ICOS PE (ebioscience), 
anti-PD-1 PE-Cy7 (Biolegend, San Diego, CA), anti-CD4 APC e-fluor 780 (ebioscience), 
and anti-CD44 FITC (in-house).  See table 2.2 for more details of the antibodies used for T 
follicular helper cell staining.  Cells were stained for 1 hour on ice, and then washed in 
FACS buffer.  Cells were then stained with Streptavidin-APC (BD Biosciences) for a further 
30 minutes, on ice.  After washing, cells were either resuspended in FACS buffer for 
acquisition or fixation / permeabilization buffer for intracellular transcription factor staining 
(see below). 
 
Intracellular cytokine, transcription factor, and Ki67 staining 
For intracellular cytokine staining, splenocytes were stimulated with PMA/ionomycin 
(Sigma) at 10ng/mL and 1µg/mL, respectively, for 4 hours, in the presence of Golgi Stop 
(BD Biosciences).  For transcription factor and Ki67 staining, cells were taken directly ex 
vivo.  In all cases, cells were washed and surface stained, as described above, with anti-CD4 
PerCP (BD Biosciences) and either anti-CD44 PE (BD Biosciences) or anti-CD44 FITC 
(Abcam).  Cells were then washed and fixed in fixation / permeabilization solution 
(ebioscience) overnight.  The following day, intracellular staining was performed in 
permeabilization buffer (ebioscience, diluted 1 in 10 in distilled water) for 30 minutes, on 
ice, using the following antibodies (all ebioscience, unless otherwise stated), together with 
Fc receptor blocking antibody (clone 2.4G2, in-house): anti-IFN" FITC (Biolegend, San 
Diego, CA), anti-IL-17 PE, anti-FoxP3 APC, anti-Tbet PerCP-Cy5.5, anti-Ror"t-PE, anti-
Ki67 PE (BD Bioscience), rat IgG PE isotype control, rat IgG FITC isotype control 
(Biolegend), rat IgG APC isotype control, rat IgG PerCP-Cy5.5 isotype control.  For further 
details of the antibodies used, see table 2.2.  After intracellular staining, cells were washed in 
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Cytokine ELISA 
Culture supernatants were assayed to determine the concentrations of IL-2, IL-6, IL-10, IL-
17A, and IFN".  The standard capture ELISA technique was performed, using commercially 
available paired antibody sets.  Briefly, Nunc Maxisorp plates (Fisher Scientific, 
Loughborough, UK) were coated overnight at 4°C with the relevant capture antibody at 
5µg/mL in PBS.  After washing, plates were blocked for 2 hours at room temperature with 
1% bovine serum albumin (BSA, Sigma) in PBS.  Plates were washed and supernatants, 
together with standards, added and incubated for a further 2 hours.  Where appropriate, 
supernatants and standards were diluted in BSA.  Following washing, the relevant 
biotinylated detection antibodies were added for 1 hour.  Streptavidin-alkaline phosphatase 
(Sigma) was then added and incubated for 45 minutes.  Finally, the substrate p-Nitrophenyl 
phosphate (PNPP, Southern Biotechnology Associates, Birmingham, AL) in Diethanolamine 
substrate buffer (1 tablet per 5mL) was added and the colour allowed to develop.  The plates 
were read at 405nm using Labsystems Multiskan plus, and data analysed using GraphPad 
Prism software.  The unknown cytokine concentrations were determined by extrapolation 
from the standard curve.  The limits of detection are as follows:  IL-2 = 0.3ng/mL, IL-6 = 
0.3ng/mL, IL-10 = 0.1ng/mL, IL-17A = 0.1ng/mL, IFN" = 0.8ng/mL.  All antibodies were 
from BD Biosciences.  Throughout this thesis, IL-17 refers specifically to IL-17A. 
 
Antibody ELISA 
Serum was separated from whole blood after centrifugation at 10,000 g in a micro-centrifuge 
for 5 minutes, and stored at -20°C until quantification by ELISA.  To quantify the levels of 
antigen-specific antibody in the serum, Nunc Maxisorp plates (Fisher Scientific) were coated 
with the relevant antigen at 10µg/mL (for S. typhimurium SL3261 crude sonicate and DNP) 
or 20µg/mL (for H19env peptide) and incubated at 4°C overnight.  Plates were then blocked 
with 1% BSA for 2 hours at room temperature before being washed.  Serum was then added, 
serial two-fold dilutions performed across the plate, and incubated for a further 2 hours at 
room temperature.  Dilutions were performed in BSA.  After washing, alkaline phosphate-
labelled detection antibodies, specific for the different antibody isotypes (Southern 
Biotechnology Associates), were added and the plates incubated for another 1 hour at room 
temperature.  Following a final wash, plates were developed and read as described above for 
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Immunohistology 
Spleens were placed in cryomoulds (BDH Laboratory Supplies, Poole, UK) in OCT-
embedding medium (BDH Laboratory Supplies) and stored at -80°C until required.  Tissue 
sections of 5µm in thickness were cut, dried and fixed in acetone, before being stored at -
20°C until use.  Sections were blocked in 1% BSA for 20 minutes, and then stained with the 
following antibodies (all BD Bioscience unless otherwise stated):  anti-IgM Texas Red 
(Southern Biotechnology Associates), anti-Ly5.1 FITC (Abcam), purified anti-IgD, anti-
MOMA-1 biotin (Abcam), anti-F4-80 FITC, anti-MHC class II biotin (clone M5114, in-
house), anti-CD11b PE, Streptavidin Alexa fluor 350 (Invitrogen), Streptavidin-FITC 
(Southern Biotechnology Associates), anti-rat IgG Alexa fluor 350.  Between staining with 
primary and secondary antibodies, and after secondary antibody staining, slides were washed 
3 times for 5 minutes each by immersion in PBS.  After staining, cover slips were mounted 
using Mowiol (Hoechst, Frankfurt, Germany).  Slides were viewed on an Olympus BX50 
microscope under reflected light fluorescence, and images captured using OpenLab software 
(Improvision, Walthman, MA).  A summary of the antibodies used for histology can be 
found in table 2.3. 
 
Statistics 
Student’s t-test and two-way ANOVA tests were used to calculate significance values where 
appropriate.  Such statistical analysis was performed using Prism GraphPad (GraphPad 
Software Inc., San Diego, CA). 
 
Data from repeat peptide immunisation experiments was pooled, where indicated, using 
MINITAB software (Minitab Inc., Pittsburgh, PA), and analysed using a general linear 
model ANOVA, and Tukey’s multiple comparison test, adjusting the means with 
‘experiment’ as a factor (table 6.6 only).   
 
Throughout, p-values are given in the figures, and illustrated as follows:  p=0.01 to 0.05 *, 
p= 0.001 to 0.01 **, p<0.001 ***, NS = not significant (p>0.05). 
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Mouse strain Housing Screening Reference 
C57BL/6 Normal cages on water None N/A 
MyD88-/- Filter cages on water PCR for Neomycin [246] 
TRIF-/- Filter cages on water PCR for Neomycin [247] 
TLR2-/- Filter cages on water PCR for Neomycin [248] 
TLR9-/- Filter cages on water PCR for Neomycin [249] 
Ly5.1+ Normal cages on water Stain for Ly5.1 N/A 
µMT Filter cages on water Stain for CD19 [140] 
CD4-dnTGF#RII Filter cages on water 
PCR for dominant negative 
TGF#RII and CD4 promoter [43] 
CD1d-/- Filter cages on water 
PCR for Neomycin,  
stain for CD21 by CD23 [250] 
CD62L(E) chimeras Filter cages on Borgal Stain for CD19 & CD62L [75,181] 
 
 
Table 2.1:  Mouse strains utilised.  The table contains details of the mouse strains used in 
this PhD, together with the housing conditions, screening procedures, and relevant 
reference(s).  N/A = not applicable. 
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Staining protocol Antibody Source Dilution 
Anti-CD21 FITC (clone 7G6) BD Bioscience 1 in 100 
Anti-CD21 Pe-Cy7 (clone 7E9) BD Bioscience 1 in 200 
Anti-CD23 PE BD Bioscience 1 in 200 
B cell subsets 
Anti-CD5 biotin ebioscience 1 in 200 
Anti-CD62L FITC Abcam 1 in 100 
Anti-CD80 biotin BD Bioscience 1 in 200 
Anti-CD86 biotin BD Bioscience 1 in 200 
Anti-MHC class II FITC In-house (clone M5114) 1 in 100 
Anti-GL7 FITC BD Bioscience 1 in 100 
Anti-IgD biotin In-house (clone 1126C) 1 in 100 
Anti-CD40 FITC In-house 1 in 100 
Anti-CD20 PE BD Bioscience 1 in 200 
B cell activation 
CD138 APC BD Bioscience 1 in 200 
Anti-CD62L FITC Abcam 1 in 100 
Anti-CD44 FITC / APC In-house/BD Bioscience 1 in 100/200 
Anti-CD25 APC BD Bioscience 1 in 200 
Anti-Ly6C FITC BD Bioscience 1 in 100 
Anti-CD28 biotin BD Bioscience 1 in 200 
Anti-CD40L FITC In-house (clone MR1) 1 in 100 
Anti-KLRG1 PE-Cy7 ebioscience 1 in 200 
T cell activation 
Anti-IL-7Ra FITC ebioscience 1 in 100 
Tetramer-PE NIH 1 in 100 
Control tetramer-PE NIH 1 in 100 
Anti-CD4 APC e-fluor 750 ebioscience 1 in 200 
Anti-CD19 PerCP BD Bioscience 1 in 200 
Tetramer staining 
Anti-F4-80 APC / PE-Cy7 ebioscience 1 in 200 
Anti-CXCR5 biotin BD Bioscience 1 in 200 
Anti-ICOS PE ebioscience 1 in 200 
Anti-PD-1 PE-Cy7 Biolegend 1 in 200 
Anti-CD44 FITC In-house 1 in 100 
T follicular helper 
cell staining 
Live/Dead stain AmCyan Invitrogen 1 in 500 
Anti-IFNg FITC Biolegend 1 in 100 
Anti-IL-17 PE ebioscience 1 in 100 
Anti-FoxP3 APC ebioscience 1 in 100 
Anti-Tbet PerCP Cy5.5 ebioscience 1 in 100 
Anti-Ror"t PE ebioscience 1 in 100 
Anti-Ki67 PE BD Bioscience 1 in 50 
Anti-BrdU FITC BD Bioscience 1 in 100 
Rat IgG FITC isotype control Biolegend 1 in 100 
Rat IgG PE isotype control ebioscience 1 in 100/50 
Rat IgG APC isotype control BD Bioscience 1 in 100 
Intracellular  
staining 
Rat IgG PerCP Cy5.5 isotype control ebioscience 1 in 100 
 
 
Table 2.2:  Summary of antibodies used for flow cytometry.  The table contains details of 
the antibodies used in each of the flow cytometry staining protocols, including fluorochrome, 
source and dilution used.  Optimal dilution was calculated by titration. 




To visualise Antibody Source Dilution Secondary antibody 
Anti-IgM Texas Red Southern Biotech 1 in 100 N/A 
Anti-IgD purified BD Bioscience 1 in 100 Anti-rat Alexa 350 
Anti-CD19 PE BD Bioscience 1µg i.v. N/A 
Marginal zone 
Anti-CD21 FITC BD Bioscience 1µg i.v. N/A 
MZ metallophilic 
macrophages Anti-MOMA-1 biotin Abcam 1 in 50 Streptavidin FITC 
Anti-F4-80 FITC BD Bioscience 1 in 100 N/A Macrophages 
Anti-CD11b PE BD Bioscience 1 in 100 N/A 
Antigen- 
presenting cells 
Anti-MHC class II 
biotin 
In-house (clone 
M5114) 1 in 100 
Streptavidin Alexa 
350 
Transferred cells Anti-Ly5.1 FITC Abcam 1 in 50 N/A 
 
 
Table 2.3: Antibodies used for immunohistology.  Details of the antibodies used in 
immunohistology, including fluorochrome, source, dilution and secondary antibodies, are 
displayed in the table.  MZ = marginal zone, N/A = not applicable. 
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CHAPTER 3:  TLR-mediated loss of CD62L focuses B cell 





B cells as antigen presenters and antibody producers are a major component of the adaptive 
immune response, however, they also have the ability to respond to pathogens in an innate 
fashion.  They do this by recognising structurally conserved pathogen ligands through TLRs 
expressed at the cell surface and in the endosomal compartment.  Murine B cells express an 
array of these TLRs [124], although there is differential expression in certain subsets.  As 
mentioned in the introduction, stimulation through these receptors induces B cell 
proliferation and differentiation into antibody-secreting plasma cells [125,126,127].  
Additionally, stimulation of B cell TLRs results in enhanced antigen presenting capacity, by 
inducing upregulation of MHC class II and co-stimulatory molecules, and cytokine secretion 
[124].  Thus TLR-stimulated B cells show signs of activation and have the potential to 
programme early CD4+ T cell responses, as has been reported [151]. 
 
This study began with the observation that certain TLR ligands alter B cell expression of 
CD62L in vitro.  This adhesion molecule binds carbohydrate ligands expressed at HEVs and 
sites of inflammation, initiating lymphocyte tethering and rolling, and allowing subsequent 
migration of cells into tissues [175,176].  CD62L has been shown to be essential for the 
entry of lymphocytes into the lymph nodes across the HEVs, and therefore CD62L-/- cells are 
unable to enter the lymph nodes by this means [178].  CD62L is not required, however, for 
lymphocyte entry into the spleen [178].  As mentioned in the main introduction, immune 
responses are impaired in these CD62L-/- mice [179,180], highlighting the importance of this 
adhesion molecule. 
 
An interesting characteristic of CD62L is its ability to be rapidly shed from the cell surface 
by a metalloprotease, ADAM17 (also known as TACE) [184].  Surface expression of 
CD62L is therefore highly regulated, with cells controlling expression both at the cell 
surface by shedding, and internally by transcription regulation.  Naïve B and T cells (which 
are CD62L+) have previously been shown to shed CD62L rapidly, in response to cognate 
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antigen and PMA stimulation [185].  However, the effects of TLR ligands on B cell 
expression of CD62L have not previously been reported. 
 
To study TLR-dependent B cell responses in a more natural environment, the S. typhimurium 
infection model is used.  The roles of TLRs [207,208,210] and of B cells [154,155,212] in 
this model have been studied separately, however less attention has been paid to the specific 
effects of B cell TLR stimulation.  Data from our own laboratory, which does address this, 
made use of mixed bone marrow chimeras in which the B cell compartment lacked the 
MyD88 adaptor protein (MyD88B-/-).  Although the focus was on antibody production, 
primary T cell IFN" production was found to be impaired in the absence of B cell MyD88 
signalling [126], suggesting that B cell TLR stimulation is important in initiating antigen 
presentation by B cells, which in turn drives the early Th1 response in this model.  A more 
recent paper from our laboratory confirms the role of MyD88 signalling in B cells in driving 
the early Th1 response in this infection [151].  This dependence on B cells for optimal Th1 
cell priming was due mainly to cytokine production, and did not rely on direct antigen 
presentation by B cells [151]. 
 
In this chapter, I characterise the changes in CD62L expression that results from activation 
of B cells by a variety of TLR ligands.  As CD62L is necessary for the migration of 
lymphocytes from the bloodstream to the lymph nodes across the HEVs, I hypothesised that 
TLR-stimulated B cells would display altered migration patterns in vivo.  I go on to analyse 
B cell expression of CD62L during S. typhimurium infection, how this impacts upon their 
migration, and discuss the likely effects this will have on the developing T helper cell 
response. 




B cells isolated from the blood express higher levels of CD62L than those found 
in the spleen and lymph nodes 
B cells were isolated from the blood, spleen and lymph nodes of wild type mice and analysed for 
their expression of CD62L.  B cells in the blood were found to express the highest levels of 
CD62L, while B cells in the lymph nodes express intermediate levels, and those in the spleen 
express low levels (figures 3.1A & B).  The splenic population of B cells displays a bimodal 
pattern of CD62L expression (figure 3.1A, left).  The B cell subsets within the spleen were 
therefore identified, and CD62L expression levels between them compared.  Follicular B cells 
were found to express higher levels of CD62L than marginal zone B cells (which is consistent 
with previously published data [255]), while B2 cells express greater amounts of CD62L than B1 
cells (figure 3.1C).  Thus B cells from different organs, and different B cell subsets, express 
varying levels of CD62L. 
 
Loss of CD62L expression on B cells in response to some TLR ligands   
B cells are known to lose expression of CD62L following the ligation of their BCR [256].  I 
wished to know whether activation via innate receptors, such as TLRs, altered expression of this 
molecule.  To examine the effect of TLR stimulation of B cells on their expression of CD62L, 
purified B cells were cultured with a variety of TLR ligands in vitro.  I found that B cells lose 
expression of CD62L in response to specific TLR ligands, namely PAM3 CSK4 (a TLR2 
ligand), CpG DNA (TLR9 ligand), and partially lose CD62L in response to poly I:C (a TLR3 
ligand).  However, stimulation with zymosan, peptidoglycan (both TLR2 ligands), LPS, flagellin 
or loxoribine (ligands for TLRs 4, 5, and 7, respectively) did not induce loss of this molecule 
(figure 3.2A).  The partial loss in response to Poly I:C was found to be dose-dependent (figure 
3.2B), and therefore I would suggest that complete loss is likely to occur in response to a higher 
concentration of this stimulus. 
 
Using cells from MyD88-/-, TRIF-/-, TLR2-/-, and TLR9-/- mice, it was confirmed that the loss of 
CD62L on B cells in response to PAM3 CSK4 is MyD88- and TLR2-dependent, its loss in 
response to poly I:C is TRIF-dependent, and in response to CpG DNA is MyD88- and TLR9-
dependent (figure 3.2C).  All knockout B cells lost CD62L expression when stimulated with 
PMA/ionomycin (figure 3.2C) or by cross-linking their BCR (data not shown). 
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Loss of CD62L expression by B cells stimulated with CpG DNA is rapid and due 
to shedding from the cell surface 
An analysis of CD62L expression over time after CpG stimulation revealed that B cells lost 
surface expression of CD62L within 2 hours of culture (figure 3.3A).  This expression was not 
restored within the 12 hours analysed.  B cells lost CD62L expression within 4 hours, even in 
response to very low concentrations of CpG DNA (figure 3.3B).  To establish whether B cells 
lose CD62L expression in vivo in response to CpG DNA, mice were injected with 20 µg CpG 
DNA.  As can be seen in figure 3.3C, the percentage of B cells in the blood that express high 
levels of CD62L was significantly reduced at 2, 4, and 8 hours after injection.  B cell populations 
in the blood returned to normal by 24 hours post-injection.  Expression of CD62L on B cells, as 
determined by MFI, was significantly reduced at 2 hours post-immunisation (figure 3.3D). 
 
As splenic B cell subsets differed in their expression levels of CD62L (figure 3.1C), I wanted to 
investigate if all B cell subsets lose CD62L expression following CpG DNA stimulation.  The 
data presented in figure 3.3E reveal that both follicular and marginal zone B cells (the two main 
B cell populations in the spleen) lost expression of CD62L following CpG stimulation. 
 
It seems likely that the mechanism by which B cells rapidly down-regulate CD62L is by 
shedding from the surface, as characterised previously with respect to activation by PMA [181]. 
To demonstrate that this was the case, the metalloprotease inhibitor Ro 31-9790 was used, which 
has previously been shown to inhibit CD62L shedding [257].  Ro 31-9790 also inhibits shedding 
of TNF! [258] and is therefore thought to target ADAM17 (TACE). When this inhibitor was 
included in the B cell culture with CpG DNA, the loss of CD62L from the cell surface at the 4-
hour time-point was completely abolished (figure 3.3F).  This confirms that the loss of surface 
CD62L by B cells in response to CpG DNA was due to shedding by the surface metalloprotease 
ADAM17 (TACE), and not any other mechanism. 
 
CpG-stimulated B cells are excluded from lymph nodes and Peyer’s patches 
It is well known that CD62L is essential for leukocyte entry into the lymph nodes across the high 
endothelial venules [177].  I predicted, therefore, that CpG-stimulated B cells that have a 
CD62Llo phenotype would show altered migration patterns in vivo.  To investigate this, I 
transferred CpG-stimulated or unstimulated B cells, after 4 hours of culture (figure 3.4A), into 
congenic Ly5-distinct hosts, and looked the following day at their localisation.  The CpG-
stimulated CD62Llo donor cells were excluded from the lymph nodes and from Peyers’ patches, 
but trafficked normally to the spleen (figure 3.4C).  Although equivalent numbers of 
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unstimulated and CpG-stimulated B cells were found in the spleen, these B cells differed in their 
localisation within the white pulp.  Unstimulated B cells were dispersed throughout the white 
pulp, whereas CpG-stimulated B cells localised specifically to the B/T cell border (figure 3.4D).  
As CXCR5 expression is known to determine localisation within the white pulp, CXCR5 levels 
were analysed on these stimulated B cells (figure 3.4B).  However, no differences in CXCR5 
expression were identified, which suggests that a mechanism(s) other than CD62L shedding is 
involved in B cell localisation within the follicle.  These data conclude that TLR stimulation of B 
cells can impact on their migration patterns in vivo via changes in surface expression levels of 
CD62L. 
 
B cells recover surface expression of CD62L around 2-3 days after stimulation, 
and subsequently gain entry into lymph nodes and Peyer’s patches 
Having established the kinetics of CD62L shedding from the surface of B cells in response to 
TLR stimulation, I next analysed the recovery of expression both in vitro and in vivo.  Following 
culture with CpG DNA, B cells were washed extensively and either plated out again with fresh 
media in vitro, or adoptively transferred into Ly5-distinct recipient mice.  Figure 3.5A shows 
that B cells recovered CD62L expression after 3 days in culture, and in vivo the re-expression 
happened after 2 days (figure 3.5B, top).  The adoptive transfer showed that donor CpG-
activated B cells were present in the lymph nodes and Peyer’s patches by day 5 (figure 3.5B, 
middle & bottom), in numbers equivalent to unstimulated B cells.  The lag of 3 days between 
CD62L re-expression in the spleen on day 2, and B cell migration to lymph nodes and Peyer’s 
patches on day 5 is likely due to the normal homing patterns of B cells, in that they pause in 
secondary lymphoid tissues before re-entering the circulation. 
 
B cells stimulated with CpG DNA in the presence of the inhibitor later shed 
CD62L, and are excluded from lymph nodes and Peyer’s patches 
In order to prove without any doubt that it was the effect of CpG DNA on B cell expression of 
CD62L, and not any other effect of TLR stimulation, which was responsible for the exclusion of 
these cells from the lymph nodes, I stimulated B cells with CpG DNA in the presence of the 
inhibitor and transferred them in vivo.  The theory was that B cells stimulated with CpG DNA in 
the presence of the inhibitor would retain expression of CD62L, and retain the ability to migrate 
to the lymph nodes. 
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The data presented in figure 3.6A show that B cells stimulated with CpG DNA alone shed 
CD62L, while in the presence of the inhibitor remain CD62Lhi, as seen above.  After washing, 
cells were either left in vitro for a further 4 hours, or transferred in vivo for 4 hours.  In both 
cases, these cells subsequently shed CD62L (figure 3.6B and figures 3.6C & D, respectively).  In 
vivo, these cells were excluded from the lymph nodes and Peyer’s patches, in a similar manner to 
cells stimulated with CpG DNA alone (figure 3.6E).  Thus, this experimental design is not 
suitable for confirming that it is the shedding of CD62L, and not any other effect of CpG DNA 
on B cells, that is causing the altered migration patterns in vivo. 
 
B cells shed CD62L when stimulated with antigens from Salmonella 
Although interesting that B cells shed CD62L in response to purified TLR ligands, I wished to 
investigate if B cells shed CD62L when encountering TLR ligands in the form of pathogenic 
bacteria.  To do this, B cells were stimulated with antigens from the Gram-negative bacteria 
Salmonella enterica serovar Typhimurium (hereafter referred to as S. typhimurium).  The data 
presented in figure 3.7A reveal that B cells shed CD62L when stimulated with heat-killed 
bacteria, a crude sonicate of bacteria or a semi-purified C5 antigen.  However, no shedding 
occurred in response to live bacteria in vitro. 
 
To determine if a specific TLR and adaptor molecule is responsible for shedding induced by 
these bacterial antigens, knockout cells were used.  The data in figure 3.7B show that TLR2 and 
the adaptor molecule MyD88, rather than TLR9 or TRIF, are utilized to induce shedding in 
response to these bacterial antigen preparations. 
 
B cells also shed CD62L in response to the Gram-positive bacteria P. acnes but 
not when stimulated with Schistosomal egg antigen 
I wished to determine whether or not B cells shed CD62L in response to other antigens that 
potentially contain TLR ligands.  Therefore, B cells were stimulated with various concentrations 
of a heat-killed preparation of the Gram-positive bacteria, P. acnes (figure 3.8B), or with 
Schistosomal egg antigen (SEA, figure 3.8C), and compared these results to stimulation with S. 
typhimurium antigens (figure 3.8A).  B cells were found to shed CD62L in a dose-dependent 
manner when stimulated with heat-killed P. acnes.  Although shedding does not reach minimum 
levels as indicated by CpG DNA, this was presumably due to the use of sub-optimal 
concentrations.  However, no shedding was apparent in response to physiological concentrations 
of SEA (figure 3.8C). 
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Altered localisation of B cells during S. typhimurium infection 
The data shown so far would predict that TLR-induced changes in CD62L expression will result 
in altered migration of B cells during systemic infection with S. typhimurium.  To test this 
hypothesis, wild type mice were infected with S. typhimurium, and B cell localisation measured 
during infection.  The data presented in figures 3.9A & B show that S. typhimurium infection 
caused profound alterations in the localisation of B cells.  In the lymph nodes and Peyer’s 
patches there was a rapid decrease in both the percentages (figure 3.9A) and absolute numbers 
(figure 3.9B, lymph nodes only) of B cells during the first week of infection.  This was most 
apparent in the Peyer’s patches, where the proportion of B cells dropped from around 80% in 
uninfected mice, to 20% by day 8 of infection.  In the spleen, the percentage of B cells remains 
unchanged at day 4, and was reduced at day 8 (figure 3.9A), largely due to an influx of other 
cells (eg. macrophages).  However, looking at absolute numbers (figure 3.9B), there was actually 
a 2- to 3-fold increase in splenic B cell numbers at day 4 when compared to uninfected mice, and 
numbers remained elevated at day 8 of infection. 
 
The increase in B cell numbers in the spleen at this early stage of infection does not seem to be 
due to B cell proliferation, as BrdU incorporation by B cells was little above background, and 
minimal in comparison to T cell division (figure 3.9C and D).  Together these data support the 
notion that B cells shed CD62L in response to bacteria, and consequently are excluded from 
lymph nodes, so enter the spleen in greater numbers, as entry to the spleen is independent of 
CD62L [259]. 
 
TLR-deficient mice show a reduced accumulation of B cells in the spleen during 
S. typhimurium infection 
In order to determine if the accumulation of B cells in the spleen during S. typhimurium infection 
is dependent on TLR signalling through the MyD88 adaptor protein, B cell localisation was 
examined during the infection of MyD88-deficient mice.  The data presented in figure 3.10A 
reveal that there was a reduced loss of B cells from the Peyer’s patches at day 7 of infection.  
Meanwhile, there was also reduced accumulation of B cells in the spleen at day 7 when 
compared to wild type mice (figure 3.10B).  Together, these data suggest that the altered 
localisation of B cells during S. typhimurium infection is predominantly MyD88-dependent, and 
therefore mediated by TLR signalling. 
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CD62Lhi B cells shed and migrate to the spleen, not lymph nodes, when 
transferred into Salmonella-infected mice 
The data shown so far suggests that B cells shed CD62L during S. typhimurium infection in a 
TLR-dependent manner, and that this is the cause of the altered migration patterns.  To 
address this more directly, CD62Lhi B cells were isolated from the blood of Ly5.2+ donor 
mice, and transferred into either S. typhimurium-infected or uninfected Ly5.1+ recipient 
mice.  Ly5.2+ donor B cells were identified (see figure 3.11A for example staining) and 
CD62L expression analysed, after 18 hours.  The results displayed in figure 3.11B 
demonstrate that in uninfected mice, donor Ly5.2+ B cells migrated to both the lymph nodes 
and the spleen, whereas in infected mice the Ly5.2+ B cells were found in much greater 
numbers in the spleen, and significantly reduced numbers in the lymph nodes.  Donor cells 
identified in the spleens of uninfected mice had maintained their CD62Lhi phenotype, 
whereas in the spleens of infected mice, donor B cells had shed and were predominantly 
CD62Llo (figure 3.11C).  These data confirm that B cells shed CD62L early during S. 
typhimurium infection and that this is the cause of their enhanced entry into the spleen and 
relative exclusion from the lymph nodes and Peyer’s patches. 
 
When B cells are unable to shed CD62L, primary T cell responses are 
impaired during S. typhimurium infection 
In order to give insight into the effect of B cell shedding of CD62L on the developing 
immune response, cells from a strain of mice that express a mutant form of CD62L, which 
cannot be shed from the surface (CD62L(E) mice), were used.  These mice were generated 
by replacing the membrane-proximal region of the CD62L gene (containing the site of 
metalloproteinase binding) with that of E-selectin (CD62E), which is not cleaved from the 
cell surface, and thus does not contain a metalloproteinase binding site [181].  Therefore the 
extracellular CD62L domain in the CD62L(E) mice resembles normal CD62L in all ways, 
except that it cannot be cleaved from the cell surface.  Using bone marrow from these mice, I 
generated mixed bone marrow chimeras, in which the B cell compartment expresses the 
mutant CD62L(E), while other cells predominantly express normal CD62L (hereafter 
referred to as CD62L(E) chimeras).  Therefore, in these mice, B cells alone are unable to 
shed CD62L from their surface. 
 
It was firstly confirmed that B cells from these CD62L(E) chimeras did not shed CD62L 
when stimulated with CpG DNA in vitro (figure 3.12A).  The chimeric mice were then 
infected with S. typhimurium, and the very early immune response analysed on day 4.  The 
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bacterial load in the CD62L(E) chimeras was equivalent to the wild type chimeras at this 
time-point (figure 3.12B).  However, the T cell cytokine response, in terms of IL-10, IL-17 
and IFN", was impaired in the CD62L(E) chimeras (figure 3.12C), suggesting that early T 
cell activation is impaired when B cells are unable to shed CD62L.  Unfortunately, due to the 
lack of availability of these mice, I was unable to extend this study any further.  It would 
have been interesting to see if the T cell response recovered to normal levels, and if bacterial 
clearance was delayed in these mice. 
 
TLR2 and TLR9 are involved in early cytokine responses, as well as antibody 
responses, during S. typhimurium infection, but are not required for bacterial 
clearance 
In order to further characterise the general roles of TLR2 and TLR9 in Salmonella infection, 
the primary, memory and antibody responses were analysed in TLR2-/- and TLR9-/- 
Salmonella-infected mice. 
 
At the primary time-point, splenic bacterial load in both the TLR2-/- and TLR9-/- mice was 
equivalent to that of wild type mice (figure 3.13A).  Looking at T cell activation, in terms of 
expression of the activation markers CD62L, CD44 and CD25, there were no obvious signs 
of reduced activation in either the TLR2-/- or TLR9-/- animals (figure 3.13B).  However, T 
cell cytokine production, namely IL-10 and IFN", appeared reduced in the TLR2-/- mice 
(figure 3.13C).  T cell cytokine responses in TLR9-/- appeared normal (figure 3.13C).  
Looking at B cell activation in these mice, there were no significant differences between 
groups in the expression of the activation markers CD62L, CD80 and CD86 on day 7 of 
infection (figure 3.13D).  B cell IL-6 production appeared reduced in the TLR2-/- mice, while 
IFN" and IL-10 production appeared normal (figure 3.13E).  However, cytokine production 
by B cells from the TLR9-/- mice was, if anything, enhanced (figure 3.13E). 
 
Infected TLR2-/- and TLR9-/- mice were also analysed 8 weeks post-infection, when bacterial 
clearance and T cell memory were analysed.  As can be seen in figure 3.14A, bacteria had 
almost been cleared in both strains of knockout mice, as well as in wild type mice.  Bacterial 
loads were minimal in comparison to those on day 7 of infection (compare figure 3.14A to 
figure 3.13A), suggesting bacteria were being cleared.  Bacterial loads in the TLR9-/- mice 
appeared significantly higher than the wild type mice, however, as this is at the limit of 
detection for this assay, no strong conclusions can be made.  T cell cytokine production, in 
terms of IL-2, IL-10 and IFN" production, was equivalent in all 3 groups (figure 3.14B), 
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indicating that T cell memory generation was normal in the absence of TLR2 or TLR9.  T 
cell IL-17 production appeared higher in the wild type group than either of the knockout 
strains, but due to variability this was not a significant difference, and T cell IL-17 
production in both the TLR2-/- and TLR9-/- mice is likely to be normal.   
 
B cell cytokine production in response to heat killed bacteria at this memory time-point 
follows similar kinetics to that at the primary response.  IL-6 production in the TLR2-/- mice 
appeared reduced, while IL-10 and IFN" production was largely normal (figure 3.14C).  
Again, cytokine production, mainly IL-6 and IFN", by B cells from the TLR9 -/- mice 
appeared slightly enhanced (figure 3.14C).  This may be simply because there were perhaps 
greater numbers of bacteria present in the spleen of these mice (figure 3.14A), and therefore 
there was more antigen present. 
 
B cell antibody production has also been shown to be dependent on TLR activation, more 
specifically; certain subclasses of immunoglobulin, namely IgG1, IgG2b and IgG2c, are 
thought to be MyD88-dependent [126].  Here, it can be seen that IgG1 and IgG2c production 
was significantly impaired in both the TLR2-/- and TLR9-/- mice, but IgG2b responses were 
normal (figure 3.15). 
 
Together, these data suggest that TLR2 and TLR9 are involved in the early T and B cell 
cytokine production, and for antibody responses, in the Salmonella infection model.  
However, neither TLR2 nor TLR9 were essential for bacterial clearance, or for T cell 
memory generation. 




The data presented here indicate that stimulation of B cells through TLRs 2, 3, and 9 induces 
shedding of CD62L, which impacts on their migration patterns and results in their exclusion 
from lymph nodes and Peyer’s patches.  During Salmonella typhimurium infection, this 
process causes B cells to accumulate in the spleen during the first week.  Additionally, using 
TLR-deficient mice, TLR2 and TLR9 were found to be involved in early B and T cell 
cytokine responses, as well as antibody responses, during S. typhimurium infection. 
 
Regulation of B cell expression of CD62L 
The differential expression of CD62L by B cells isolated from different organs (figure 3.1B) 
would suggest that surface expression of this molecule is rapidly and regularly altered.  
Circulating B cells were found to express very high levels of CD62L, presumably to allow 
them to bind to HEVs and migrate into lymph nodes.  As cross-linking of CD62L by its 
ligand induces shedding [186,187], one might predict that CD62L shedding would therefore 
occur during extravasation, as has been suggested [260,261].  Indeed this would fit with the 
data presented here, that B cells within lymph nodes were found to express lower levels of 
CD62L than B cells found in the blood.  However, this is a controversial topic and others 
provide evidence that CD62L is not shed upon extravasation [181].  As CD62L is not 
required for entry into the spleen, this may be the default site of migration for CD62Llo B 
cells.  Within the spleen, marginal zone B cells were found to express lower levels of CD62L 
than follicular B cells (figure 3.1C).  This may be because follicular B cells continuously 
circulate around the body between secondary lymphoid tissues, while marginal zone B cells 
are predominantly non-circulating and remain in the spleen [262].  However, both follicular 
and marginal zone B cells within the spleen were found to shed CD62L when stimulated 
with CpG DNA (figure 3.3E) indicating that this phenomenon is not restricted to any 
specific subset of B cells. 
 
B cell shedding of CD62L in response to specific TLR ligands 
Stimulation of B cells with certain TLR ligands (PAM3CSK4, Poly I:C and CpG DNA) 
induced shedding of CD62L by B cells in vitro, while other TLR ligands did not have such 
an effect (figure 3.2A).  Interestingly, PAM3CSK4, which binds TLR2/1 hetero-dimers, 
induced shedding, while other TLR2 ligands, zymosan and peptidoglycan, which bind 
TLR2/6 hetero-dimers, had no such effect.  Differences with the zymosan signal could be 
explained by its dependence on dectin-1 [263] which is not expressed by B cells [264].  
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However, the reason is more likely to be due to differential expression of TLR1 and TLR6 
by B cells.  There is evidence to suggest that, although B cells express TLR6 at the mRNA 
levels [124,125], they display a greater proliferative response to TLR2/1 stimulation than to 
TLR2/6 [125], which would support the notion of increased expression of TLR1 compared 
to TLR6.  Therefore, although these two forms of TLR2 signal via the same pathway and so 
produce the same effects [265], differential expression would account for the differences 
seen between these stimuli. 
 
Shedding of CD62L by B cells in response to TLR stimulation has not previously been 
reported.  However, other groups have indicated that human neutrophils rapidly lose 
expression of CD62L following stimulation with TLRs in vitro [266,267], and this method 
has been utilised to detect defects in the TLR signalling pathway [266].  However, these two 
articles do not agree on which TLRs induce shedding.  On the one hand, Von Bernuth et al. 
suggested that shedding of CD62L by human neutrophils was stimulated by ligands for all 
the TLRs expressed by granulocytes (TLRs 2/1, 2/6, 4, 5, 7, 8) [266]. In contrast, Hayashi et 
al. only saw neutrophil shedding of CD62L in response to TLRs 2/1, 2/6, 4, and 7/8 but not 
TLRs 3, 5 or 9 [267].  The differences seen between these results in relation to TLR5-
induced shedding may be due to different mechanisms of extracting neutrophils, or the 
varying concentrations and sources of flagellin used.  These results also contrast to my own 
data on mouse B cell shedding of CD62L (figure 3.2A), in that I do not see shedding induced 
by TLRs 4, 5, or 7.  Importantly, in addition to the shedding induced by defined TLR 
ligands, I also saw shedding of CD62L by B cells in response to Salmonella antigens (figure 
3.7A).  This shedding appears to be largely MyD88-dependent, but not mediated entirely by 
either TLR2 or TLR9 (figure 3.7B).  However, no shedding was observed in response to live 
bacteria in vitro following 4 hours of culture.  This is likely due to the short incubation time 
of this culture, where there will be little bacterial death (B cells alone are unlikely to induce 
bacterial killing) and, therefore, only small amounts of accessible TLR ligand. 
 
Furthermore, the interaction between the TLR signalling pathway and the shedding of 
CD62L remains ill-defined.  The mechanism of CD62L shedding is thought to be controlled 
by Calmodulin binding to the cytoplasmic domain.  The release of Calmodulin, initiated by 
the phosphorylation of serine residues on the cytoplasmic domain of CD62L, allows a 
conformational change in CD62L which exposes the cleavage site [172,183].  As this 
phosphorylation of the intracellular tail of CD62L is mediated by members of the protein 
kinase C family, and some members of this family may be activated during TLR signalling 
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[268], this is perhaps the mechanism of interaction of these two signalling pathways.  
However, whether the specific PKCs required for CD62L phosphorylation are activated in 
the TLR signalling pathways remains to be determined.  Clearly, additional study of the 
signalling pathway, which leads from the intracellular TLR signal to the phosphorylation of 
CD62L, is required. 
 
The roles of TLR2 and TLR9 in S. typhimurium infection 
The TLRs that induce shedding of CD62L by B cells in response to bacteria (TLRs 2, 3, and 
9) are not the most abundant or obvious TLR ligands to have an effect during Salmonella 
infection. Although the immune roles of LPS (TLR4) and flagellin (TLR5) in the Salmonella 
infection model have been investigated [269,270], the TLRs highlighted here have received 
less attention.  Interestingly, it has been noted that infection with S. typhimurium results in an 
increase in expression of TLRs 2 and 9 in the infected liver (unfortunately, the spleen was 
not investigated), suggesting they have the potential to play a role [271].  Here, the roles of 
these receptors were more fully analysed, using TLR2- and TLR9-deficient mice. 
 
TLR2 was found to be involved in early B and T cell cytokine responses (figures 3.13C & 
E), however it remains unclear whether this is due to the lack of TLR2 on B and T cells 
themselves (B cells certainly express TLR2 [124], and human T cells have also been shown 
to express TLR2 [272]), or due to an impairment in the function of other cell types, such as 
dendritic cells.  The authors who originally made the TLR2-/- mice suggested that, as the 
major target ligand is peptidoglycan, TLR2 was more likely involved in the recognition of 
Gram-positive bacteria [248].  Therefore, by extrapolation from this, TLR2 would seem 
unlikely to play a major role in the Gram-negative bacterial infection of S. typhimurium, 
where the peptidoglycan is not exposed to as great an extent.  Another study agrees with this 
theory, showing that TLR2-deficient macrophages produce similar amounts of cytokine to 
wild type macrophages when stimulated with heat-killed S. typhimurium [273].  This is in 
contrast to a study by Weiss and colleagues, which states that TLR2 is involved later in the 
immune response for efficient macrophage function [208]. 
 
Some limited data on the role of TLR9 in Salmonella infection has previously been 
published.  Incubation of hepatocytes with CpG DNA, for example, was seen to significantly 
inhibit the intracellular growth of S. typhimurium in vitro, suggesting that stimulation via 
TLR9 can enhance bacterial killing [274].  Rumio et al. also demonstrated that pre-treatment 
with CpG-DNA for 72 hours in vivo increases survival when mice are then infected with 
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virulent S. typhimurium [275], again suggesting a role for this TLR in inducing bacterial 
killing.  The authors propose that this increased survival is due to the responses of Paneth 
cells, although they did not investigate this directly.  This effect may, instead, be partly due 
to the TLR9-induced changes in B cell localisation and activation.  The data presented here 
in figures 3.13-3.14 indicate that both primary and memory B and T cell cytokine responses 
are largely normal in the absence of this receptor.  At day 7, B cell cytokine responses 
actually appeared greater in the TLR9-/- mice when compared to wild type mice.  As TLR9 is 
documented to have stimulatory, not inhibitory, effects on B cells [124,125], this result 
seems perplexing.  The only explanation may be that the TLR9-/- mice have slightly higher 
bacterial loads and therefore, with more antigen present, B cells are making larger cytokine 
responses.  Although TLR9-/- mice appear to have higher bacterial loads at week 8 post-
infection (figure 3.14A), and indeed this does reach statistical significance, in reality these 
bacterial loads are at the limit of detection, and therefore I cannot conclude that bacterial 
clearance is in any way impaired in these mice. 
 
How B cells would be activated by bacterial DNA during infection remains to be clarified, as 
it seems that unless it is released as ‘soluble’ material following bacterial cell death, the 
bacterial particles would require receptor (BCR)-mediated uptake [276,277] and so only 
Salmonella-specific B cells might be activated via TLR9.  However, the data presented in 
figure 3.6 suggest that this is not the case, as B cells cultured with CpG DNA plus the 
inhibitor later shed CD62L after extensive washing to remove the stimulus.  Therefore, it 
appears that the CpG DNA was taken up by the whole B cell population.  Furthermore, 
stimulation of TLRs 2 and 3 is unlikely to be B cell specificity-dependent, as these receptors 
are located on the cell surface, and have the potential to stimulate a polyclonal population of 
B cells. 
 
Both TLR2 and TLR9 were found to be required for a full spectrum of antibody subclass 
production, as the deficient mice had reduced levels of IgG1 and IgG2c (figure 3.15).  This 
is consistent with previous findings where TLR2-/- mice showed reduced IgG production in 
response to Salmonella typhi porin immunisation, although the authors did not look at 
specific IgG subclasses [278].  Previous data from other members of our laboratory also 
support my findings:  TLR signalling, in the form of MyD88, has been shown to be essential 
for efficient antibody responses, specifically IgG2c and IgM responses to T-dependent 
antigens [126].  There are discrepancies between this data and my own data, in terms of 
reduced IgG1 seen in figure 3.15 that was not seen previously, and conversely reduced IgM 
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which was observed previously in the MyD88B-/- chimeras but is not seen here.  These 
differences are likely due to the mice (MyD88B-/- chimeras versus TLR knockouts) and 
antigens (protein immunisation versus S. typhimurium infection) used.  Here, using specific 
TLR knockout mice it was possible to identify the roles of individual TLRs on antibody 
production, as opposed to the more profound impairment in TLR signalling seen in MyD88-
deficient mice.  However, I am unable to determine whether these receptors are required on 
the B cells themselves or on other cell types.  To determine this, a B cell chimera system for 
each of the TLR2-/- and TLR9-/- would need to be used. 
 
Despite the apparent impairments in primary T cell and antibody responses, bacterial load at 
the peak of infection on day 7 was equivalent in the wild type, TLR2-/- and TLR9-/- groups 
(figure 3.13A).  This lack of effect on bacterial numbers is likely a timing issue, that at the 
time-point analysed there was no significant difference but perhaps the kinetics of bacterial 
growth and decline might differ between groups.  Similarly, both TLR2- and TLR9-deficient 
mice were able to clear bacteria and generate normal T cell memory (figure 3.14), indicating 
that TLR2 and TLR9 are ultimately dispensable for the recovery from this infection.  This is 
not surprising, as previously reported data indicate that MyD88-deficient mice, which have a 
more profound impairment in TLR signalling, are able to clear this infection but suffer from 
a significantly higher bacterial load during the early stages of infection [151,210]. 
 
Interestingly, the amount of cytokine produced by B cells at week 8 of infection is 
comparable to at day 7 (figures 3.13E & 3.14C).  While T cell cytokine responses were 
greatly enhanced at week 8 when compared to day 7 (figures 3.13C & 3.14B), indicative of 
T cell memory, the same does not hold true for B cell cytokine production.  This would 
suggest that B cell cytokine production does not show memory (although this is not to say 
that B cells themselves do not have a memory phenotype).  Indeed this absence of B cell 
cytokine memory has been observed before in our laboratory (T.A. Barr, S. Brown & D. 
Gray, unpublished data). 
 
The kinetics of TLR-induced shedding of CD62L by B cells 
The TLR-induced shedding of CD62L by B cells had a profound impact on their migration 
in vivo.  These TLR-stimulated B cells were completely excluded from the lymph nodes and 
Peyer’s patches, and trafficked only to the spleen (figure 3.4).  Interestingly, B cells 
stimulated with CpG DNA in the presence of the inhibitor Ro 31-9790 later shed CD62L 
both in vitro and in vivo, and were therefore excluded from the lymph nodes and Peyer’s 
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patches (figure 3.6).  These data demonstrate that CpG DNA must enter the cell, presumably 
in vesicles, and continue stimulating the cell even after both the CpG DNA and the inhibitor 
have been washed off.  Therefore, the inhibitor cannot be used to confirm, without any 
doubt, that it is the effect of CpG DNA on B cell CD62L, and not any other effect of TLR9 
stimulation, that is responsible for the exclusion of these cells from the lymph nodes.  In 
order to show conclusively that the key molecule is CD62L, the shed-resistant (CD62L(E)) 
B cells would have to be used.  In this situation, I would expect that B cells which cannot 
shed CD62L from their surface would continue to migrate to the lymph nodes and Peyer’s 
patches after stimulation with CpG DNA.  Unfortunately, due to the availability of these 
mice, it was not possible to perform this experiment. 
 
The data here suggests that, following a single stimulation with TLR ligands, B cell CD62L 
returns to normal levels in 2-3 days, and these cells are then able to traffic normally to the 
lymph nodes and Peyer’s patches (figure 3.5).  Others have shown that, in T cells, activation 
by anti-CD3 induces a similar short-term reduction in surface CD62L, with normal levels 
achieved 2-3 days later [172,279].  This is followed, 7 days later, by full activation of T cells 
and down-regulation of surface CD62L as a result of transcriptional regulation [279].  In the 
Salmonella infection model, the reduction of B cell numbers in the lymph nodes and Peyer’s 
patches is only apparent for the first 8 days of infection, and thereafter B cells numbers in 
these organs begin to return to normal (figure 3.9).  In the spleen, B cell numbers are 
elevated on days 4 and 8, but not from day 12 onwards.  This would suggest that the 
focussing of B cells to the spleen by TLR-induced changes in CD62L expression, as seen in 
Salmonella infection, is a short-term phenomenon. 
 
The implications of B cell accumulation in the spleen 
The data presented indicate that, during Salmonella infection, TLR stimulation of B cells 
induces a short-term reduction in levels of surface CD62L, which in turn results in increased 
B cell trafficking to the spleen (Figure 3.9).  This may be a mechanism to non-specifically 
attract a polyclonal population of B cells to the spleen. This is likely to have two effects. 
First, it will enhance the BCR-dependent activation/selection of antigen-specific B cells in 
the spleen, both by exposing greater numbers of B cells to bacterial antigens and also by 
TLR-mediated augmentation of expression of MHC class II and co-stimulatory molecules 
[142,144,149]. Second, the subsequent polyclonal activation by these and other TLR ligands, 
will drive B cell cytokine production [124]. This cytokine release by B cells has a significant 
effect on the programming of the early, primary CD4+ T cells response [151].  The fact that 
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TLR-stimulated B cells localise to the B/T cell border within the white pulp of the spleen 
(figure 3.4D) would support the notion that these B cells may be interacting with T cells, and 
have the potential to drive early T cell responses.  Indeed the data presented in figure 3.12 
suggest that this is the case:  The CD62L(E) chimeras, in which the B cell compartment is 
unable to shed CD62L, show impaired T cell priming in S. typhimurium infection.  Although 
these data provide evidence to support the theory of B cells influencing early T cell 
responses, it should be noted that a proportion of the T cells in these chimeras also have an 
impairment in their ability to shed CD62L, which may impact upon their activation status, 
and subsequent cytokine production. 
 
In addition to driving T cell responses, the non-specific accumulation of B cells in the spleen 
may enhance the secretion of natural antibody directly to the site where the bacteria have 
amassed.  Therefore, TLR-induced IgM in the spleen could bind to the bacteria and 
contribute to the initiation of the primary response, as has been reported [280,281], and 
ultimately enhance bacterial killing.  However, splenic bacterial load on day 4 of infection in 
the CD62L(E) chimeras was equivalent to that in wild type mice (figure 3.12B), suggesting 
that the accumulation of B cells to the spleens of wild type mice is not impacting on bacterial 
numbers.  This lack of impact on numbers of bacteria colonising the spleen may simply be a 
timing issue, in that although no difference was seen on day 4, perhaps differences in 
bacterial numbers may be apparent at an earlier or later time-point.  A detailed analysis of 
bacterial load over time, in the CD62L(E) chimeras, would be required. 
 
Whether the TLR/CD62L-mediated changes to B cell migration enhance the initiation of the 
adaptive immune response to Salmonella or whether TLR-activated B cells also play roles in 
the regulation of the inflammatory response [282,283,284] or changes to lymphoid tissue 
structure during infection [285,286], the global change in migration behaviour upon TLR 
ligation will likely have significant consequences for the immunopathology of this infection. 
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CHAPTER 4:  S. typhimurium-induced changes in the spleen 
include the accumulation of antigen-presenting macrophages 





The data presented so far using the Salmonella typhimurium murine infection model reveal 
significant changes in the B cell population early in infection due to TLR-induced alterations 
in surface CD62L expression.  The subsequent effects on B cell migration resulted in a 2- to 
3-fold increase in B cell numbers in the spleen during the initial few days of infection, as a 
result of influx from other lymphoid organs. 
 
In addition to changes in the B cell population, it has previously been reported that the 
spleen undergoes profound changes to other immune cell populations during Salmonella 
infection.  The most obvious phenotype of these changes is the splenomegaly induced by this 
infection, which is thought to be due mainly to the infiltration of macrophages and 
neutrophils [287,288], although as we saw in chapter 3, B cells also contribute.  
Macrophages, members of the reticuloendothelial system, are not only the cells in which the 
bacteria live and divide [197], but are also essential for the early control of the exponential 
growth phase of this bacterial infection [287].  Without this early control of bacterial growth, 
mortality rates are significantly increased [289]. 
 
The normal site of entry for Salmonella is via the oral route, and the invasion of the M-cells 
in the gut epithelium.  From there, the bacteria pass through the Peyer’s patches and 
mesenteric lymph nodes, and enter the bloodstream [201].  In the infection model used here, 
bacteria are injected intravenously, and the infection is immediately systemic.  In both cases, 
systemic bacteria mean that the spleen is the major site of immune defence.  The structure of 
the spleen enables the innate and adaptive arms of the immune response to come together 
and remove any blood-born pathogens they encounter.  Macrophages are particularly 
important in this process.  However, the clearance of Salmonella and the generation of 
protective immunity are dependent, not only on innate cells such as macrophages, but also 
on adaptive B and T cell responses [201].  IFN" production by T cells and natural killer cells 
is necessary to enhance bacterial killing by innate cells residing in the spleen [201].  
Chapter 4:  Salmonella-induced changes in spleen 
! *$!
Furthermore, as already mentioned above, both T cell memory responses and B cell antibody 
production are generated, and involved in protective immunity [201].  Thus the spleen is the 
major site of bacterial accumulation, and is epicentre of the battle against this infection. 
 
Here, the splenic changes induced by S. typhimurium infection are analysed in more detail by 
means of flow cytometry and immunohistology.  The increasing macrophage population is 
investigated, as is the impact of infiltrating cells on splenic architecture, and the role of 
TLRs.  Additionally, one of the early observations is the loss of the marginal zone 
population of B cells within the first few days of infection.  I go on to consider the fate of 
these cells, and the downstream effects of losing these cells on the entry of blood-borne 
particles into the white pulp regions of the spleen. 




Infection with S. typhimurium causes splenomegaly and changes to 
lymphocyte population numbers within the spleen 
Infection with Salmonella typhimurium is known to cause splenomegaly in mice [206].  
Using spleen weight as a measure of splenomegaly, the data presented in figure 4.1A reveal 
that the onset of splenomegaly was rapid and severe.  By day 7 of infection, spleen weight 
had increased by around 6-fold, and by day 12 reached a plateau at ~0.8g.  In MyD88-/- mice 
this initial increase in spleen weight was reduced in comparison to wild type mice (figure 
4.1B), suggesting that splenomegaly is partially, although not wholly, dependent on TLR 
stimulation.  The time-course did not extend as far in the MyD88-/- mice so it was not 
possible to determine whether the onset of splenomegaly was simply delayed in the absence 
of MyD88 signalling, or whether the peak of spleen weight was reduced. 
 
Looking at the kinetics of bacterial growth and contraction in wild type mice, splenic 
bacterial load, shown per gram (figure 4.1C) and per spleen (figure 4.1D), peaked around 
day 8, with bacteria being reduced to very low levels around 4 weeks after infection.  
However, a few bacteria still remained even 8 weeks after infection, suggesting that 
complete clearance of bacteria and the development of sterilising immunity is a relatively 
slow process in this infection model. 
 
As mentioned in figure 3.9, B cell proportions and numbers within the spleen were found to 
change drastically during S. typhimurium infection.  This is shown again in figures 4.1E & F, 
extending the time-course further.  The percentage of B cells within the spleen decreased 
drastically, constituting only ~10% of live cells by day 30, compared to 50-60% in 
uninfected mice (figure 4.1E).  Following the initial increase, absolute numbers of B cells 
were also reduced at this time-point (figure 4.1F).  Furthermore, the proportion of CD4+ T 
cells within the spleen was reduced during the early stages of infection, up until day ~30 
(figure 4.1G).  However, when absolute numbers of T cells were calculated, T cell numbers 
were seen to be increased throughout infection (figure 4.1H).  This increase is likely due to T 
cell division, as was seen in figure 3.9 when BrdU incorporation was studied.  B and T cell 
numbers returned to normal levels around 80 days post-infection, indicating that the changes 
in lymphocyte populations within the spleen during Salmonella infection were inherently 
long-lived.  The return of lymphocyte numbers in the spleen to pre-infection levels appeared 
to correlate with the clearance of bacteria. 
Chapter 4:  Salmonella-induced changes in spleen 
! *&!
 
Macrophage influx disrupts splenic architecture early in infection 
The splenomegaly associated with Salmonella infection is likely caused by the influx of 
immune cells, probably macrophages [287,288].  To confirm the identity of these cells and 
further investigate the changes within the spleen, immunohistological analysis of infected 
spleen sections was performed.  The representative photographs shown in figure 4.2 confirm 
that, by day 8 of infection, a large proportion of cells within the spleen were macrophages, as 
identified by CD11b staining (red).  In uninfected mice (day 0), the CD11b+ cells were found 
exclusively in the red pulp, surrounding the IgD+ B cell follicles (blue areas).  Pre-infection, 
macrophages were fairly dispersed throughout the red pulp, with few CD11b bright cells.  
By day 1 of infection, there were many more CD11b+ cells within the red pulp, suggesting 
either an early influx of macrophages or an upregulation of this molecule on existing cells.  
Looking at day 4- and day 8-infected mice, there was a clear increase in CD11b+ cell 
numbers, with CD11b+ cells appearing in clumps in the red pulp region.  Moreover, these 
cells appeared to have infiltrated the white pulp, as there were more cells staining red in the 
IgD+ B cell follicles (blue), while the B cell areas appeared to be fragmenting at the later 
time-points.  Thus, by this early stage of infection, the white pulp regions are being disrupted 
by infiltrating macrophages. 
 
Further investigation suggests that these infiltrating macrophages are presenting antigen 
(figure 4.3).  On day 0, the macrophages, identified by F4-80 staining (green), were focussed 
in the red pulp surrounding the areas of white pulp, in a similar pattern to the CD11b staining 
seen on day 0 in figure 4.2.  In uninfected mice (day 0), the white pulp, consisting of the B 
cell follicles and T cell zones, exhibited MHC class II+ cells (blue).  These were B cells 
within the follicles and dendritic cells within the T cell zone, both of which have the capacity 
to present antigen.  The F4-80+ macrophages in the red pulp were MHC class II- in the 
uninfected mice (i.e. green not blue).  Progressing through the pictures of day 1, day 4, and 
day 8 infected mice, it can be seen that the macrophage population increased (more green), 
and also that these macrophages had increased expression of MHC class II (more green-blue 
double-positive cells).  By day 8, these MHC class II+ macrophages were found to be 
widespread throughout the spleen, with the areas of white pulp less distinguishable.  
Together, these data indicate that, during Salmonella infection, antigen-presenting 
macrophages influx into the spleen.  Additionally, splenic architecture, in terms or red and 
white pulp regions, is severely disrupted, which may be due to the infiltrating macrophages. 
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Marginal zone B cells are lost in the first few days of infection 
In addition to the influx of macrophages into the infected spleen, it has already been noted 
above that the white pulp regions are disrupted, and that the B cell population also undergoes 
significant changes.  To investigate the changes to the B cell regions in more detail, 
immunohistological analysis of infected spleen sections, together with flow cytometry, were 
used to visualise B cell subsets. 
 
By staining for CD21 and CD23 by flow cytometry, it was possible to distinguish between 
marginal zone B cells (CD21hi CD23int-lo) and follicular B cells (CD21int-hi CD23hi) within the 
spleen.  In uninfected mice, marginal zone B cells constitute ~5% of B cells (figure 4.4A, far 
left, gated cells).  The data presented in figure 4.4A reveal that this population of B cells, 
visible as a separate population on day 0, is either lost, or changes phenotype, early in 
infection.  Although still visible on day 1, by days 4 and 8 this population is no longer 
distinguishable from follicular B cells.  Also, the expression of CD23 by the large population 
of follicular B cells was reduced, even by day 1 of infection, while marginal zone B cells 
also appeared to have down-regulated expression of this molecule (figure 4.4A).  Thus, from 
the flow cytometry data, it is not possible to determine whether marginal zone B cells 
disappear (by death, differentiation, or migration out of the spleen) or simply alter their 
phenotype, in terms of CD21 and CD23 expression, such that they can no longer be 
identified by flow cytometry.  Sections from infected spleens were therefore analysed in an 
attempt to determine the fate of this cell population. 
 
Marginal zone B cells can be identified by histology as IgM+ IgD- cells, in contrast to 
follicular B cells that express both these markers.  In uninfected mice the border of marginal 
zone B cells is clearly visible surrounding the follicles (figure 4.4B, day 0, red cells 
surrounding the purple follicular B cells).  By day 1 of infection, this population looks to 
have dispersed, with few IgM+ IgD- cells remaining in situ.  On days 4 and 8 of infection, 
there is no distinguishing border to the follicles, as the marginal zone population of B cells 
no longer exists.  By this stage, macrophages were infiltrating the white pulp (as seen in 
figures 4.2 & 4.3), contributing to the disrupted nature of the follicles.  Therefore, it seems 
apparent that the marginal zone B cells do not simply alter CD21 and CD23 expression, 
making them undetectable by flow cytometry, but disappear completely from their usual 
position surrounding the white pulp regions of the spleen. 
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The absence of MyD88 signalling delays, but does not prevent, the loss of 
marginal zone B cells 
Having established that marginal zone B cells are lost within 1-3 days of S. typhimurium 
infection, I wished to investigate whether this process was dependent on TLR stimulation.  
To do this, MyD88-/- mice were infected with S. typhimurium, and splenic B cell populations 
analysed by histology and flow cytometry, as in figure 4.4 above. 
 
By flow cytometry, marginal zone B cells were clearly distinguishable from follicular B 
cells, by CD21 and CD23 expression, up to day 4 of infection of MyD88-/- mice (figure 
4.5A).  By day 8 of infection, a small population of marginal zone B cells looks to still be 
present.  This is in contrast to wild type mice, in which this population was entirely lost by 
day 4 (figure 4.4A).  Thus the loss of marginal zone B cells in MyD88-/- mice appears to be 
delayed by around 4 days.  Additionally, follicular B cell reduction in CD23 expression 
appeared delayed in the absence of MyD88 signalling (figure 4.5A), suggesting that this, too, 
is partially dependent on TLR stimulation. 
 
Immunohistological analysis provided more insight into the delayed loss of marginal zone B 
cells in MyD88-/- mice (figure 4.5B).  On day 1 of S. typhimurium infection, when marginal 
zone B cells were already lost in wild type mice, there was a clear border of IgM+ IgD- 
marginal zone B cells around the follicle (red cells around the purple follicular B cells).  By 
day 4, this population was beginning to fragment, but was still visible.  By day 8, however, 
only the remnants of this population remained.  Together, the data presented in figure 4.5 
conclude that the loss of the marginal zone population of B cells is delayed, but not 
prevented, in MyD88-deficient mice.  Therefore, a component of the loss of this population 
is mediated by TLR signalling.  This begs the question of what is happening to this 
population of cells.  One hypothesis would be that marginal zone B cells differentiate into 
plasma cells following TLR stimulation.  This theory is further investigated below. 
 
An early extrafollicular plasma cell response develops by day 4 of S. 
typhimurium infection 
In an attempt to identify the fate of the marginal zone B cell population, observations were 
made on the differentiation of plasma cells in the early stages of infection.  Staining for IgM 
on infected spleen sections is a means, not only of identifying B cell follicles, but also of 
visualising IgM-secreting plasmablasts and plasma cells, which appear as very bright cells.  
The photographs presented in figure 4.6 reveal the presence of plasmablasts / plasma cells by 
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day 4 of infection (see arrows), which appeared to be producing IgM, but did not express 
IgG (data not shown).  These IgM-secreting cells were located out-with the white pulp, in 
the red pulp region, rather than within GCs in B cell follicles, and thus are termed an 
extrafollicular plasma cell response.  Again, the pictures presented in figure 4.6 demonstrate 
the disruption of the follicles by days 4 and 8 of infection, when marginal zone B cells are 
lost and the plasma cell response is most apparent.  In order to quantify the development of 
these plasma cells and investigate the involvement of TLR stimulation, further analysis by 
flow cytometry was required. 
 
MyD88-/- and CD1d-/- mice show impaired early plasma cell differentiation and 
IgM production during S. typhimurium infection 
In order to quantify the early extrafollicular plasma cell response in Salmonella-infected 
mice, flow cytometry for the B cell markers B220 and CD138 was used.  Example staining is 
shown in figure 4.7A.  Plasmablasts, the precursors of plasma cells, are identified as B220+ 
CD138+ cells (right hand gate), while fully differentiated plasma cells are B220int-lo CD138+ 
(left hand gate).  Both these cell types are capable of antibody secretion and therefore IgM-
secreting plasmablasts and plasma cells were revealed by immunohistology in figure 4.6 
above.  By flow cytometry, plasmablast numbers were elevated at days 4 and 8 of infection 
in wild type mice, while plasma cells were only readily detectable in day 8-infected mice 
(figures 4.7B, circles).  These plasmablasts and plasma cells appeared to be secreting IgM, as 
detectable levels of Salmonella-specific IgM were present in wild type mice on both day 4 
and day 8 (figure 4.7C, circles), while Salmonella-specific IgG was not detected at this time-
point (data not shown). 
 
Given the above results that marginal zone B cell loss is delayed in MyD88-/- mice, I wished 
to determine whether plasma cell differentiation and/or IgM production was also delayed in 
these mice.  This will provide insight into whether marginal zone B cells are likely to be the 
source of the IgM-secreting plasma cells found in wild type mice.  In addition to looking at 
the early plasma cell responses in MyD88-/- mice, I also made use of CD1d-/- mice, which do 
not possess marginal zone B cells.  Therefore, if the theory that marginal zone B cells 
differentiate into IgM-secreting plasma cells in response to TLR stimulation is correct, then 
one would expect MyD88-/- mice to have delayed plasma cell differentiation and IgM 
production, and CD1d-/- mice to have significant impairments in these functions. 
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The data displayed indicate that both MyD88-/- and CD1d-/- mice have reduced plasmablast 
numbers when compared to wild type mice, throughout the time-course of the experiment 
(figure 4.7B, left).  Furthermore, plasma cell numbers were also reduced in MyD88-/- mice at 
day 8, while in CD1d-/- mice plasma cells were virtually absent (figure 4.7B, right).  
Salmonella-specific IgM was also diminished in both MyD88-/- and CD1d-/- mice (figure 
4.7C).  Taken together, these data indicate that early plasma cell differentiation and IgM 
production was reduced in MyD88-/- mice and significantly impaired in CD1d-/- mice.  
Therefore, the loss of the marginal zone B cell population in S. typhimurium infection 
correlated with the generation of IgM-secreting plasma cells.  Thus it seems possible that the 
early extrafollicular plasma cell response was as a result of marginal zone B cell 
differentiation following TLR stimulation. 
 
Staining of B cells in vivo is reduced during S. typhimurium infection 
Due to the location of the marginal zone within the spleen, directly adjacent to the marginal 
sinuses, cells within the marginal zone are among the first to encounter blood-born antigen 
[2].  Indeed, marginal zone B cells have been shown to capture such blood-borne particles 
[252].  Here, I use an in vivo staining technique, by injecting fluorescently labelled 
antibodies, to further explore the loss of marginal zone B cells during S. typhimurium 
infection. 
 
When fluorescently labelled antibodies against B cell markers are injected into mice, they 
are predominantly taken up by the marginal zone B cell population [252].  Here, anti-CD21 
FITC and anti-CD19 PE were injected i.v. into recipient (uninfected) mice and, 20 minutes 
later, splenic B cell subsets analysed for binding by flow cytometry.  Anti-CD21 FITC 
should be bound preferentially by marginal zone B cells, as this cell population expresses 
greater levels of CD21 on their surface.  Anti-CD19 PE, however, has the ability to bind 
both marginal zone and follicular B cells, with no preference for either subset, in vitro.  
Here, 40-45% of follicular B cells bound (either) antibody in 20 minutes of exposure in vivo, 
while for marginal zone B cells the figure was much higher – around 65-70% (figure 4.8A).  
This confirms previous findings that marginal zone B cells are the first subset of B cells to 
encounter systemic particles [252]. 
 
As marginal zone B cells are lost during S. typhimurium infection (and these cells express 
highest levels of CD21), a fall in the number of B cells binding the anti-CD21 FITC 
antibody during infection would be expected.  This is exactly the case, in that the proportions 
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of B cells binding anti-CD21 FITC in 20 minutes in vivo was significantly reduced following 
injection on days 1, 4, and 7 of infection (figure 4.8B).  However, it was not known what 
effect the loss of marginal zone B cells would have on anti-CD19 PE binding during 
infection.  One might expect binding of anti-CD19 PE to decrease also, due to the loss of 
marginal zone B cells.  Alternatively, binding of anti-CD19 PE may be expected to increase, 
for two reasons.  Firstly, early in infection, B cell numbers in the spleen have been shown to 
increase due to influx from other lymphoid organs (as presented in chapter 3).  Secondly, the 
loss of marginal zone B cells may result in the exposure of follicular B cells to blood-borne 
particles.  The results presented in figure 4.8C indicate that, during infection, anti-CD19 PE 
binding by B cells was also reduced, although to a lesser extent than binding of anti-CD21 
FITC.  These results suggest that, although marginal zone B cells are lost during infection, 
particles from the blood (in this case fluorescently labelled antibodies) do not have free 
access to follicular B cells.  Thus it appears that a ‘barrier’ remains in place in the marginal 
zone region during infection, despite the loss of the marginal zone B cell population. 
 
Labelled antibodies continue to accumulate in the marginal zone during 
infection, and do not enter the follicles 
The data presented in figure 4.8C above suggest that, despite the loss of marginal zone B 
cells during infection, blood-borne particles do not have access to the follicles.  In order to 
further investigate the maintenance of this ‘barrier’ in the marginal zone region, spleen 
sections from mice injected with anti-CD19 PE were analysed, to identify the location of 
injected antibody within the spleens of infected mice. 
 
In figure 4.9 it can be seen that, in uninfected mice, the anti-CD19 PE antibody (red) was 
found to accumulate in the marginal zone.  Dull staining was seen in the red pulp region, 
surrounding the B cell follicles, perhaps due to non-specific binding by macrophages.  
Meanwhile staining appeared strongest at the marginal zone, presumably due to binding by 
marginal zone B cells.  Across all time-points of infection, it appears that the antibody had 
concentrated in regions around the follicles, in the marginal zone.  Even in day 8-infected 
spleens, when marginal B cells had been lost and the follicles had partially broken up, 
antibody still accumulated around the follicles.  The follicles themselves appeared as black 
voids, with no antibody binding (highlighted by ‘F’ in the pictures), indicating that antibody 
had not infiltrated these regions.  These data strengthen the argument that, although marginal 
zone B cells are lost during infection, a barrier remains intact between the red pulp and white 
pulp areas of the spleen, and systemic particles accumulate in this region. 
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Marginal zone metallophilic macrophages become partially fragmented during 
S. typhimurium infection, but remain around the follicles 
Another cell type found in the marginal zone is the marginal zone metallophilic macrophage, 
which can be identified by staining for MOMA-1 (metallophilic macrophage antibody).  
This population is also thought to be involved in the removal of antigens from the 
bloodstream [290].  Previous data suggests that marginal zone B cells play a role in the 
generation and/or maintenance of this cell type [15].  Therefore, it was uncertain whether 
marginal zone metallophilic macrophages would be affected by the loss of marginal zone B 
cells during S. typhimurium infection.  Furthermore, identifying any changes to the 
distribution of these cells during infection will provide insight into the retention of the 
‘barrier’ between the red pulp and white pulp regions.   
 
It was found that, during infection, the marginal zone metallophilic macrophage population 
became partially fragmented but was not lost (figure 4.10).  In uninfected mice (day 0), the 
marginal zone metallophilic macrophages (green) can be seen between the follicular and 
marginal zone B cells (identified by IgM staining, red).  By days 4 and 8 of infection, when 
the marginal zone B cells had been lost, the marginal zone metallophilic macrophages were 
still seen surrounding the follicular B cell population, although appeared slightly dispersed.  
Thus their presence in the marginal zone region was not dependent on marginal zone B cells.  
Therefore, these cells may form part of the barrier that remains around the white pulp when 
marginal zone B cells are lost, and function to prevent particles from the bloodstream from 
entering the follicles. 
 




The data presented here confirm that antigen-presenting macrophages influx into the spleen 
during the first week of S. typhimurium infection, and that the white pulp regions become 
disrupted at this time.  The initial splenomegaly, together with the loss of marginal zone B 
cells, is partially dependent on TLR signalling.  However, despite the loss of the marginal 
zone B cell population during infection, a physical barrier to blood-borne particles remains 
between the red and white pulp regions.  Furthermore, an early extrafollicular plasma cell 
response develops in S. typhimurium infection.  Due to the evidence of TLR-induced 
differentiation of IgM-secreting plasma cells, and the lack of these plasma cells in CD1d-/- 
mice that lack a marginal zone, I speculate that the origin of these plasma cells is likely to be 
the marginal zone B cell population. 
 
Macrophage influx into the spleen during S. typhimurium infection 
The data presented in figures 4.2 & 4.3 confirm that the major cell-type infiltrating the 
spleen during infection was macrophages, as determined by their expression of CD11b and 
F4-80.  This influx of macrophages was rapid, with numbers of CD11b+ cells appearing 
elevated after just 24 hours of infection (figure 4.2).  Alternatively, the increase in CD11b 
staining may be as a result of upregulation of this molecule by macrophages already present 
in the red pulp of the spleen.  Indeed, TLR stimulation has previously been shown to induce 
such an upregulation both in macrophages [291] and neutrophils [292].  Therefore, the 
presence of bacteria is likely to induce upregulation of surface CD11b on macrophages in the 
S. typhimurium infection model, as well as the influx of monocytes from the bloodstream 
and subsequent differentiation into functional macrophages.  Also, some subsets of murine 
dendritic cells have been shown to express CD11b [293], and they, together with neutrophils, 
may be responsible for some of the CD11b staining seen here in figure 4.2. 
 
Furthermore, the data displayed in figure 4.1B suggest that splenomegaly is partially 
dependent on TLR signalling, as the initial increase in spleen weight was reduced, but not 
absent, in MyD88-/- mice.  Both the increase in numbers of newly differentiated 
macrophages in the spleen, and the influx of B cells from other lymphoid organs (as outlined 
in chapter 3) show dependence on TLR stimulation, and were likely to have contributed to 
the rapid and severe splenomegaly identified in the first week or so of infection. 
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Loss of marginal zone B cells 
In addition to changes in the innate cells of the spleen, adaptive immune cells, such as B 
cells, also underwent alterations in terms of cell number, subsets and localisation, during S. 
typhimurium infection.  One of the most striking changes to the B cell population was the 
loss of the marginal zone B cell subset.  From the histology pictures, this cell population 
appeared dispersed in wild type mice by day 1 of infection, and was unidentifiable by flow 
cytometry by day 4 (figure 4.4).  One explanation for the differences in the timescale of 
marginal zone B cell loss between the flow cytometry and histology results is that, by day 1, 
marginal zone B cells may have migrated away from the marginal zone into the red pulp and 
so not be visible by histology in the marginal zone region, but still identifiable by flow 
cytometry via the expression of CD21 and CD23. 
 
The loss of marginal zone B cells was seen to be delayed by around 4 days in MyD88-/- mice 
(figure 4.5).  This loss of marginal zone B cells in vivo following injection of heat-killed E. 
coli or TLR ligands has been reported previously [294,295].  Furthermore, the loss of 
marginal zone B cells during infection has been shown in various models, such as relapsing 
fever caused by Borrelia crocidurae, where this population was reduced 2-fold by day 6 
[296], and Trypanosoma brucei, where analysis on day 10 of infection revealed this 
population to be absent [297].  There are three possible explanations for the loss of marginal 
zone B cells during infection: migration, death or differentiation.  Due to the knowledge that 
marginal zone B cells are non-circulating in mice [262], migration of these cells out of the 
spleen seems unlikely.  However, early data by Gray et al on the loss of marginal zone B 
cells reports that these cells migrate in an intra-splenic manner to the B cell follicles, for the 
delivery of antigen to follicular dendritic cells [294].  More recent data also indicates a role 
of marginal zone B cells in the transport of antigen into the follicles [252], and so migration 
of these cells into the follicles is one plausible explanation for their loss.  Alternatively, 
marginal zone B cells may be lost by apoptosis.  Indeed, the authors using the T. brucei 
system attributed the loss of marginal zone B cells to be due mainly to apoptosis, as 
apoptotic cell markers such as Annexin V and 7AAD were elevated [297].  However, in the 
B. crocidurae system, the authors imply that the loss of marginal zone B cells is as a result of 
differentiation into IgM+ plasma cells [296].  Here, I propose that the TLR-induced loss of 
marginal zone B cells in S. typhimurium infection is due to differentiation into IgM-secreting 
extrafollicular plasma cells. 
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Marginal zone B cell differentiation into plasma cells 
The data presented show that the loss of marginal zone B cells occurred at approximately the 
same time as the generation of plasmablasts within the spleen, between days 1 and 4 of 
infection (figures 4.4 & 4.7).  This, together with the finding that the early plasma cell 
response was virtually absent in CD1d-/- mice that lack marginal zone B cells (figure 4.7), 
suggests that differentiation into plasma cells is the likely fate of marginal zone B cells.  
However, it should be noted that CD1d-/- mice also have a deficiency in invariant natural 
killer T cells (iNKT cells) [250].  As iNKT cells have been shown to ‘help’ B cell antibody 
responses [298,299,300], this may be an alternative explanation for the lack of early IgM 
production in the CD1d-/- mice.  Alternatively, reduced numbers of B1 cells would explain 
the lack of IgM production, as well as the lower numbers of splenic plasmablasts in naïve 
mice seen in figure 4.7B.  However, data from both our own laboratory (S. Brown, T.A. Barr 
& D. Gray, unpublished observations) and a published report [301] suggests B1 cell numbers 
to be normal in CD1d-/- mice. 
 
Additionally, the loss of marginal zone B cells was delayed (figure 4.5), and the early plasma 
cell response reduced (figure 4.7), in the absence of MyD88 signalling, indicating a role for 
TLR stimulation.  TLR stimulation of B cells is known to result in the differentiation of 
plasma cells in a T cell-independent manner [125], with MyD88-deficient mice showing 
reduced steady-state levels of serum antibody [127].  Looking specifically at marginal zone 
B cells, they are thought to be poised for plasma cell differentiation, making ~6-fold more 
IgM than follicular B cells in response to LPS stimulation in vitro [125], and doing so in 
shorter periods of time [255].  Moreover, several other studies have reported the 
differentiation of plasma cells from marginal zone B cells, in a Borrelia infection study 
[296], and in an antigen-loaded Streptococcus pneumoniae model [162].  Further data 
suggests that this differentiation of marginal zone B cells into plasma cells involves an 
interaction with blood-derived dendritic cells, by-passing the need for T helper cells [302].  
Thus, it seems a feasible explanation that TLR stimulation of marginal zone B cells would 
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Early production of IgM that is capable of binding Salmonella antigens 
TLR-dependent differentiation of plasmablasts and plasma cells in the spleen was apparent 
by days 4 and 8 of infection, respectively.  This correlated with an increase in serum IgM 
that was capable of binding Salmonella antigens (figure 4.7).  These IgM-secreting plasma 
cells were located primarily out-with the follicles, in the red pulp region (figure 4.6), and 
thus constitute an extrafollicular plasma cell response.  Due to the polyclonal nature of TLR 
stimulation, this plasma cell response is likely to have occurred in a T cell-independent 
manner, as antigen-specific T cell help for B cells seems unlikely at this early stage of 
infection.  Thus the antibody produced would be expected to represent the diverse 
specificities of the marginal zone BCRs, and therefore constitute ‘natural’ or cross-reactive 
IgM. 
 
Marginal zone B cells are the main source of cross-reactive IgM in the spleen.  Although 
capable of opsonisation and neutralisation, IgM functions mainly to activate the complement 
system, thus acting as a kick-start to the immune response.  Marginal zone B cells, together 
with peritoneal B1 cells, are thought to be responsible for the initial wave of IgM production 
in response to blood-borne particulate antigen [162].  Such IgM has been shown to be vital 
in immune responses to bacteria, with mice expressing a mutant form of IgM, that cannot be 
secreted, showing increased mortality in a peritonitis model [281].  Data from previous 
studies also highlights the importance of early TLR-induced IgM production in infection; in 
Borrelia hermsii infection, TLR-induced IgM production is essential in controlling bacterial 
growth very early in infection [303], and an impairment in TLR signalling leads to delayed 
IgM production which, in turn, results in more severe bacteraemia [303].  Therefore, the 
early extrafollicular plasma cell response and IgM production seen in S. typhimurium 
infection is one of the first components of the innate immune response against the bacterial 
infection, confirming the role of marginal zone B cells in innate immunity. 
 
The early extrafollicular plasma cell response in S. typhimurium infection 
Extrafollicular plasma cell responses can occur in a T cell-dependent or -independent 
manner, and the resulting antibody that is generated is of low affinity, as the B cells have not 
undergone somatic hypermutation within a GC.  An early extrafollicular plasma cell 
response has been reported previously with regards to S. typhimurium infection [206].  
Similar to my own data, the authors reported that the extrafollicular plasma cell response 
was detectable by day 3 of infection.  However, the remainder of their data differed 
significantly from my own findings.  The authors found some of the resulting plasma cells to 
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be class switched, secreting IgG2c, and this aspect was, therefore, strongly dependent on the 
presence of T cells [206].  In contrast, the plasma cells indentified here in figure 4.6 had an 
IgM+ phenotype and had not switched to IgG (data not shown), suggesting a T cell-
independent mechanism.  Importantly, published data shows the extrafollicular antibody 
response (including low affinity IgM) to play a role in preventing the colonisation of splenic 
macrophages by Salmonella, following pre-incubation of bacteria with serum [206], 
highlighting its importance in this infection model. 
 
Marginal zone B cells are the first B cell subset in the spleen to encounter 
systemic antigen 
Here, I make use of an in vivo staining technique to study the binding of fluorescently 
labelled antibodies by cells in the spleen, and the effects of the loss of marginal zone B cells 
on antibody entry into the follicles.  Looking firstly in uninfected mice, a much greater 
proportion of marginal zone B cells bound the antibodies (either anti-CD21 FITC or anti-
CD19 PE) than follicular B cells (figure 4.8), indicating that marginal zone B cells were first 
to access blood-borne particles.  One discrepancy in the data presented is that, by flow 
cytometry, ~40% of follicular B cells were found to have bound anti-CD19 PE (figure 4.8A), 
while the histology data shows virtually no staining within the follicles (figure 4.9, day 0).  
The likely explanation for the differences in these findings is that further binding of anti-
CD19 PE may have occurred during preparation of the samples for flow cytometry (i.e. 
mashing of the spleens), which disrupted splenic architecture and may have allowed 
antibodies present in the red pulp to bind follicular B cells.  Interestingly, the histology 
pictures reveal dim anti-CD19 PE staining in the red pulp of uninfected mice (figure 4.9).  
One possible explanation for this is that macrophages in this region may have bound the 
antibody non-specifically, perhaps through Fc receptors. 
 
An elegant study by Cinamon and colleagues [252] revealed the role of marginal zone B 
cells in capturing blood-borne antigen and delivering it into the follicles.  Using the same in 
vivo staining technique that I use here, the authors provide evidence that marginal zone B 
cells continuously shuttle between the marginal zone and follicular regions in uninfected 
mice, delivering antigen to follicular dendritic cells [252].  My data presented here certainly 
confirm that marginal zone B cells are the first B cell subset in the spleen to access systemic 
labelled antibodies.  The loss of these shuttling marginal zone B cells may be a further 
explanation for the decrease in anti-CD19 PE binding during Salmonella infection (figure 
4.8C). 
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Despite the loss of the marginal zone B cell population during S. typhimurium infection, a 
physical barrier to blood-borne antigen was retained in the marginal zone region.  While the 
bright staining of the marginal zone region was seen throughout all time-points of infection 
(figure 4.9), there was virtually no staining of B cells in the follicles.  This suggests that, not 
only were fluorescently labelled antibodies prevented from entering the follicles, but also the 
injected antibodies continued to accumulate in the marginal zone despite the loss of marginal 
zone B cells. 
 
Marginal zone metallophilic macrophages are maintained during infection and 
may capture the injected antibodies in the marginal zone 
The marginal zone metallophilic macrophage population, although partially dispersed, was 
retained in the marginal zone, despite the loss of marginal zone B cells (figure 4.10).  This 
provides evidence, contrary to published data [15], that marginal zone B cells are not 
essential for the maintenance of this population of macrophages.  In agreement with my data, 
previous studies showing the loss of marginal zone B cells following injection with TLR 
ligands [295], and in Borrelia infection [296], both indicate that marginal zone metallophilic 
macrophages are maintained.  This cell type is known to be involved in the early innate 
response in the spleen, secreting type I interferons during viral infection [304].  Furthermore, 
they have been implicated in the generation of antibody responses to T cell-dependent 
particulate bacterial antigens [305].  As marginal zone metallophilic macrophages do not 
express MHC class II and therefore cannot present antigen [306], the likely role for these 
cells in the development of T cell-dependent antibody responses is as an intermediate cell 
type, perhaps capturing antigen and passing it on to professional APCs, such as dendritic 
cells, or even marginal zone B cells.  Further data in support of antigen capture by marginal 
zone metallophilic macrophages, from Aichele and colleagues, indicates that marginal zone 
metallophilic macrophages, together with marginal zone macrophages, are essential for 
trapping particulate antigen from the bloodstream, but are dispensable for antigen 
presentation and the development of T cell responses [290].  Therefore these marginal zone 
metallophilic macrophages certainly play an immune role, and may be responsible for 
binding the labelled antibody (perhaps recognising the foreign structure generated in rats, or 
the PE region, or simply via Fc receptors) and trapping it in the marginal zone region during 
S. typhimurium infection, thus preventing its entry into follicles. 
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CHAPTER 5:  The role of B cells in the generation of T cell 
memory and T follicular helper cell populations - use of the 





The data presented so far reveal the innate responses of whole populations of B cells in 
response to TLR stimulation.  In Salmonella typhimurium infection, I have shown that these 
TLR-induced changes to B cells include the shedding of CD62L, and subsequent alterations 
in migration patterns, and the differentiation of marginal zone B cells into IgM-secreting 
plasma cells.  These rapid responses of B cells, which occur within the first few days of 
infection, contribute to the innate defence.  In addition to these innate functions, B cells have 
the capacity to present cognate antigen via MHC class II, following endocytosis through 
their BCR.  This antigen presentation by B cells, together with their ability to secrete 
cytokines, means they have the potential to drive T helper cell differentiation, and thus direct 
the adaptive T cell response. 
 
Here, I investigate the role of B cells in influencing adaptive immune responses in vivo, 
specifically, in the differentiation of CD4+ T cells.  To do this, I again make use of the S. 
typhimurium infection model, as well as a peptide immunisation strategy (see chapter 6).  In 
the S. typhimurium infection model, antigen-specific T helper cell responses are analysed by 
measuring cytokine production following in vitro restimulation.  As the immune response to 
this infection is characterised by a strong Th1 response and IFN" production [201], this 
cytokine is most indicative of the in vivo CD4+ T cell response to this infection. 
 
In order to further dissect the specific requirement for B cells in the generation of CD4+ T 
cell responses, I use anti-CD20 B cell depletion antibodies.  This antibody, approved for use 
in humans in the form of the drug Rituximab, is used to efficiently deplete B cells in 
lymphoma patients [219].  Here, I use a murine clone of anti-CD20 to deplete B cells in mice 
at various times throughout the immune response (in this case following S. typhimurium 
infection) and follow the generation of T helper cell responses. 
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There are several advantages of the anti-CD20 depletion system over the use of B cell-
deficient mice.  Firstly, in the mice used (normal C57BL/6 mice) the T cells have developed 
in the presence of B cells.  Therefore, their immune system and lymphoid tissues are normal, 
unlike B cell-deficient mice which have been shown to have abnormal T cells [216].  
However, it cannot be guaranteed that T cells remain normal after B cell depletion.  
Additionally, these mice have normal levels of ‘natural’ serum antibody (before depletion), 
which is known to be involved in early immune responses [281].  Importantly, this system 
allows the control of the presence or absence of B cells during an immune response.  For 
example, in some experiments presented below, B cells were depleted on day 10 of 
infection.  The initial priming of the immune response therefore occurred in a B cell-
sufficient environment, with B cells absent during the later stages of infection.  Conversely, 
mice depleted of B cells on day -7 (i.e. before infection) lacked B cells throughout the 
immune response, and should resemble B cell-deficient µMT mice. 
 
I, therefore, use anti-CD20 depletion antibodies in the S. typhimurium infection model to 
further dissect the role of B cells in generating CD4+ T cell responses.  Specifically, I focus 
on the involvement of B cells in T cell memory generation.  It has previously been shown, 
both in the S. typhimurium infection model [154,155] and in other infections [152,153], that 
T helper cell memory is impaired in B cell-deficient mice.  However, the exact role of B 
cells in influencing T cell memory generation remains unknown.  Previous data indicates 
that B cell expression of MHC class II is required for efficient T cell memory generation 
[142], indicating that direct contact between cognate B and T cells is essential.  This would 
suggest that B cells are required to provide a specific signal that other APCs, such as 
dendritic cells, are unable to supply.  This may be a specific signalling molecule expressed 
only by B cells, or alternatively, a signal that other APCs can express, but that is not of the 
correct quantity, quality or ‘context’ for T cell memory to be generated.  Thus, by depleting 
B cells on different days of infection, I aim to determine the window of time in which B cells 
are required for T cell memory generation.  It should be noted that, although the data 
presented discusses the role of B cells in the generation of memory T cells, the fact that B 
cells are thought to also play a role in the maintenance of T cell memory should not be 
ignored [116].  As B cell depletion is fairly long-lived, the distinction between generation 
and maintenance of memory T cells proves difficult. 
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In addition to analysing the generation of T cell memory, I also investigate the effects of B 
cell depletion on the CD4+ T cells most intimately associated with B cells in the follicular 
regions; the TFH cells.  B cells are critically dependent on ‘help’ from TFH cells for the GC 
reaction to occur, and the subsequent differentiation of class switched effector and memory 
cells [54].  The secretion of IL-21 by such TFH cells is thought to aid the differentiation of 
plasma cells, while the high expression levels of co-stimulatory molecules by TFH cells 
ensures B cell survival and differentiation [54].  The location of this T cell subset within the 
follicles allows direct contact with B cells, and thus it seems likely that B cell depletion will 
affect this cell population. 
 
Therefore, using anti-CD20 B cell depletion in S. typhimurium infection, I aim to investigate 
the role of B cells in the generation and maintenance of TFH cells, and analyse at what time-








CD20 expression by B cells 
The B cell depletion antibody targets the surface molecule CD20, which is expressed only by 
B cells.  Firstly, B cells from different organs were analysed for their expression of this 
molecule (figure 5.1A).  B cells from the spleen, lymph nodes and peritoneal cavity were 
found to express an intermediate level of CD20, while expression of CD20 by B cells in the 
bone marrow was lowest.  Interestingly, the Peyer’s patches were found to have two distinct 
populations of B cells, which differed in their expression of CD20 (figure 5.1A).  These cells 
were further analysed in order to determine the nature of their differences.  In figure 5.1B it 
can be seen that the CD20hi population expressed higher levels of CD40 and CD80, and 
lower levels of CD62L than the CD20lo population, suggesting that they are in a more 
activated state.  The CD20hi cells were analysed for GL7 and IgD expression, to determine if 
they are GC B cells with a GL7+ IgD- phenotype.  The CD20hi cells appeared to have more 
of a GC phenotype, in that they expressed higher levels of GL7 and lower levels of IgD than 
the CD20lo population (figure 5.1C).  By analysing this in a different way, it was clear that 
by gating on the GL7+ IgD- GC B cells, they expressed higher levels of CD20 then the GL7- 
IgD+ non-GC B cells (figure 5.1D).  Therefore, these CD20hi B cells are likely activated 
cells, some of which are undergoing the GC reaction. 
 
B cell subsets in the spleen were also analysed for their surface expression levels of CD20.  
Figure 5.2 shows that marginal zone B cells (CD21hi CD23int-lo) were found to express higher 
levels of CD20 than follicular B cells (CD21int-hi CD23hi) (figure 5.2A), while B1 cells 
(B220int CD5int) expressed greater levels than B2 cells (B220hi CD5lo) (figure 5.2B).  All B 
cell subsets expressed levels of CD20 above isotype control levels. 
 
Together, the data from figures 5.1 & 5.2 indicate that B cell subsets, and B cells from 
different tissues, express varying levels of CD20.  However, in all cases, B cells expressed 
CD20 to some degree (above isotype control levels), and therefore should be depleted by the 
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B cell depletion is efficient with immunisation, and lasts upwards of 5 weeks 
In order to determine the efficiency and timescale of B cell depletion in vivo, a depletion 
experiment was performed, in which mice were treated with a single dose of anti-CD20 
depletion antibody.  Mice were subsequently immunised the following day, and B cell 
numbers followed over time in various lymphoid tissues.  The data presented in figure 5.3A 
reveal that B cells numbers were vastly reduced even by day 3 post-treatment in all organs 
analysed, and this reached baseline by day 10 (red line).  In the spleen, the major site of B 
cell localisation, B cell numbers constituted less than 0.5% by day 10 post-treatment, 
indicating efficient depletion.  Non-depleted mice showed an increase in B cell numbers in 
the peritoneal cavity, as would be expected following the i.p. immunisation (blue line).  In B 
cell-depleted mice, however, this increase did not occur, and B cell numbers reached 
baseline by day 3 post-treatment.  Interestingly, the population of B cells that remained in 
the bone marrow were found to be CD20- (see figure 5.11B later).  A population of B cells 
was also seen to remain in the Peyer’s patches, constituting around 15% of live cells, 
although these cells were not further investigated.  However, B cell numbers in the Peyer’s 
patches were still reduced, as starting levels in uninfected mice were ~60-70%.  Looking at 
B cell subsets within the spleen, both marginal zone and follicular B cells were fully 
depleted by day 10 post-treatment, although the decline of marginal zone B cells appeared 
slower than that of follicular B cells (figure 5.3B). 
 
B cell repopulation was not seen in any organ investigated during the 5-week time-course of 
this experiment (except for one mouse which showed ~8% B cells in the lymph nodes at day 
38, figure 5.3A), indicating that depletion was surprisingly long-lived.  Antigen-specific 
antibody responses following boosting (i.e. day 38 post-treatment) were also analysed in 
these mice (figure 5.3C).  All antibody isotypes were reduced in the depleted mice when 
compared to non-depleted mice, but some isotypes, specifically IgG1, appeared significantly 
higher in depleted mice than naïve unimmunised mice, suggesting that they mounted a 
partial antigen-specific antibody response. 
 
It is clear, therefore, that anti-CD20-mediated B cell depletion is both efficient and long-
lasting.  Importantly, depletion was effective with immunisation, allowing this system to be 
used to follow antigen-specific immune responses following immunisation or during 
infection. 
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T cell memory is impaired in B cell-deficient mice following S. typhimurium 
infection 
As mentioned above, one of the aims of this project was to analyse the role of B cells in the 
generation of CD4+ T cell memory.  Firstly, I wanted to confirm that B cell-deficient mice 
have impaired T cell immunity following S. typhimurium infection, as has previously been 
studied [154,155].  T helper cell cytokine production following in vitro restimulation with 
Salmonella C5 antigen was used as a measure of memory.  In these cultures, irradiated 
whole spleen cells were used as APCs, and thus both dendritic cells and B cells were present 
as antigen presenters.  However, antigen-specific/primed B cells are absent in these cultures, 
as T cells from infected mice were positively selected prior to culture, and thus B cells were 
excluded.  IFN" is the ‘hallmark’ Th1 cytokine, and its production, together with IL-2, is 
most representative of T cell memory to Salmonella.  The data presented in figure 5.4 reveal 
that B cell-deficient (µMT) mice had significantly impaired T cell IL-2, IL-10, IFN", and IL-
17 recall responses to Salmonella antigen 12 weeks post-infection when compared to wild 
type mice.  These data confirm that B cell-deficient mice have an impairment in T cell 
memory, and that the S. typhimurium infection model is a suitable system for investigating T 
cell memory. 
 
B cell-depleted mice show normal primary T cell responses to S. typhimurium 
In order to investigate the timing of the involvement of B cells in the generation of T helper 
cell responses, B cells were depleted at different times during S. typhimurium infection.  The 
protocol used is outlined in figure 5.5.  Briefly, mice were treated with a single dose of anti-
CD20 B cell depletion antibody on either day -7, day 2, or day 10.  Control groups of mice 
received an isotype control on the same days.  All mice were infected with S. typhimurium 
on day 0.  The primary (day 7) and memory (week 12) T cell responses were assayed.  At 
these time-points, splenic bacterial load was measured, and T cell responses analysed by 
means of in vitro restimulation, and activation marker expression directly ex vivo.  B cell 
numbers were also analysed to determine depletion status. 
 
Looking at the primary time-point, it was confirmed that B cells had been depleted from the 
spleens of both the day -7 and day 2 depleted groups, but not the isotype control-treated 
groups (figure 5.6A).  Percentages of B cells in the spleen of the day 2 depleted group were 
<0.5%, indicating that B cells were fully depleted by 5 days after treatment.  Splenic 
bacterial load, both per gram and per spleen, was found to be equivalent in the non-depleted 
and depleted mice (figure 5.6B), indicating that the absence of B cells did not impact on the 
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early control of bacterial growth.  By isolating the CD4+ T cell population, these cells were 
analysed for the activation markers CD62L, CD44, and CD25.  The data in figure 5.6C 
reveal that T cells from mice depleted on day -7 appeared less activated (i.e. express more 
CD62L, less CD44 and less CD25) than the isotype-treated controls.  Mice depleted on day 
2, however, appeared to have normal levels of T cell activation markers.  This would suggest 
that T cell priming is slightly impaired when B cells are absent at the initiation of the 
immune response. 
 
When restimulated in vitro, T cell cytokine production was largely equivalent across the 
depleted and non-depleted groups (figure 5.6D).  Certainly, no impairment in IFN", the 
typical Th1 cytokine, was identified, while T cell IL-10 production appeared slightly 
enhanced in both the B cell-depleted groups.  T cell IL-17 production appeared slightly 
reduced in the day -7 depleted group.  However, IL-17 levels were low at this early stage of 
infection, so no strong conclusions on the role of B cells in Th17 cell priming can be made.  
IL-2 production by T cells is undetectable at this early stage (data not shown).  Together, 
these data indicate that the early Th1 response was largely normal in B cell-depleted mice, 
which supports published data that B cells are not required for driving primary T cell 
responses [145,146]. 
 
Mice depleted of B cells on day -7 or day 2 of S. typhimurium infection show 
impaired T cell memory generation 
In addition to analysing the primary T helper cell response, B cell-depleted animals were 
analysed 12 weeks post-infection to look at bacterial clearance and memory T cell presence.  
This experiment aimed to determine the timing of the involvement of B cells in the 
generation of T cell memory, in the S. typhimurium infection model. 
 
As can be seen in figure 5.7A, in depleted groups the B cells had repopulated the spleen by 
this late time-point.  Interestingly, B cells had not fully repopulated the spleens of two of the 
mice in the day -7 depleted group.  The kinetics of B cell repopulation following depletion 
during infection are discussed later (see figure 5.11).  Meanwhile, splenic bacteria had 
almost been cleared in all of the groups of mice, with just a few viable bacteria remaining 
(figure 5.7B).  The depletion of B cells did not therefore affect the clearance of this 
pathogen, despite the lack of antibody and impaired T helper cell responses. 
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CD4+ T cell cytokine production following restimulation with Salmonella antigen was 
assayed, as a measure of T cell memory, in mice depleted of B cells at different times during 
infection.  It is clear from the data presented in figure 5.7C that the day -7 and day 2 depleted 
groups show impaired T cell IL-2 and IFN" responses, the main Th1-associated cytokines.  
This is indicative of impaired memory generation when B cells were depleted on day -7 or 
day 2 of infection.  T cell IL-17 production was also defective in the day -7 and day 2 
depleted groups, suggesting Th17 memory was also impaired in these groups.  In all cases, 
cytokine production by T cells from the day 10 depleted group was equivalent to that of the 
non-depleted group, indicating normal memory generation.  It should be noted, however, that 
although T cell cytokine production is reduced in the day -7 and day 2 depleted groups in 
comparison to non-depleted mice, levels are above that of naïve T cells, suggesting that 
some memory is formed, even in the absence of B cells. 
 
T cell IL-10 production, seen in figure 5.7C, was equivalent in the depleted and non-depleted 
groups.  Interestingly, this IL-10 production by infected mice was also equivalent to levels 
produced by naïve T cells, suggesting that T cell IL-10 production in response to Salmonella 
antigen in culture is not a memory response, and therefore that IL-10 production by T cells 
cannot be utilised as a measure of memory in this model.  Together, the data presented in 
figure 5.7C highlight a role for B cells during the first ~10 days of infection for efficient T 
helper cell memory generation. 
 
Antibody responses are reduced in depleted groups, while B cell cytokine 
responses after repopulation appear normal 
The Salmonella-specific serum antibody responses were measured in B cell-depleted and 
non-depleted mice 12 weeks post-infection.  Unsurprisingly, antibody responses (total 
Salmonella-specific immunoglobulin) were reduced in mice depleted on days -7 or 2 (figure 
5.8A).  Mice depleted on day 10 of infection had strong antibody responses, but this was still 
reduced when compared to isotype control-treated mice. 
 
As mentioned above, B cells had repopulated the spleens of depleted mice by 12 weeks post-
infection (see figure 5.7A).  These B cells were isolated, stimulated in vitro, and cytokine 
production analysed, in order to determine if they were capable of responding to the bacterial 
antigen, and not refractory in any way.  Figure 5.8B shows that B cell IL-6, IL-10 and IFN" 
production was largely equivalent across both depleted and non-depleted groups.  B cell 
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production of IFN! was particularly variable at this time (figure 5.8B, far right), and minimal 
in comparison to levels of T cell-derived IFN!.  Indeed, the levels of cytokine produced by B 
cells 12 weeks post-infection were comparable with that produced by naïve B cells (figure 
5.8B).  This would imply that B cells from infected mice do not possess cytokine memory, 
as was discussed in chapter 3. 
 
B cells are required for T follicular helper cell generation and maintenance 
The data presented in figure 5.7 indicate a role for B cells during the first ~10 days of 
infection for the generation of T helper cell memory.  However, the exact function of B cells 
in driving T cell memory formation remains unknown.  As the B cell follicles are the most 
likely site of B-T cell interaction, T cells with the TFH phenotype were investigated during 
Salmonella infection.  These TFH cells can be identified by several different ways according 
to the unique markers they express.  Here, I identified TFH cells by flow cytometry either by 
ICOS and CXCR5 expression, or by PD-1 and CXCR5 expression.  Example staining and 
gating of TFH cells, for each method of identification, is given in figure 5.9A.  It was found 
that, during the early stages of S. typhimurium infection in B cell-sufficient mice, the TFH cell 
population in the spleen expanded up until day 7, before reaching a plateau (figures 5.9B & 
C, blue line).  B cell-deficient µMT mice lacked this population of T cells entirely (figures 
5.9B & C, purple line).  By treating mice with anti-CD20 B cell depletion antibody on day 2, 
the numbers of TFH cells rose slightly above µMT levels, but did not really get the chance to 
establish, and remained at low levels.  Meanwhile, treating with anti-CD20 on day 10 of 
infection resulted in the initial expansion of this population, which was then rapidly lost.  In 
both cases, by day 16 of infection the TFH cell population had been completely abolished 
(figure 5.9B and C, red lines).  These data indicate that B cells are essential for both the 
generation and maintenance of TFH cells during S. typhimurium infection, and suggests that B 
cells may provide a survival niche or signal for the TFH cell population. 
 
A large proportion of T follicular helper cells appear to be Th1 effector cells 
These TFH cells, found in large numbers during the early stages of S. typhimurium infection, 
precede the helper function, as GCs do not appear in this model until ~4 weeks [206].  
Therefore, these early TFH cells were further analysed for their expression of the Th1-
associated transcription factor, Tbet, and the activation marker, CD44, to determine if they 
have a Th1 phenotype.  Figures 5.10A & B show that, by day 7 of infection, around 70% of 
the TFH cell population were CD44hi and expressing Tbet, suggesting that they are activated 
Th1 cells.  While at the same time-point only around 10% of non-TFH cells expressed these 
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markers.  Thus at this early stage of infection, when TFH cell numbers were increasing, a 
greater proportion of TFH cells had this Th1 effector cell phenotype than non-TFH cells 
(figure 5.10B), indicating either that T cells expressing the Th1 master regulator are over-
represented in the TFH cell subset, or that TFH cells begin to express Th1 markers. 
 
Further data confirming that these TFH cells are Th1 effector cells is shown in figure 5.10C, 
from Dr Tom Barr’s work.  These data show that, by gating on either IFN!+ or IFN!- T cells 
identified by intracellular staining in naïve or day 7-infected mice, the IFN!+ T cells present 
in large numbers on day 7 of infection have an ICOS+ CXCR5+ TFH cell phenotype.  In other 
words, the IFN!-producing T cells at this early stage of infection are predominantly of the 
TFH cell phenotype.  It should be noted, however, that many more T cells within the spleen 
express Tbet than secrete IFN!.  Together, the data presented in figure 5.10 highlight the 
plasticity between the Th1 and TFH cell populations.  The data further imply that a large 
proportion of T cells with the TFH cell phenotype on day 7 of infection are antigen-specific 
Th1 effector cells, responding to the pathogen. 
 
B cell repopulation is enhanced when B cells are depleted during established 
S. typhimurium infection 
The kinetics of B cell repopulation in uninfected and Salmonella-infected mice were 
analysed, to determine the effects of immune activation on the efficacy of anti-CD20-
mediated B cell depletion.  To do this, mice were treated with a single dose of anti-CD20 B 
cell depletion antibody on day 0.  Mice were either infected with S. typhimurium before 
depletion (day -7), after depletion (day 7), or left uninfected.  B cell numbers in the spleen, 
lymph nodes and bone marrow were analysed in the weeks following depletion.  It appears 
that by depleting B cells before infection, B cell repopulation was delayed in comparison to 
depletion during infection (figure 5.11A).  In other words, when B cells were depleted after 
Salmonella infection had already established, they returned sooner.  These data also agree 
with that seen in figure 5.7A, where two mice in the day -7 depleted group had not fully 
repopulated B cells in the spleen 12 weeks after infection, while B cell repopulation was 
complete in both the day 2 and day 10 depleted groups. 
 
Additionally, this experiment provided interesting information on the B cell populations 
within the bone marrow.  In naïve bone marrow there appeared to be 2 distinct populations 
of B cells when CD19 was plotted against CD20 (figure 5.11B, far left, see gates).  These are 
likely to be CD19+ CD20+ mature B cells, and CD19+ CD20- immature pro-B cells.  When 
Chapter 5:  Role of B cells in T cell memory (Salmonella) 
! "#)!
mice were treated with anti-CD20 B cell depletion antibody, only one of these populations 
(the CD19+ CD20+ mature B cells) was depleted (figure 5.11B, second from the left).  Non-
depleted mice infected with S. typhimurium underwent profound changes in their bone 
marrow, and the CD19+ CD20- B cell population was lost while only the CD19+ CD20+ 
population remained (figure 5.11B, second from the right).  Anti-CD20 treatment combined 
with S. typhimurium infection resulted in the loss of both B cell populations in the bone 
marrow (figure 5.11B, far right).  These data reveal that the changes in lymphocyte subsets 
induced by S. typhimurium infection are not restricted to the spleen (as outlined in chapter 
4), but lymphocytes in the bone marrow, too, are altered.  These data also explain that seen 
in figure 5.11A, where in the bone marrow anti-CD20 treatment alone (square symbols) did 
not efficiently deplete the B cell population, as by gating on CD19+ cells included the CD20- 
pro-B cell population that resisted depletion. 




Levels of CD20 expressed by B cell subsets 
CD20 expression by B cells was found to vary depending on the organ and subset from 
which they were isolated (figures 5.1 and 5.2).  While expression of CD20 by B cells from 
the spleen and lymph nodes was similar, in the bone marrow CD20 expression levels were 
much lower.  This is likely due to the presence of immature pro-B cells in the bone marrow, 
which express the B cell marker CD19 but do not yet express CD20 [220,228].  In the 
Peyer’s patches, a population of B cells was found to express high levels of CD20 (although 
a further CD20- population, which was resistant to depletion, may also be present).  Upon 
further investigation, these CD20hi cells were found to be in a more activated state, and 
resemble GC B cells.  As the Peyer’s patch B cells are involved in IgA production for gut 
immunity, they are thought to have large numbers of GCs [307].  Although published data 
indicates that GC B cells maintain surface expression of CD20 [228], I have found no data 
suggesting they express this molecule at higher levels.  However, there is evidence to 
suggest that signalling through CD20 functions in rescuing GC B cells from apoptosis [308], 
so it would make sense that these cells therefore express CD20 at higher levels, explaining 
the results seen here in figure 5.1.  These CD20hi B cells were also found in small numbers in 
the spleen and lymph nodes, where the number of B ells undergoing the GC reaction in naïve 
mice is lower.  CD20 expression levels on B cells in the peritoneal cavity were similar to B 
cells from the spleen.  Thus there appears no reason that this population of B2 cells should 
be resistant to depletion, as has previously been suggested [309]. 
 
B cell depletion kinetics 
Depletion of B cells from the spleen, lymph nodes, blood and peritoneal cavity following 
immunisation was both efficient and long-lived (figure 5.3).  However, populations of B 
cells were found to remain in both the bone marrow and Peyer’s patches.  The population of 
CD19+ cells that remained in the bone marrow was found to be CD20- and are therefore 
likely to be immature pro-B cells.  The B cell population in the Peyer’s patches that was 
resistant to depletion was not further investigated.  However, assuming that these cells are 
CD20-, they may be CD19+ CD20- plasmablasts, on their way to becoming CD19- CD20- 
fully differentiated plasma cells [228], although few B cells in the Peyer’s patches appeared 
CD20- before depletion (figure 5.1A).  Alternatively, these cells may be GC B cells, which 
are more resistant to depletion than follicular B cells [241].  As mentioned above, Peyer’s 
patches, together with mesenteric lymph nodes, have large numbers of GCs for the 
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generation of IgA-secreting plasmablasts, which then migrate to the lamina propria and 
maintain gut immunity [307,310].  A more detailed analysis of this population would be 
required to confirm the phenotype of these resistant Peyer’s patch B cells. 
 
B cell numbers reached baseline levels in the blood, bone marrow and peritoneal cavity by 3 
days post-depletion, while in the spleen, lymph nodes and Peyer’s patches, baseline levels 
had been reached by day 10 (figure 5.3).  These data therefore indicate that depletion takes 
3-10 days.  The data in figure 5.6A allow the more accurate analysis of the time interval 
required for B cell depletion, as mice depleted on day 2 of infection had <0.5% B cells in the 
spleen 5 days later.  Thus it can be concluded that B cell depletion takes around 3-5 days.  
This interval of 3-5 days for B cells to be depleted should be kept in mind when analysing 
results from mice treated on different days on infection.  For example, mice treated on day 2 
of infection will still have some, although significantly less, B cells on day 5. 
 
B cell subset depletion 
The depletion kinetics of B cells within the spleen appeared to differ depending on the subset 
analysed.  The data in figure 5.3B indicate that follicular B cell numbers were rapidly 
diminished, while the loss of the marginal zone B cell population was delayed.  This is in 
agreement with previously published data, which shows marginal zone B cells to be more 
resistant to depletion than follicular B cells [241].  This result was surprising as marginal 
zone B cells expressed higher levels of surface CD20 than follicular B cells (figure 5.2), and 
are known to be the first B cell subset in the spleen to access circulating antibodies (see 
chapter 4), and thus one might have expected the marginal zone population to be depleted 
first.  These data therefore suggest that marginal zone B cells have an innate resistance to 
depletion.  Thus, the susceptibility or resistance to depletion does not appear to correlate 
with surface expression of CD20.  One possible explanation for the resistance of marginal 
zone B cells is that the induction of apoptosis, one of the mechanisms by which B cells are 
depleted [224], may be less efficient in these cells, either due to survival factors in the 
marginal zone or characteristics of the long-lived marginal zone cells themselves. 
 
It should be noted that all data presented in figure 5.3A relates to CD19+ B cells.  B1 cells 
(B220int CD5int) found predominantly in the peritoneal cavity were not included in this 
analysis.  Therefore the kinetics of depletion (and repopulation) of these cells in this model 
remain unknown.  However, some published data provides insight into these cells, stating 
that they are more resistant to depletion than splenic B cells [240,309].  This may be due to 
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an innate resistance mechanism, similar to marginal zone B cells, or due to reduced access to 
depletion antibodies as a result of their non-circulatory status.  A study by Hamaguchi et al 
went some way to answering this question.  By adoptively transferring splenic B cells into 
the peritoneal cavity the authors found these cells to be similarly resistant to depletion, 
suggesting that the reason for their resistance is that lack of antibody access to this site [309].  
Although my data does not address the resistance of the B1 cell population within the 
peritoneal cavity, conventional CD19+ B2 cells in this site were efficiently depleted (figure 
5.3A). 
 
The duration of B cell depletion 
B cell depletion was surprisingly long lasting, with numbers still at basal levels for the 
duration of the initial depletion experiment, upwards of 5 weeks post-depletion (figure 
5.3A).  The anti-CD20 depletion antibody used was the 18B12 clone of the IgG2a isotype, 
which should therefore follow an exponential decay cycle, with a half-life of 6-8 days [311].  
Unfortunately, circulating anti-CD20 levels were not analysed here.  Analysing such serum 
IgG2a would perhaps reveal how long after treatment this antibody remains in circulation in 
vivo, and would help establish the timescale of its effectiveness.  The initial report, by the 
authors who made this particular clone of anti-mouse CD20, shows B cell numbers to be on 
the increase ~4 weeks post-depletion, with numbers returning to non-depleted levels around 
7-8 weeks post-treatment [242].  Thus, B cell depletion seen here appears to last longer than 
previously reported, despite giving the same dose of anti-CD20 via the same route.  The 
difference in longevity of depletion seen here may be due to the mouse strain used.  
However, analysis ~11-12 weeks post depletion revealed B cell numbers in the spleen to 
have returned to non-depleted levels (figure 5.7A).  Furthermore, these B cells that returned 
to the spleen continued to express CD20 on the cell surface at similar levels to pre-depletion 
(data not shown), and so should not be resistant to further depletion.  This would suggest that 
no selection for CD20- B cells has taken place after this single does of anti-CD20, as has 
been suggested in a previous study following long-term treatment in humans [312].  
Additionally, the repopulating splenic B cells responded to heat-killed bacterial antigen in 
vitro in a similar way to non-depleted B cells and naïve B cells (figure 5.8B), indicating that 
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B cell repopulation in S. typhimurium infection 
Interestingly, the kinetics of B cell repopulation appeared to be accelerated in mice with 
established S. typhimurium infection, in comparison to mice depleted of B cells before 
infection (figure 5.11A).  In other words, depletion before infection was longer lived than 
depletion during infection.  This would suggest that the pathogen, or the immune response to 
it, is causing B cells to repopulate the lymphoid tissues at a faster rate.  There are several 
possible explanations for this.  B cell depletion may be less effective during an ongoing 
immune response, perhaps due to the activated state of the cells.  Indeed GC B cells have 
been shown to be more resistant to depletion than both follicular and marginal zone B cells 
[241].  However, the data presented in figure 5.11A suggest that this is not the case, as B 
cells reached basal levels of <0.5% before repopulation, even when depleted during 
infection.  Alternatively, anti-CD20 may decay and be removed from the circulation at a 
faster rate during infection.  The increase in number and activation status of splenic 
macrophages will result in a greater phagocytic capacity, and may be more efficient at 
removing particles from the bloodstream.  The removal of anti-CD20 from circulation would 
therefore allow the regeneration of mature B cells from their precursors in the bone marrow 
sooner.  However, as this antibody is generated in mice [240], it should not appear as a 
foreign particle, and therefore whether or not enhanced degradation or removal is likely, I’m 
unsure.  A more likely explanation is that infection may increase B cell maturation from their 
precursors in the bone marrow, and enhance recruitment of such cells to the spleen.  This 
increase in B cell maturation and proliferation, as well as apoptosis, in both the bone marrow 
and spleen during infection may be ‘mopping up’ the anti-CD20 antibodies. 
 
Further investigation of the bone marrow of B cell-depleted and S. typhimurium infected 
mice revealed interesting changes to B cell populations in this site (figure 5.11B).  Anti-
CD20 depletion alone depleted only mature B cells (CD19+ CD20+), whereas in S. 
typhimurium infection the population of pro-B cells (CD19+ CD20-) was lost.  B cell 
depletion combined with S. typhimurium infection resulted in the loss of both populations of 
B cells from the bone marrow.  This decrease in pro-B cell numbers in the bone marrow 
during S. typhimurium infection has previously been reported [313].  The authors attributed 
the loss of this population to be due to either increased apoptosis, as a result of direct 
colonisation of these cells by the bacteria, or elevated rates of B cell maturation.  While the 
exact mechanism of loss of pro-B cells from the bone marrow requires further investigation, 
these data clearly highlight that the bone marrow, in addition to the spleen (see chapter 4), 
undergoes profound changes to lymphocyte populations during this bacterial infection.  
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These changes may be induced by the presence of bacteria, as Salmonella has been shown to 
live within the B cell [313] and phagocyte [314] populations of the bone marrow, or as a 
result of increased maturation and recruitment of bone marrow cells to the spleen [204]. 
 
Due to the loss of the B cell precursors from the bone marrow during infection, one might 
expect B cell repopulation to be delayed in infected mice.  However, as discussed above, the 
opposite was true, and B cell repopulation was in fact enhanced by infection.  This may be 
due to the more rapid turnover and maturation of B cells and their precursors during 
infection, and subsequent recruitment to the spleen. 
 
Serum antibody levels following depletion 
As the mice used for B cell depletion were immuno-sufficient C57BL/6 mice, natural 
antibody was present in the serum before depletion.  Furthermore, existing long-lived plasma 
cells situated in the bone marrow, which are CD20-, should remain unaffected by anti-CD20 
treatment, and therefore serum antibodies specific for previously encountered antigen should 
also be present.  As mentioned in the introduction to this chapter, these existing levels of 
serum antibody are one of the advantages of this B cell depletion system over the use of B 
cell-deficient mice.  However, these levels of circulating antibody have been shown to drop 
following repeated anti-CD20 treatment in humans, with both total IgM [315] and class-
switched IgG [316,317] affected.  While the reduction in IgM levels is likely caused by the 
loss of splenic marginal zone and peritoneal B1 B cells, the loss of IgG is thought to be due 
to the death of long-lived plasma cells, as, due to the depletion of memory B cells, they are 
no longer replenished from the memory B cell pool [167].  Unfortunately, antibody levels in 
unimmunised B cell-depleted mice were not measured here, so the effects of a single dose of 
anti-CD20 in mice on serum antibody levels remain unknown.  However, the data presented 
here show antibody responses to ‘new’ antigens, encountered when B cells are depleted, to 
be impaired (figures 5.3C & 5.8A). 
 
Antigen-specific antibody production following B cell depletion 
One interesting observation from my data was that, in the initial B cell depletion experiment 
with DNP-KLH immunisation, DNP-specific antibodies in B cell-depleted mice, although 
reduced in comparison to non-depleted mice, were significantly above levels in naïve mice, 
despite anti-CD20 treatment one day before immunisation (figure 5.3C).  This antigen-
specific antibody was predominantly of the IgG1 isotype, which would suggest a T cell-
dependent mechanism, although T cell-independent IgG production has been reported in a 
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viral infection model [318].  The presence of antigen-specific class switched antibody in 
these immunised mice, which were depleted 1 day prior to immunisation, was unexpected.  
Serum was taken at the end-point of the experiment (day 37 post-treatment, which was 6 
days post-boost), at which time B cell numbers were still at basal levels.  Therefore, antibody 
production in response to the boost seems unlikely, so this antigen-specific antibody must 
have been produced during priming.  As depletion of B cells takes 3-5 days, this may have 
allowed time for B cell activation and IgG-secreting plasmablast/plasma cell differentiation, 
which are CD20- and resist depletion. 
 
Additionally, with anti-CD20 depletion in Salmonella infection, antigen-specific antibody 
was found, 12 weeks post-infection, in the day 10-depleted group (figure 8A).  Again, these 
data indicate early production of antigen-specific antibody in this system.  However, 
previous reports suggest the GC reaction doesn’t occur until late in this infection, around 4-5 
weeks [206].  Thus the presence of such antigen-specific antibody in B cell-depleted mice 
was unexpected. 
 
Together, the presence of antigen-specific antibody in B cell-depleted mice, in both the 
DNP-KLH immunisation system and in Salmonella infection, suggests early production of 
class-switched antibody before B cell depletion was completed.  These data leave us with 
unanswered questions as to how, if this antibody was produced during the first few days of 
immune priming, was it still present 5 weeks (in the DNP-KLH immunisation system) or 12 
weeks (in the Salmonella model) later:  Were long-lived IgG1-secreting plasma cells 
generated within the first few days of the immune response?  Another explanation would be 
that, as B cell depletion was not complete (0.1-0.5% CD19+ cells remain in the spleen, ~15% 
CD19+ remain in the Peyer’s patches), antigen-specific activated B cells might be in some 
way resistant to depletion, and therefore selected for survival.  As mentioned above, B cells 
that have entered the GC reaction are thought to be more resistant to depletion than either 
follicular or marginal zone B cells [241].  However, again this seems an unlikely 
explanation, as the numbers of CD19+ cells found in the spleens of day -7 and day 2 depleted 
mice appeared equivalent (<0.5%), although the Peyer’s patches were not analysed in this 
particular experiment.  Furthermore, B cell-deficient µMT mice also show ‘background’ 
CD19+ cell staining in the spleen (data not shown), presumably due to non-specific binding 
by other cell types, so how much of the remaining CD19 staining in depleted mice is real B 
cell staining is unknown.  Thus the development of this antigen-specific antibody despite B 
cell depletion required further investigation, and is discussed further later, in chapter 6. 
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B cell involvement in primary T helper cell responses 
Whether or not B cells play a role in the initial priming of T cell responses remains a topic of 
dispute.  While some authors report an impairment in primary T cell proliferation in the 
absence of B cells [142,143], others state that B cells are dispensable at this early stage 
[145,146].  Here, the use of anti-CD20-mediated B cell depletion allowed further analysis of 
the role of B cells in early T cell differentiation.  Initially, T cells isolated on day 7 of 
infection from B cell-depleted mice appeared to be in a less activated state, in terms of the 
cell surface activation markers CD62L, CD44 and CD25 (day -7 group, figure 5.6C).  
However, production of IFN", the main Th1-associated cytokine, was not impaired in either 
the day -7 or day 2 depleted groups (figure 5.6D).  If anything, IFN" production by T cells 
was higher in the B cell-depleted groups in comparison to the non-depleted groups.  This 
enhanced Th1 response in the absence of B cells has been reported previously, and may be 
due to the absence of B cell-derived IL-10 and subsequent increase in IL-12 production by 
dendritic cells [319].  Interestingly, this primary T cell IFN! production was normal in B 
cell-depleted groups, despite the loss of the TFH cell population (figure 5.9), which contains 
some cells of the Th1 phenotype (figure 5.10).  Thus although some TFH cells have a Th1 
phenotype and secrete IFN!, the loss of this population during the primary response does not 
result in impaired production of IFN! by the whole splenic T cell population. 
 
Further to the Th1 response, IL-17 production by T cells in the day -7 depleted group 
appeared reduced when compared to the other groups (figure 5.6D), which may point to a 
role of B cells in priming the early Th17 response.  Indeed, in vitro data suggests B cells are 
capable of supporting Th17 cell differentiation [320].  However, as IL-17 levels are low at 
this early stage of infection, it is impossible to draw any conclusions on the role of B cells in 
Th17 cell differentiation from this data. 
 
Conversely, IL-10 production by T cells from depleted mice appeared elevated.  Enhanced 
IL-10 production would suggest a more regulatory phenotype, but as IFN" production was 
also increased, this seems counter-regulatory.  Instead, IL-10 production may originate from 
the Th1 cells themselves, as Th1 effectors have also been shown to secrete IL-10 as a 
mechanism of self-regulation [321], and thus reflect the greater Th1 response.  In summary, 
B cell-depleted mice show fairly normal primary T cell responses to S. typhimurium, and 
thus the involvement of B cells in T cell priming appears minimal. 
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B cells are required for the generation of T cell memory 
It was firstly confirmed, with the use of B cell-deficient µMT mice, that T cell memory was 
significantly impaired following Salmonella infection in the absence of B cells (figure 5.4).  
T cell production of IL-2, IL-10, IL-17 and IFN" twelve weeks post-infection were all 
significantly impaired in the µMT mice.  These data are in agreement with previous findings 
in the same infection model [154,155], where B cell-deficient mice were shown to lack 
protective immunity, as mortality rates were significantly increased following challenge.  
The authors demonstrate that the lack of protective immunity is likely due to the lack of T 
cell-derived IFN" [154,155].  Therefore, here, the severe impairment in T cell IFN! 
production in µMT mice is likely to confer the lack of protective immunity. 
 
The use of anti-CD20-mediated B cell depletion allowed me to control the presence or 
absence of B cells, and investigate the timing of their involvement in the generation of 
memory T cells, by depletion on different days of infection.  Th1 cell memory, as identified 
by IL-2 and IFN" production, was significantly impaired when B cells were depleted on day 
-7 or day 2 of infection, whereas normal memory was generated with B cell depletion on day 
10 (figure 5.7C).  Similarly, IL-17 production was also reduced in the day -7 and day 2 
depleted groups, but not when treated with anti-CD20 on day 10.  However, even in the two 
groups with impaired T cell memory, production of IL-2, IL-17 and IFN" was higher than 
that produced by naïve mice.  These data therefore suggest that memory is not an ‘all or 
nothing’ concept, and, although reduced in the day -7 and day 2 B cell-depleted groups, it 
was not entirely absent.  It would have been interesting to then challenge these groups of 
mice with the virulent C5 strain, and establish whether the impairment in T cell memory, 
especially IFN! production, in the day -7 and day 2 depleted groups correlates with a lack of 
protective immunity.  Interestingly, IL-10 production by T cells was equivalent in all groups, 
including the naïve mice, indicating that this is not a memory response.  Therefore, IL-10 
production by T cells in this system cannot be used as a measure of T cell memory. 
 
The data presented indicate a role for B cells in the generation of T cell memory, but do not 
determine the nature of this role.  Previous data shows that the addition of immune serum 
does not rescue protection when B cell-deficient mice are challenged with the virulent strain 
[154], suggesting that antigen presentation, rather than antibody production, is required.  The 
transfer of immune serum to depleted mice, here, would be required to confirm that lack of 
antigen-specific antibody is not the cause of the impairment in T cell memory.  Importantly, 
these data provide strong evidence for the requirement of B cells during the first ~10-15 days 
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(taking into account the time it takes for B cells to be depleted) of infection for the efficient 
generation of T cell memory.  Given that this infection takes 4-6 weeks to be cleared, and 
GC formation and switched antibody production doesn’t occur until 1 month after infection 
[206] (and T.A. Barr, S. Brown, T. Slocombe & D. Gray, unpublished data), this result was 
unexpected.  Furthermore, my result is contradictory to previous reports that B cells are not 
involved in antigen presentation until late in immune responses, either because they cannot 
prime naïve T cells [139], or because the numbers of cognate B cells capable of presenting 
antigen are too low before proliferation in the GC [133].  These results therefore leave us 
with the question as to what it is that B cells are doing between days 2 and 10 of infection 
that is impacting on T cell memory generation.  This concept is discussed in greater detail 
below, and in the final discussion in chapter 7. 
 
The generation and maintenance of T follicular helper cells is dependent on 
the presence of B cells 
In addition to functioning as APCs for the generation of T cell memory, B cells were found 
to be essential for both the generation and maintenance of TFH cells (figure 5.9).  During S. 
typhimurium infection, the TFH cell population expanded in non-depleted mice, whether 
through proliferation or increased migration to the follicles remains undetermined.  Baseline 
levels of TFH cells were lower in uninfected µMT mice, while the expansion of this 
population during infection did not occur, suggesting that B cells are required for their 
generation and/or maintenance.  The use of anti-CD20 allowed a fuller investigation into the 
dependence of this population on B cells.  Depletion of B cells on day 2 of infection resulted 
in the initial increase in TFH cell numbers, but these cells were rapidly lost following anti-
CD20 treatment.  Meanwhile, depletion on day 10 allowed normal expansion of TFH cells, 
but again this population was lost.  The rapid loss of TFH cells within a few days after B cell 
depletion suggests that B cells provide a survival niche or signal for the maintenance of this 
population.  Together, these data show that B cells are required for both the expansion and 
maintenance of this population during S. typhimurium infection. 
 
Previously published data comments on the role of B cells in TFH cell presence and function.  
B cell numbers, for example, have been shown to correlate well with the number of T cells 
situated in the follicle [75].  The authors show the accumulation of T cells in the follicles 
following immunisation to be dependent on dendritic cells, and their expression of CD40 and 
OX40-ligand, together with T cell expression of CXCR5 [75].  However, neither the 
expression of CD40 or MHC class II by B cells is necessary for the migration of T cells to 
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the follicles [75].  The absence of ICOSL expression by B cells results in significantly 
decreased numbers of TFH cells following KLH immunisation, although numbers are not 
reduced to levels seen in B cell-deficient mice [40].  Thus, my data highlight that B cells are 
not only required for the expansion of the TFH cell population during an immune response, 
but are also essential for their maintenance under steady-state conditions.  Whether this is 
solely dependent on B cell expression of ICOSL, or whether other signals are involved, 
remains to be investigated. 
 
B-T cell interaction in the follicles 
Activated Th1 cells, identified by Tbet expression and IFN! production (figure 5.10), were 
over-represented in the TFH cell compartment during the initial week of infection.  In other 
words, a large proportion (~70% on day 7 of infection) of TFH cells appeared to be activated 
Th1 cells.  This would suggest, therefore, that many of these cells are antigen-specific T cells 
responding to the infection, although antigen-specificity is not assayed directly here.  Other 
members of the laboratory have proved that the increase in cells of the TFH cell phenotype by 
flow cytometry correlates with an increase in T cell staining within the follicles (T.A. Barr, 
S. Brown & D. Gray, unpublished data), confirming that these cells enter the B cell regions 
of the spleen.  This migration of newly activated T cells into the follicles has been shown 
previously, and is due to the rapid upregulation of CXCR5 expression by T cells upon 
activation [322].  Therefore, what is currently identified with these markers as a TFH cell 
population may, in the early stages following activation, be a transient phase that activated T 
helper cells go through.  During this time, antigen-specific T cells would have the 
opportunity to interact with B cells in the follicles.  I predict that these early TFH cells, seen 
clearly during S. typhimurium infection, will be different in gene expression and function 
from the bona fide TFH cells that help select B cells in the GC.  Because GCs form only 
beyond day 40 during Salmonella infection [206], there is a separation of these early TFH 
cells from those that go on to inhabit GCs.  Thus, the Salmonella infection model is ideal for 
dissecting the heterogeneity of the TFH cell population.  This matter is discussed more 
extensively in the final discussion presented in chapter 7. 
 
Could T follicular helper cells be memory precursors? 
The presence or absence of TFH cells correlated with the generation of T cell memory.  
Specifically, by depleting B cells on day 2 of infection, the TFH cell population did not 
expand, and T cell memory was not generated.  Conversely, B cell depletion on day 10 of 
infection resulted in the initial expansion of TFH cells until the plateau phase was reached, 
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before these cells were lost, and memory generation was normal (figures 5.7 & 5.9).  I 
propose that these TFH cells with a Th1 phenotype found during the first ~1-3 weeks after 
infection are antigen-specific T cells that interact with B cells within the follicle, and receive 
the signal necessary for memory generation.  Therefore, these cells with the transient TFH 
phenotype, or a proportion of them, may be memory precursors.  The dependence of T cell 
memory generation on the presence of B cells would be explained by the fact that TFH cells 
are also dependent on B cells.  With B cell depletion on day 10 of infection, having normal 
numbers of TFH cells for the initial ~10-12 days appears to be enough for T cell memory to 
be generated. 
 
However, this theory is purely speculative, and my data does not directly link the TFH cell 
population to the generation of memory cells.  Clearly, this apparent correlation between TFH 
cells and T cell memory generation requires further investigation.  In order to more directly 
link TFH cell expansion during infection to memory cell development, one experiment would 
be to prevent the expansion of TFH cells, and note the effect on memory generation.  As 
CXCR5 expression by T cells is required for the accumulation of T cells in the follicles after 
immunisation [75], then migration to the follicles can be prevented using CXCR5-deficient 
T cells.  The use of either CXCR5-/- T cell transfers, or making chimeras in which the T cell 
population alone is deficient in CXCR5, would prevent the migration of such T cells to the 
follicles, and may inhibit the B-T cell interaction required for T cell memory generation.  It 
would therefore be interesting to see if the development of T cell memory is impaired in 
such systems. 
 
Disadvantages of the B cell depletion system 
Although anti-CD20 B cell depletion has been used here as a better alternative to the use of 
B cell-deficient mice, this system is not without its drawbacks.  Firstly, B cell depletion early 
in the immune response (on days -7 or 2 of infection) resulted in an impairment in antigen-
specific antibody production (figure 5.8A).  Therefore, the data presented do not rule out a 
role of antigen-specific antibody on influencing T cell responses.  Immune serum transfer 
into these mice would be required to prove that the lack of T cell memory (and TFH cell 
development) is not as a result of diminished antibody levels, as has been done previously in 
B cell-deficient mice [154].  Furthermore, depleted mice receive a massive dose (0.25mg) of 
anti-CD20 i.v., and thus have unnaturally high levels of circulating IgG2a of this particular 
specificity.  Binding of this antibody to B cells results in their deletion by a variety of 
mechanisms, including antibody-dependent cellular cytotoxicity, complement-dependent 
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cytotoxicity and activation of the apoptotic pathway [223].  This process of removing ~60% 
of splenocytes is likely to impact upon other the other immune cells involved, such as 
phagocytes, and could therefore have a knock-on effect on the generation of immune 
responses to pathogens.  However, there is no doubt that the advantages of this system 
outweigh the drawbacks, and thus the data presented here provides great insight into the 
specific role B cells are playing in the generation of T cell responses in vivo. 
 
Implications for Rituximab treatment in human patients 
The use of anti-CD20 to analyse the effects of B cell depletion on the generation of T helper 
cell responses generated several interesting results.  B cells were found to be important in the 
generation and maintenance of TFH cells, and in the generation of T cell memory.  These 
results therefore have important implications for human patients undergoing Rituximab 
treatment.  The data presented suggest that T cell memory responses to antigens encountered 
when B cells are depleted will be severely impaired.  Moreover, existing T helper cell 
memory may also be lost with long-term B cell depletion, as B cells have been shown to be 
involved in the maintenance of such memory [116].  Antibody responses to antigens 
encountered during anti-CD20 treatment will also be impaired.  Thus patients undergoing 
anti-CD20 treatment are unlikely to gain immunity to any infectious agents or vaccine 
antigens encountered during the time of depletion, while existing immune memory, in terms 
of both T cells and antibody, is also at risk.  Furthermore, the observation that B cell 
repopulation was enhanced following depletion during ongoing S. typhimurium infection 
implies that anti-CD20-mediated B cell depletion may be less effective, in terms of duration 
of depletion, in patients with ongoing immune responses.  Although the data here was 
generated in an infection model, the same may well be true for ongoing autoimmune 
responses, such as Rheumatoid Arthritis and SLE, that Rituximab is used as a treatment for 
[228].  Indeed, in mice models of autoimmune diseases, B cell depletion by anti-CD20 is less 
effective [240].  Thus, the data presented in this chapter using anti-CD20-mediated B cell 
depletion may have significant implications for Rituximab treatment in human patients. 
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CHAPTER 6: The role of B cells in the generation of T cell 





The results from the use of anti-CD20-mediated B cell depletion in the S. typhimurium 
infection model revealed a role for B cells as APCs in the initial ~10 days of infection for the 
efficient generation of T helper cell memory.  However, using the S. typhimurium infection 
model for the analysis of T helper cell memory has its limitations, namely that the presence 
or absence of memory is measured by splenic T cell restimulations with antigen for 3 days of 
culture, and the subsequent measure of cytokine production.  In effect, a single aspect of T 
cell memory function is being measured, rather than the identification of the memory T cells 
themselves.  In order to more directly quantify the presence of antigen-specific memory T 
cells, I make use of MHC class II tetramers in a peptide immunisation system.   
 
As mentioned in the main introduction, MHC class II tetramers are a useful tool for 
identifying antigen-specific T cells directly ex vivo following immunisation with the peptide 
of interest [214].  Tetramers are composed of 4 biotinylated MHC class II molecules with the 
peptide, in this case the H19env peptide, covalently attached.  These complexes are then 
bound by PE-labelled Streptavidin [323].  An annotated diagram of an MHC class II 
tetramer is shown in figure 6.1A.  The tetramer complex mimics an APC, binding the TCR 
of antigen-specific cells, and thus these cells show up positive for PE by flow cytometry.  
One of the major advantages of using MHC class II tetramers to measure T cell responses is 
that the antigen-specific cells are being directly visualised, rather than being measured by 
function.  In addition, the use of flow cytometry allows the phenotype of tetramer+ T cells to 
be analysed by other cell markers, for example, to determine their activation status. 
 
The kinetics of T cell expansion and decline following immunisation with the H19env 
peptide have been characterised by a previous member of the laboratory, Megan MacLeod 
[215].  Following immunisation with H19env peptide in CFA subcutaneously, for example, 
the peak of antigen-specific T cell numbers in the spleen and draining lymph nodes is around 
day 9.  Thereafter, T cell numbers decline until a stable memory pool is reached.  Such 
memory cells could be identified in the spleen, albeit in small numbers, up to ~200 days after 
priming [215].  This method of identifying memory T cells has been used successfully in the 
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past in MHC class II-B cell chimeras (MHC class IIB-/-).  In these mice, the B cell 
compartment does not express MHC class II and thus cannot present antigen to CD4+ T 
cells.  Using tetramers, it was found that T helper cell memory was severely reduced in these 
MHC class IIB-/- chimeras following peptide immunisation [142].  Therefore, MHC class II 
expression by B cells, and thus antigen presentation, is required for the generation of 
memory T helper cells [142]. 
 
Here, I aim to more fully investigate the role of B cells in the development of T helper cell 
memory using the peptide immunisation system and detecting antigen-specific T cells 
directly using tetramers.  To do this, I use anti-CD20 treatment to deplete B cells on different 
days before or after immunisation, and analyse the effects on T cell memory development, in 
a similar way to in the S. typhimurium model, in chapter 5.  The results presented in chapter 
5, above, showed memory to be deficient after B cell depletion on day -7 or day 2 of S. 
typhimurium infection.  If the reduction in cytokine production in such groups equates to a 
reduction in numbers of antigen-specific T cells present, rather than reduced capacity, then 
here I expect early depletion of B cells to result in reduced numbers of tetramer+ T cells six 
weeks after peptide immunisation, at the memory time-point.  Additionally, the tetramer 
system allows the antigen-specific T cells generated in B cell-deficient or -depleted mice to 
be analysed for expression of cell surface markers, such as activation markers, and so I will 
determine any differences between T cell responses that develop in the presence or absence 
of B cells. 
 
In addition to further investigating memory generation in B cell-deficient and -depleted 
mice, I want to characterise the role of TGF" in regulating T helper cell responses in vivo, in 
order to determine the effects of the lack of TGF"-mediated regulation on the effector and 
memory responses.  The MHC class II tetramer system is ideal for doing this, as the antigen-
specific T cell response can be measured directly.  The TGF" family of cytokines influence a 
wide variety of cells within the body, including immune cells, regulating cell behaviour.  
Specifically, TGF" influences T helper cell subset differentiation, by the induction of 
FoxP3+ iTreg cells (or Th17 cells when IL-6 is present, or Th9 cells when IL-4 is present) 
[32].  Recently, a genetically modified strain of mice has been generated, in which all T cells 
express a mutant form of the TGF" receptor that is unable to transmit the signal 
intracellularly (called CD4-dnTGF"RII mice) [43].  Thus, both CD4+ and CD8+ T cells in 
these mice are unable to respond to TGF" signalling.  The resulting effects on the cytotoxic 
T effector cell response during infection have been studied in detail.  The authors report the 
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peak of CD8+ T cell numbers at the primary response to be significantly increased in the 
absence of TGF" signalling on T cells, followed by a delayed decline of this population 
[324].  The effector function of these CD8+ effector T cells, however, was unaffected by the 
lack of TGF" signalling.  The report concludes that TGF" influence on cytotoxic T cells 
regulates the contraction phase, by the induction of apoptosis [324].  Therefore, here, I aim 
to establish whether or not TGF" mediates the same effects on CD4+ T cells, following 
immunisation with the H19env peptide.  Specifically, does the lack of T helper cell 
regulation by TGF" lead to an enhancement in differentiation of short-lived effector cells 
during the primary response?  And is subsequent memory generation impaired?  The theory, 
therefore, is that in the absence of TGF"-mediated regulation of CD4+ T cells, a greater 
primary effector response soon after priming may be uncontrolled, resulting in the inability 
to generate long-lived memory cells. 
 
In summary, I make use of MHC class II tetramers to follow antigen-specific T helper cell 
responses in vivo.  By doing so, I more fully explore the requirement of B cells for T helper 
cell priming and memory development, and investigate the role of TGF" signalling in T cells 
in the regulation of the effector response, as well as memory generation. 




Identification of antigen-specific T cells using MHC class II tetramers 
MHC class II tetramers are a useful method of identifying in vivo-generated endogenous 
antigen-specific T cells, following immunisation with peptide.  Example staining and gating 
of cells, stained with the tetramer, is outlined in figure 6.1B (left to right).  Briefly, a live 
lymphocyte gate was set using forward and side scatter, and then B cells, macrophages and 
dead cells were removed from analysis by gating out B220-, F4-80- and Propidium Iodide 
(PI)-positive cells.  This excluded all non-T cells that may have bound the tetramer in a non-
specific manner, and therefore helped to reduce the number of false-positive readings.  After 
gating on CD4+ T cells, tetramer-positive cells were then viewed, usually against a T cell 
activation marker such as CD44 (figure 6.1B, left to right).  Tetramer+ T cells were 
consistently found to be in an activated CD44+ state.  Typical staining at the primary 
response generated ~0.3% tetramer+ T cells in the spleen (figure 6.1B, far right, top), while 
after boosting ~1% of T cells were likely to be tetramer+ (figure 6.1B, far right, bottom).  
The use of tetramers was, therefore, an efficient method of detecting antigen-specific T cells 
directly ex vivo, and allowed the further characterisation of these cells using other cell 
surface markers. 
 
Test of different immunisation strategies for the efficient detection of antigen-
specific T helper cell responses 
Initially, different peptide immunisation strategies were tested in order to generate a visible 
population of antigen-specific T cells, detected using MHC class II tetramers.  The primary 
and boost time-points were analysed for the presence of tetramer-binding T cells in the 
spleen and draining (inguinal) lymph nodes.  The two immunisation strategies used were as 
follows:  strategy A – priming with peptide in CFA s.c. followed by boosting with peptide in 
LPS s.c. and i.p., and strategy B – primed with activated peptide-pulsed dendritic cells i.v. 
and boosted with peptide in CFA s.c.  The data presented reveal that, at the primary time-
point on day 8, tetramer+ T cells were readily detectable in the spleens of both groups of 
mice (figure 6.2A, left), suggesting that both immunisations were inducing a splenic T cell 
response.  The group receiving the peptide immunisation in CFA s.c. (strategy A) also 
showed a strong T cell response in the draining lymph nodes (figure 6.2A, right).  However, 
the group immunised with peptide-pulsed dendritic cells i.v. (strategy B) did not have 
increased numbers of tetramer+ T cells in the inguinal lymph nodes when compared to 
background staining in naïve mice (figure 6.2A, bottom).  Thus both immunisation strategies 
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induced a strong primary T cell response in the spleen, with tetramer+ T cells clearly visible.  
Immunising with peptide emulsified in CFA by the subcutaneous route also induced a strong 
T cell response in the draining lymph nodes, so for analysing lymph node responses this 
method has clear advantages over the use of peptide-pulsed dendritic cells. 
 
The data presented in figure 6.2B (left) show that, following boosting at week 6, mice treated 
with strategy B (boosted with H19env peptide in CFA) had much greater numbers of 
antigen-specific T cells in the spleen than mice immunised with strategy A (boosted with 
LPS).  Indeed, in the group boosted with LPS, tetramer+ T cell numbers in the spleen were 
barely above that in naïve mice (figure 6.2B, left).  In the inguinal lymph nodes, the numbers 
of tetramer+ T cells were comparable between the two treatment groups (figure 6.2B, right).  
Together, these data show that immunisation strategy B (priming with peptide-pulsed 
dendritic cells, boosting with peptide in CFA) induced a much greater splenic T cell 
response after boosting than strategy A (priming with peptide in CFA, boosting with LPS). 
 
However, the use of peptide-pulsed dendritic cells for priming in immunisation strategy B 
has several drawbacks.  Firstly, due to immunising i.v. there was no primary draining lymph 
node response (figure 6.2A, right).  Secondly, as I wanted to use this model to analyse the 
role of B cells as APCs in both the early and late phases of the response, using antigen-
loaded dendritic cells may have bypassed antigen presentation by B cells, and thus may be 
an artificial model.  Therefore, for all subsequent immunisations below, I used peptide in 
CFA as a primary immunisation, and boosted with peptide-pulsed dendritic cells. 
 
B cell-depleted mice show largely normal primary T cell expansion following 
peptide immunisation 
The aim of optimising the peptide immunisation strategy for the generation of strong T cell 
responses in vivo, and the visualisation of such responses directly ex vivo using MHC class II 
tetramers, was to then combine this system with anti-CD20-mediated B cell depletion, and 
analyse the generation of T cell memory.  Thus, I wish to determine whether B cells are 
required for T helper cell responses in peptide/adjuvant immunisations in the same way as 
during S. typhimurium (see chapter 5).  The immunisation and depletion protocol used was 
similar to that used in chapter 5 above, and is outlined in figure 6.3.  Briefly, groups of mice 
were treated with a single dose of the anti-CD20 depletion antibody on either day -7, day 2, 
or day 10.  The wild type (WT) group received the anti-CD20 isotype control on day 2, and 
represents the non-depleted group.  B cell-deficient µMT mice were also included.  All mice 
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were immunised on day 0 with peptide emulsified in CFA, via the subcutaneous route.  
Where appropriate, mice were boosted 6 weeks post-immunisation with peptide-pulsed 
dendritic cells i.v.  Spleens and draining (inguinal) lymph nodes were removed on day 9 
(primary), week 6 (memory), and 5 days post-boost (boost) to detect antigen-specific T cell 
numbers using MHC class II tetramers. 
 
On day 9 after immunisation, the percentages and absolute numbers of tetramer+ T cells in 
the spleen was approximately equivalent across all the groups (figure 6.4A), although there 
is clearly large variation.  Certainly, there were no significant differences between groups.  
Thus B cell deficiency, by either depletion or in µMT mice, did not result in an impairment 
in T cell expansion in the spleen during priming.  Similarly, in the draining lymph nodes, 
there were no statistically significant differences between the percentages or numbers of 
antigen-specific T cells in different experimental groups (figure 6.4B).  However, there was 
a general trend for the numbers of tetramer+ T cells in the draining lymph nodes of µMT 
mice to be lower compared to in wild type mice (figure 6.4B, purple symbols versus blue 
symbols), although this did not reach statistical significance.  The trend for lower T cell 
responses in the draining lymph nodes in the absence of B cells was also apparent in B cell-
depleted mice (figure 6.4B, red symbols).  Therefore, although T cell priming appears 
normal in the spleen, there may be slight reduction in T cell expansion in the draining lymph 
nodes in the absence of B cells.  Due to a broad distribution of frequency of tetramer+ T 
cells, larger group sizes would have improved statistical analysis. 
 
Early depletion of B cells impairs memory T cell responses in the draining 
lymph nodes 
Detecting antigen-specific memory T helper cells 6 weeks post-immunisation in immunised 
versus unimmunised (naïve) mice was possible (see figure 6.12 below).  However, due to the 
variability within groups and the extremely low numbers of tetramer+ T cells, the use of 
MHC class II tetramers for the detection of significant differences in memory generation 
between anti-CD20 treatment groups proved unsuccessful (data not shown).  Either very 
large group sizes or a tetramer enrichment protocol [325] would have been required to detect 
any differences between B cell-depleted and non-depleted groups.  Therefore, I decided to 
boost the response using peptide-pulsed dendritic cells, and analyse T cell numbers on day 5 
post-boost as representative of memory.  However, one should bear in mind that this boost 
data also contains cells undergoing a primary response. 
 
Chapter 6:  Role of B cells in T cell memory (tetramers) 
! "&)!
The results presented in figure 6.5A reveal that B cell-deficient µMT mice had much higher 
proportions of tetramer+ T cells in the spleen than wild type mice after boosting (figure 6.5A, 
left, purple versus blue symbols).  However, when absolute numbers were calculated, 
antigen-specific T cell numbers were equivalent in the wild type and B cell-deficient mice 
(figure 6.5A, right).  Looking at B cell-depleted mice, the group depleted on day -7 showed 
reduced numbers and percentages of tetramer+ T cells in the spleen, while mice depleted on 
day 2 or day 10 had normal levels of antigen-specific T cells (figure 6.5A).  In the draining 
lymph nodes, however, mice depleted of B cells on day -7 or day 2, together with µMT 
mice, all had significantly reduced T cell responses.  Meanwhile, mice depleted of B cells on 
day 10 had normal numbers of tetramer+ T cells in the draining lymph node (figure 6.5B).  
This reduction in the boost T cell response in the draining lymph nodes of B cell-deficient 
mice, and mice depleted of B cells on day -7 or day 2, implies an impairment in T cell 
memory.  Interestingly, boost T cell responses in the spleen appeared more normal in the B 
cell-deficient (and -depleted) mice, suggesting that splenic memory was normal.  Together 
these data imply that, in the absence of B cells, the impairment in T cell memory, in terms of 
numbers of antigen-specific T cells, is most apparent in the draining lymph nodes but 
relatively normal in the spleen. 
 
The boost data presented in figure 6.5 were from one experiment out of three.  Data from the 
other two experiments (shown in appendix 1) did not show such significant differences 
between B cell-deficient and -sufficient groups, although on the whole the general trends 
remained.  Therefore, in order to get a more accurate picture of antigen-specific T helper cell 
responses in the anti-CD20 treated groups, I pooled the boost data from all three 
experiments, and analysed it to detect significant differences between groups.  To do this, I 
used a general linear model ANOVA, and Tukey’s multiple comparison test.  This method of 
analysis adjusted the data to take into account the variation between experiments.  The 
results from such analysis are presented in table 6.6.  The table displays the p-value and 
summary results from comparing each treatment group to the wild type group.  In other 
words, the wild type group was seen as the positive control, and each other group was 
compared to it, and it was determined whether or not the treatment group was significantly 
different to the positive control.  Starting with naïve mice, the results show that the boost 
response in both the spleen and draining lymph nodes of wild type mice was significantly 
greater than the numbers of tetramer+ T cells in naïve mice (table 6.6).  Moreover, the boost 
response in wild type mice was greater than the primary (wild type or µMT) response, 
indicating that memory had been generated.  Importantly, in B cell-deficient µMT mice, 
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although the percentage of tetramer+ T cells in the spleen differed to wild type mice, the 
numbers of antigen-specific T cells in the spleen after boosting was equivalent to in wild 
type mice (i.e. not significant).  However, the T cell response in the lymph nodes of µMT 
mice was significantly reduced compared to the wild type response, suggesting that T cell 
memory in the lymph nodes was impaired, but splenic responses were normal.  Looking at 
the effects of B cell depletion on the T cell boost response, anti-CD20 treatment on day 2 or 
day 10 resulted in normal T cell responses in both the spleen and lymph nodes (table 6.6).  
However, depletion of B cells on day -7 caused a reduction in the numbers of tetramer+ T 
cells identified in the lymph nodes post-boost.  As in the µMT group, splenic responses in 
the day -7 treatment group were normal. 
 
In summary, by pooling the data from the 3 experiments, I found that B cell depletion on day 
-7 resulted in impaired T cell boost responses in the lymph nodes, similar to in B cell-
deficient mice.  B cell depletion on day 2 or day 10, however, did not result in such an 
impairment.  Again, these data highlight a possible reduction in T cell memory in the lymph 
nodes in the absence of B cells, whereas responses appeared normal in the spleen.  The data 
highlights an early requirement for B cells in the efficient generation of CD4+ T cell 
memory. 
 
Mice depleted of B cells on day 2 or day 10 possess unexpectedly high levels 
of antigen-specific antibody 
As mentioned in chapter 5, I was surprised to find that mice depleted of B cells one day prior 
to immunisation with DNP-KLH mounted antigen-specific antibody responses that were 
significantly above naïve levels (figure 5.3C).  In order to further characterise the antibody 
response in immunised B cell-depleted mice, serum was collected throughout the time-
course of the above B cell depletion peptide immunisation experiment (figures 6.4 & 6.5).  
The results shown in figure 6.7A indicate that B cell-sufficient wild type mice mounted a 
strong antibody response against the peptide (blue line), a response which was absent in 
µMT mice (purple line).  Interestingly, antibody levels reached the plateau by day 9 post-
immunisation in wild type mice, suggesting a rapid B cell antibody response.  Mice treated 
with anti-CD20 on day -7 only began to produce detectable levels of antigen-specific 
antibody after boosting, when B cells had repopulated (red squares).  The group of mice 
depleted of B cells on day 2 post-immunisation had equivalent levels of peptide-specific 
antibody to wild type mice on day 9 (red triangles).  Thereafter, serum levels of antigen-
specific antibody in the day 2-depleted group dropped more rapidly than in wild type mice, 
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and indeed levels were significantly lower than in wild type mice.  However, the levels of 
antigen-specific antibody in this day 2 depleted group remained surprisingly high, even at 
time of boosting.  Meanwhile, peptide-specific antibody levels in mice treated with anti-
CD20 on day 10 were similar to wild type levels throughout the course of the experiment 
(red circles).  In terms of total anti-H19env antibody, levels in the day 10 treatment group 
were not significantly different to those in wild type mice (figure 6.7A).  In all groups, the 
majority of this peptide-specific antibody was of the IgG1 isotype (figure 6.7B), suggesting 
an involvement for T cells.  Together, these data show that mice depleted of B cells on day 2 
or day 10 mount substantial and long-lived peptide-specific IgG1 antibody responses. 
 
Tetramer+ T cells found in the spleens of B cell-deficient mice are in a highly 
activated state 
The hypothesis was that B cell-deficient mice have impaired T cell memory generation, and 
therefore I expected these mice to have significantly lower numbers of antigen-specific T 
cells after boosting.  In fact, as can be seen in figure 6.5A above, although responses in the 
lymph nodes appeared reduced, µMT mice had normal numbers of tetramer+ T cells in the 
spleen on day 5 post-boost.  As I did not expect to find these cells in the spleen, I analysed 
them further to determine if they were different, in terms of activation marker expression, to 
those found in wild type mice.  Both at the primary and boost responses, the antigen-specific 
T cells found in µMT mice had significantly elevated levels of CD44 in comparison to those 
in wild type mice (figure 6.8B, with representative staining shown in figure 6.8A).  
Furthermore, the tetramer+ T cells isolated from µMT mice expressed lower levels of surface 
CD62L after both priming and boosting (figure 6.8C).  Together, this would suggest that T 
helper cells from µMT mice are in a highly activated state, a phenotype that is most striking 
following boosting.  Interestingly, the antigen-specific T cells found in B cell-depleted mice 
also have this more activated phenotype after boosting, in terms of their expression of CD44 
(figure 6.8D), although levels expressed by T cells from B cell-depleted mice remained 
significantly lower than in µMT mice.  This highly activated phenotype appeared restricted 
to activated T cells following immunisation, and was not a characteristic of the total T cell 
population in naïve µMT mice (figure 6.8E).  Therefore, I went on to examine the primary 
and boost T cell responses in µMT mice further, to determine if the highly activated antigen-
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Th1 and Th17 cell priming appears normal in the absence of B cells 
In order to establish whether or not antigen-specific T cells in µMT mice, with the highly 
activated phenotype, had the same effector cell capacity as those in wild type mice, I further 
analysed T cells ex vivo at both the primary and boost time-points for their Th1 and Th17 
phenotype.  To do this, I stained for the transcription factors Tbet (Th1) and Ror!t (Th17), 
and performed intracellular cytokine staining for the typical Th1-and Th17-associated 
cytokines, IFN! and IL-17, respectively.  Such analysis will provide insight into the 
functional ability of effector T cells generated in µMT mice. 
 
Firstly, at the peak of the primary response on day 9 post-immunisation, expression of the 
Th1 cell transcription factor, Tbet, and the Th17 cell transcription factor, Ror!t, by splenic T 
cells were equivalent in wild type and µMT mice (figure 6.9A).  Furthermore, cytokine 
production, as determined by intracellular staining for IFN! and IL-17, was normal in the 
absence of B cells (figure 6.9B).  Although there were trends for lower responses in the µMT 
mice, these did not reach statistical significance, and therefore we have to conclude that 
responses were normal.  Together, these data support the tetramer+ T cell numbers data, 
above (figure 6.4), that initial T cell priming following peptide immunisation is not 
dependent on the presence of B cells.  Thus, even though T helper cells generated in the 
spleen at the primary response on day 9 after immunisation had a highly activated 
phenotype, in terms of higher CD44 levels and lower expression of CD62L (figure 6.8), they 
were neither impaired nor hyper-active in their effector cell differentiation, as measured by 
transcription factor expression, or their cytokine producing ability.  Thus, at this early time-
point, T cell priming in terms of effector responses appears normal µMT mice. 
 
Splenic Th1 and Th17 responses after boosting are equivalent in wild type and 
B cell-deficient mice 
Although T cell priming is not dependent on antigen presentation by B cells, it has already 
been established that B cells are required for T cell memory generation.  Here, however, I 
found the numbers of tetramer+ T cells in the spleen after boosting to be normal, suggesting 
that splenic memory was normal (figure 6.5A, above).  These cells differed from those in 
wild type mice, in that they appeared to have a significantly more activated phenotype, as 
they expressed higher levels of CD44 and lower levels of CD62L (figures 6.8B & C).  I 
therefore wanted to know if these cells, detectable in large numbers in the spleen after 
boosting, were capable of cytokine production and effector cell differentiation. 
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The data presented in figure 6.10A reveal that, after boosting, Tbet and Ror!t expression by 
splenic T cells was normal in µMT mice.  Additionally, production of IFN! and IL-17 by 
splenic T cells was also equivalent in the wild type and µMT groups (figure 6.10B).  These 
data suggest that the antigen-specific T cells found in µMT mice after boosting are equally 
capable of effector cell differentiation and IFN! and IL-17 secretion, compared to wild type 
cells, despite their differences in activation marker expression.  Additionally, these data 
imply that splenic T cell memory in these B cell-deficient mice was normal.  Interestingly, 
by gating on the cytokine-positive T cells, it can be seen in figure 6.10C that, again, these 
antigen-specific T cells expressed higher levels of CD44.  In other words, the highly 
activated T cells found in B cell-deficient mice were functional as cytokine-producing 
effector cells.  The reason for their variation in expression of cell surface activation markers, 
therefore, remains unknown. 
 
T cell division and effector responses are significantly impaired in the lymph 
nodes of B cell-deficient mice at the boost response 
The MHC class II tetramer staining data presented in figure 6.5B above indicate that, in the 
absence of B cells, antigen-specific T cell numbers at the boost were significantly lower in 
the lymph nodes, but normal in the spleen, in this model.  To further dissect this difference 
between splenic and lymph node responses in µMT mice, I used a BrdU incorporation 
system to investigate the expansion of T helper cells after boosting.  To do this, mice were 
injected with BrdU i.p. for three consecutive days prior to analysis.  Spleens and draining 
(inguinal) lymph nodes were then removed on day 5 post-boost and BrdU uptake measured. 
 
Figure 6.11A shows that T cell division in the spleen of immunised µMT mice was not 
significantly different from that in immunised wild type mice, although it did appear slightly 
reduced.  In the lymph nodes, however, T cell division was significantly reduced in µMT 
mice (figure 6.11B).  In fact, T cell division in the lymph nodes of immunised µMT mice 
was lower than that seen in naïve wild type mice, suggesting that constitutive turnover of T 
cells may be deficient in the µMT lymph nodes, although analysis of a naïve µMT control 
group would be required to confirm this.  Additionally, Th1 and Th17 effector cell responses 
appeared lower in the lymph nodes of B cell-deficient mice after boosting.  This was 
demonstrated by the reduced numbers of Tbet- and Ror!t-expressing T cells in the draining 
lymph nodes at this time (figure 6.11C).  Together, these data confirm that T cell responses 
at the boost were reduced in the lymph nodes of B cell-deficient mice, suggesting decreased 
T cell memory generation at this site. 
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Antigen-specific memory T cells do not appear to reside in the bone marrow 
or express Ly6C 
In addition to investigating memory T cell generation in µMT mice, I wanted to use MHC 
class II tetramers to analyse the localisation of such memory T helper cells in wild type 
mice.  A recent report by Tokoyoda et al [97] suggested that the main site of localisation of 
memory CD4+ T cells to be the bone marrow, and that memory cells resting there express the 
surface marker Ly6C.  I therefore analysed the spleen, lymph nodes and bone marrow for the 
presence of tetramer-binding T cells during the primary response on day 9, 6 weeks later at 
the memory time-point, and on day 5 post-boost.  Due to the extremely low numbers of 
CD4+ T cells present in the bone marrow (~2%), it was necessary to pool bone marrow from 
mice within the immunised or naïve groups, and perform CD4+ T cell sorts prior to tetramer 
staining, in order to enrich the T cell population. 
 
From the data presented, it can be seen that, although a large percentage of T cells in the 
bone marrow appeared to be antigen-specific at the primary and boost time-points (figure 
6.12A), when multiplied up to absolute numbers, this accounted for very few of the total 
number of tetramer+ T cells (figure 6.12B).  Similarly, at the memory analysis, the number of 
antigen-specific T cells in the bone marrow constituted a very small proportion of the total 
number of tetramer+ T cells (figure 6.12B).  It appeared, instead, that the spleen and 
(draining) lymph nodes were the major sites of localisation of the antigen-specific T cells 6 
weeks after immunisation (figure 6.12B). 
 
Furthermore, the antigen-specific memory T cells identified, either in the bone marrow or 
the spleen, did not appear to be expressing the memory ‘marker’ Ly6C (figures 6.12C & D).  
Instead, ~80% of the tetramer+ cells identified at the memory time-point, either in the spleen 
or bone marrow, appeared to be Ly6C-negative (figure 6.12D).  It should be noted, however, 
that the numbers of cells identified 6 weeks post-immunisation were small, making it 
difficult to phenotype these cells accurately.  However, I provide evidence, here, contrary to 
the above-mentioned report, and I would argue that, in this system, antigen-specific T helper 
cells do not appear to reside in the bone marrow at the memory phase, or express Ly6C.  
Thus, Ly6C does not, in my opinion, appear to be a marker for memory T helper cells, as has 
been suggested [97]. 
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T cells from naïve CD4-dnTGF"RII mice appear to be in a more activated state 
One of the most striking characteristics of antigen-specific T helper cells isolated from µMT 
mice following peptide immunisation was that they appeared in a highly activated state, in 
terms of surface activation markers.  Specifically, they expressed greater levels of CD44, and 
lower levels of CD62L (figure 6.8).  One possible explanation for this activated state is that 
the lack of B cell-derived regulatory cytokines might be resulting in an activated T cell 
phenotype.  One such regulatory cytokine is TGF". 
 
As mentioned above, the use of MHC class II tetramers is an ideal method of following 
antigen-specific T cells following immunisation.  Following reports on the influence of 
TGF" on regulating effector CD8+ T cell responses [324]; I wanted to use this peptide 
immunisation system to follow the CD4+ T cell response in CD4-dnTGF"RII mice.  These 
mice express a dominant negative (dn) form of the TGF"RII under the control of the CD4 
promoter.  This mutant form of the TGF" receptor possesses a truncated intracellular tail, 
and therefore cannot transmit TGF" signalling.  T cells in these mice are unable to respond 
to TGF".  Using the peptide immunisation system, I aim to determine the role of TGF" in 
the regulation of effector CD4+ T cell responses, including effector cell regulation and 
memory generation, following peptide immunisation. 
 
Initially, naïve CD4-dnTGF"RII T helper cells were analysed for their activation status 
using a series of cell surface markers.  Figure 6.13 shows that T cells from naïve CD4-
dnTGF"RII mice had a more activated phenotype than T cells from wild type mice.  This 
was demonstrated by higher expression of CD44 and Ly6C, and lower expression of CD62L 
(figures 6.13A & B).  These mice appeared to have greater numbers of short-lived effector T 
cells (with a KLRG1hi IL-7R#lo phenotype), as illustrated by the higher expression of 
KLRG1 and lower expression of IL-7R# by the total CD4+ T cell population (figure 6.13C).  
Furthermore, splenic T cell turnover in naïve mice, measured by Ki67 staining, was elevated 
in T cells that cannot respond to TGF" (figure 6.13D).  Due to the involvement of TGF" in 
the differentiation of Treg cells [32], the numbers of FoxP3+ T cells in the spleen were 
measured, and found to be equivalent in the CD4-dnTGF"RII and wild type mice (figure 
6.13E).  This suggests that TGF" is not required for Treg cell generation, confirming a 
previous report in these mice [52].  Splenocytes were isolated from naïve mice, and stained 
for intracellular cytokines.  The data shows that T cells from the CD4-dnTGF"RII mice had 
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much greater production of IFN! than T cells from naïve wild type mice (figure 6.13F), 
suggesting higher levels of Th1 cell priming. 
 
CD4-dnTGF"RII mice show enhanced priming in the lymph nodes, and a 
biased Th1 response in the spleen 
The CD8+ T effector cell response has been shown to be elevated in the CD4-dnTGF"RII 
mice at the peak of the primary response [324].  In this study, I immunised both wild type 
and CD4-dnTGF"RII mice with peptide in CFA, and measured antigen-specific T cell 
numbers in the spleen and draining lymph nodes at the peak of the primary T cell response, 
on day 9.  The results shown in figure 6.14A indicate that antigen-specific T cells in the 
spleen were reduced in CD4-dnTGF"RII mice, while numbers in the draining lymph nodes 
were elevated.  This shows that, in the absence of TGF" signalling in T cells, expansion of T 
cells within the draining lymph nodes was enhanced, whereas the T cell response in the 
spleen was reduced.  T cells from the spleen had a significant Th1 bias, producing more 
IFN! than wild type cells, but not producing IL-17 (figure 6.14B).  Therefore, during the 
primary response, the T cells in the spleen of the CD4-dnTGF"RII mice appeared to not only 
be having a reduced response in terms of tetramer+ T cell numbers, but were also making a 
different type of effector response.  Meanwhile, similar to in CD8+ T cells [324], effector T 
cell numbers were elevated at the site of priming, in this case in the draining lymph nodes. 
 
CD4-dnTGF"RII mice may possess more antigen-specific T cells in the spleen 
six weeks after immunisation, and continue to display a biased Th1 phenotype 
Six weeks after immunisation, the numbers of tetramer+ T cells in the spleen and draining 
lymph nodes were measured.  As can be seen in figure 6.15A, the CD4-dnTGF"RII mice 
appeared to have increased numbers of antigen-specific T cells in the spleen at this late time-
point, although the small group sizes make statistical analysis difficult.  In the draining 
lymph nodes, however, there was no significant difference between the numbers of tetramer+ 
T cells in the wild type and CD4-dnTGF"RII mice (figure 6.15A, bottom).  These data 
highlight the elevated numbers of antigen-specific T cells in the spleen, but does not indicate 
whether they are true memory cells, or a runaway effector response.  Again, similar to at the 
primary response, in the absence of TGF" signalling, splenic T cells mounted a strong Th1 
response characterised by IFN! secretion, but did not produce IL-17 (figure 6.15B).  This 
Th1 bias was not restricted to immunised mice, but the naïve CD4-dnTGF"RII mouse also 
displayed excessive IFN! production (figure 6.15B), suggesting that it is not an antigen-
specific response. 
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In the absence of TGF"  signalling in T cells the boost response, and therefore 
memory T helper cell generation, appears normal 
Although antigen-specific T helper cells were present in the spleen in large numbers six 
weeks post-immunisation in the CD4-dnTGF"RII mice, it was not known whether T helper 
cell memory had been generated.  To investigate the generation of memory in these mice, 
they were boosted with peptide-pulsed dendritic cells 6 weeks after priming, and the 
numbers of antigen-specific T cells analysed 5 days after boosting.  The data presented in 
figure 6.16A demonstrate that the boost T helper cell response was normal in both the spleen 
and draining lymph nodes of the CD4-dnTGF"RII mice, indicating that memory T cell 
generation was not impaired in the absence of TGF" signalling in T cells.  In a similar 
manner to the primary and memory responses, splenic T cells from these mice exhibited a 
strong Th1 bias, with greater IFN! production and an absence of IL-17 secretion (figure 
6.16B).  This IFN! production was not antigen-specific, as naïve CD4-dnTGF"RII T cells 
produced comparable amounts (figure 6.16B).  Together, these data suggest T cell memory 
generation and boost responses to be normal in absence of TGF" signalling in T cells, 
indicating that TGF"-mediated regulation of the CD4+ T cell population is not necessary for 
these aspects of T cell function. 
 
CD4-dnTGF"RII mice show impaired switched antibody responses, but 
increased production of IgM 
Due to the excessive T cell activation and IFN! production in the CD4-dnTGF"RII mice, I 
was intrigued as to the effects this would have on B cell antibody production.  Th1 responses 
tend to promote IgG2a/c production by B cells (in an antigen-specific manner), and thus I 
expected the unregulated IFN! production in the CD4-dnTGF"RII mice to induce a strong 
IgG2c response.  The data shown in figure 6.17A, however, indicate that this is not the case.  
In fact, when TGF" signalling was lacking on T cells, peptide-specific antibody responses 
were decreased (figure 6.17A, total Ig).  Specifically, class switched antibody was impaired 
in these mice, as both IgG1 and IgG2b were reduced (figure 6.17A, IgG1 & IgG2b).  
Notably, IgG2c and IgG3 levels were at the limit of detection (data not shown).  IgM 
responses, on the other hand, although reduced at the primary response on day 9, were 
elevated by the memory and boost time-points (figure 6.17A, IgM).  Looking at IgM 
production on day 5 post-boost in more detail, the elevated IgM phenotype was not restricted 
to immunised CD4-dnTGF"RII mice, but naïve CD4-dnTGF"RII mice also had high levels 
of serum IgM capable of binding the H19env peptide (figure 6.17B).  In summary, antigen-
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specific class-switched antibody responses, namely IgG1 and IgG2b, were impaired when T 
cells were unable to respond to TGF".  Conversely, IgM production was enhanced in these 
mice by 6-7 weeks after immunisation.  The observation that naïve CD4-dnTGF"RII mice 
also had increased serum IgM by the later stages of the experiment suggests that the 
resulting IgM is simply cross-reactive, and not related to the peptide immunisation. 
 
Together, the work using MHC class II tetramers to follow antigen specific T helper cells 
responses in CD4-dnTGF"RII mice revealed priming in the lymph nodes to be enhanced, 
whilst memory generation, and expansion after boosting, was normal.  Furthermore, T cells 
in these mice were in a more activated state in terms of cell surface markers, and were 
predisposed to IFN! production.  Class-switched antibody production, meanwhile, was 
reduced, but cross-reactive IgM was elevated.  These data highlight the involvement of 
TGF" signalling in T cells on the modulation of Th1 responses in both naïve and immunised 
mice, and reveals the knock-on effect on B cell antibody production. 
 
 




The use of MHC class II tetramers for the analysis of antigen-specific T helper 
cell responses 
MHC class II tetramers allow the direct analysis of in vivo-generated endogenous antigen-
specific T cells.  The main advantage of this system is that such antigen-specific T cells can 
be visualised directly by flow cytometry, and therefore phenotyped for other surface 
markers, such as the activation markers used here.  However, the data presented in this 
chapter highlight the drawbacks of tetramers.  Firstly, the presence of tetramer+ T cells 
indicates only that T cells of that particular specificity exist, but does not provide 
information on their functional ability.  Therefore, without further analysis, it is impossible 
to determine if tetramer+ T cells are functional, cytokine-producing effector cells.  Instead, 
they may be Treg cells, anergic tolerised cells, or cells in an inactive state.  Unfortunately, 
due to the low success rate of in vitro restimulation cultures with the H19env peptide antigen 
(data not shown), measuring cytokine production by these antigen-specific T cells to 
determine their T helper cell subset phenotype proved difficult.  Instead, I used two methods 
of determining the T helper cell phenotype in this system: transcription factor staining and 
intracellular cytokine staining.  As the intracellular cytokine and transcription factor staining 
protocol was not combined with tetramer staining, and the intracellular cytokine staining 
utilised PMA restimulation (which results in TCR downregulation and is therefore not 
compatible with tetramer staining), the effector phenotype of the antigen-specific T cells was 
not directly measured.  Therefore, the transcription factor and intracellular cytokine data 
presented reflects the total T helper cell phenotype.  It is hoped that, as these analyses focus 
on activated CD44hi cells, this will be representative of the antigen-specific T helper cell 
response, but short of using a cytokine-capture assay or sorting the tetramer+ T cells for 
culture, this will be difficult to confirm. 
 
A second drawback of the use of tetramers is the limit of detection.  At 6 weeks post-
immunisation, for example, tetramer staining was consistently higher in immunised mice 
compared to naïve mice (figure 6.12), so memory cells could be detected.  However, 
detecting significant differences between experimental groups, such as the B cell depletion 
groups, was problematic due to the large variability within groups.  To overcome this, very 
large group sizes would have been required, which was not feasible.  Alternatively, a 
tetramer enrichment protocol, such as that used by Marc Jenkins [325], could have been used 
to visualise the small numbers of tetramer+ T cells.  Therefore, for all experiments I used 
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boost responses as a measure of memory, rather than detecting memory cells themselves.  It 
should be noted, however, that this boost response will contain cells undergoing primary 
activation. 
 
Ideally, I would want to combine the S. typhimurium infection model with the use of MHC 
class II tetramers, in order to reap the benefits from both systems.  Thus, a strain of S. 
typhimurium expressing the H19env peptide (or another peptide that has corresponding 
tetramers available) would allow both the detection of antigen-specific T cells by flow 
cytometry, and the antigen-specific restimulation cultures to determine their subset 
phenotype.  The development of a bacterial strain expressing a particular peptide is an 
ongoing topic of interest in our laboratory.  In an attempt to overcome these issues, here, I 
measured the numbers of tetramer+ T cells, together with transcription factor expression and 
intracellular cytokine staining by the total T helper cell population, and assumed that the 
whole population phenotype accurately reflected that of the antigen-specific cells. 
 
Peptide immunisation strategy 
Following a trial experiment to optimise the immunisation strategy for creating a clear 
population of tetramer+ T cells (figure 6.2), in all subsequent experiments, mice were primed 
with the H19env peptide in CFA subcutaneously, and boosted with peptide-pulsed dendritic 
cells intravenously.  Although some data suggests the injection of dendritic cells i.v. to led to 
tolerance rather than immunity [326], I did not find this.  Instead, boosting with antigen-
loaded dendritic cells i.v. resulted in the expansion of antigen-specific T cells, and the 
generation of a population that was significantly higher than in a primary immune response 
(figure 6.5, blue inverted triangle wild type response versus open diamond primary 
response).  Furthermore, the injection of dendritic cells i.v. led to an increase in antigen-
specific T cell numbers in the inguinal lymph nodes – the draining site of the primary 
immune response.  This was surprising, as systemic cells do not have direct access to the 
lymph nodes like they do the spleen, and dendritic cell entry to the lymph nodes was thought 
to occur through the lymphatic system, rather than across high endothelial venules [327].  
Thus, it remains unknown how systemic fully matured and activated dendritic cells would 
access the lymph nodes to drive T cell expansion at this site.  As cells had been extensively 
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Memory T helper cell characteristics 
Having optimised the peptide immunisation system for memory T helper cell detection, the 
localisation of these memory cells was a topic of interest.  As mentioned above, published 
data indicates that memory CD4+ T cells are located preferentially in the bone marrow in 
mice, and express the cell surface marker, Ly6C [97].  In figure 6.12, however, I provide 
evidence that contradicts this published report.  I found the memory cells located in the bone 
marrow to constitute a very small proportion of total antigen-specific memory T cells.  
Instead, the spleen and (draining) lymph nodes were the major sites of memory cell 
localisation (figure 6.12B).  Furthermore, the memory cells located in both the spleen and 
bone marrow 6 weeks after priming did not express Ly6C, but instead were, for the most 
part, Ly6C-negative (figures 6.12C & D).  It should be noted, however, that the memory 
cells detected were few in number, and required pooling from separate mice and enriching 
on a CD4 column, so it was difficult to show conclusively that the tetramer+ T cells were not 
expressing Ly6C.  The differences between my own data and the earlier report may be due to 
the system used.  Tokoyoda and colleagues used two methods of memory cell detection: 
firstly a transgenic T cell transfer system and detection by Thy1 expression, and secondly, a 
protein antigen in CFA immunisation and detection of antigen-specific T cells by in vitro 
restimulation with antigen [97].  Here, by directly visualising antigen-specific memory T 
cells ex vivo following the immunisation of wild type mice, my tetramer system has distinct 
advantages over the use of transgenic cell transfers and restimulation assays for memory cell 
detection, and thus I believe my results on this matter to be more valid. 
 
As the spleen and (draining) lymph nodes, rather than the bone marrow, were found to be the 
major sites of antigen-specific memory T cell localisation (figure 6.12B), I focussed on these 
sites for all other analysis of T cell memory.  Due to the extremely small numbers of 
tetramer+ T cells located in the bone marrow, I doubt I missed any significant populations of 
antigen-specific T cells by not analysing the bone marrow in the B cell depletion 
experiments. 
 
T cell priming is not dependent on B cells 
I have previously given evidence from the S. typhimurium infection model (figure 5.6) 
supporting published findings [145,146] that the initial priming of CD4+ T cells was normal 
in B cell-deficient (and -depleted) mice, and thus B cells are dispensable for the primary T 
cell response.  Here, I provided further data on this topic, and showed the numbers of 
antigen-specific T cells in both the spleen and draining lymph nodes to be normal in B cell-
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deficient and -depleted mice (figure 6.4).  Furthermore, the differentiation of Th1 and Th17 
effector cells, expressing Tbet and Ror!t, respectively, was equivalent in B cell-deficient and 
-sufficient mice after priming (figure 6.9A).  The numbers of IFN!- and IL-17-producing 
cells, too, was normal in µMT mice during the primary response (figure 6.9B).  Together, 
these data provide strong evidence, contradictory to some previous reports [142,143,144], 
that B cells are not required for CD4+ T cell priming in this peptide immunisation system. 
 
T cell memory generation in B cell-deficient mice 
Previously, in the S. typhimurium infection model I showed T cell memory to be 
significantly impaired in B cell-deficient mice (figure 5.4).  Here, by detecting antigen-
specific T cells using tetramers, I found µMT mice to have normal numbers of antigen-
specific T cells in the spleen after boosting, but significantly lower numbers in the lymph 
nodes (figure 6.5, table 6.6 & appendix 1).  These data suggest that splenic memory in this 
system is normal in the absence of B cells, but memory in the lymph nodes shows a 
dependence on B cells.  Furthermore, splenic T cell division, expression of Tbet and Ror!t, 
and production of IFN! and IL-17 was normal in µMT mice after boosting (figures 6.10A, 
6.10B & 6.11A).  In the lymph nodes, however, T cell proliferation, as well as numbers of 
Tbet+ and Ror!t+ T cells, was significantly reduced in B cell-deficient mice (figures 6.11B & 
C).  Thus, I have provided strong evidence to suggest that, in this peptide immunisation 
system, T cell memory generation in the (draining) lymph nodes was significantly disrupted 
in the absence of B cells, while splenic memory developed normally.  While the simplest 
explanation for the defect in lymph node memory is that B cells have been shown to be 
important APCs for driving T cell responses in this site [138], the alternative possibilities are 
discussed in greater detail below. 
 
T cell memory generation in B cell-depleted mice 
In the S. typhimurium infection model, I identified a requirement for B cells during the first 
~10 days of infection for the development of T helper cell memory.  Specifically, the 
depletion of B cells on day -7 or day 2 resulted in significantly impaired memory, whereas 
with depletion on day 10, memory generation was normal (figure 5.7).  Meanwhile B cell-
deficient µMT mice had a severe reduction in T cell memory (figure 5.4).  Here, using the 
peptide immunisation system, µMT mice consistently had reduced T cell responses in the 
lymph nodes after boosting (figure 6.5, table 6.6 & appendix 1).  However, the effects of 
anti-CD20-mediated B cell depletion on T cell memory development in this peptide 
immunisation system gave variable results.  In one experiment (of three), the lymph node T 
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cell boost response was significantly impaired in the day -7 and day 2 treatment groups, and 
normal in the day 10 anti-CD20 treated group (figure 6.5).  These data, therefore, gave 
similar results to in the S. typhimurium infection model, and pointed to a role of B cells in 
the first ~10 days of the immune response for T cell memory generation.  However, in the 
other 2 repeats of this experiment (shown in appendix 1), there were no significant 
differences between the depleted and non-depleted groups.  In these 2 experiments, the 
percentages of tetramer+ T cells in the lymph nodes after boosting were lower than seen in 
the first experiment.  While in experiment 1 around 0.5% of lymph node T cells bound the 
tetramer, in experiments 2 and 3, this figure was only ~0.3% (compare blue inverted 
triangles in figure 6.5B to appendix 1).  Therefore, it appears that the immune response 
against the peptide was lower in experiments 2 and 3, making the detection of significant 
differences between groups more difficult, due to the low percentages of tetramer+ T cells. 
 
By pooling the results from all 3 experiments, the lymph node T helper cell response in the 
µMT group remained significantly reduced when compared to the wild type group (table 
6.6).  However, of the B cell-depleted groups, only anti-CD20 treatment on day -7 resulted 
in diminished T cell boost responses in the lymph node compared to the non-depleted group, 
whereas with treatment on day 2 or day 10 T cell boost responses were normal (table 6.6).  
As this pooled data analysis of the results from all 3 experiments is the most accurate 
interpretation of responses in B cell-depleted mice, this result is most valid.  It therefore 
contrasts to results from the S. typhimurium model, where the day 2 treated group had 
impaired memory (figure 5.7).  The simplest explanation for the presence or absence of 
memory in this day 2 treated group is that the kinetics of the immune response in the two 
models vary substantially.  While S. typhimurium is an infection that takes around 4-6 weeks 
to clear, the immune response to peptide antigen is likely to be short-lived.  Thus, the 
kinetics of both the T helper cell and B cell responses are likely to differ vastly between 
these two systems.  For example, looking at the B cell response, while in Salmonella 
infection the class switched antibody response is slow to arise, reaching its peak around 4-5 
weeks of infection (see figure 3.15), in the peptide immunisation model class switched 
antibody levels were high by day 9 (figure 6.7).  These differences in the timing of antibody 
appearance reflect differences in the B cell response.  Therefore, it may be that the kinetics 
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Splenic versus lymph node memory 
The finding that splenic T cell memory appeared normal in µMT mice following peptide 
immunisation (figure 6.5A) contrasts to that from the S. typhimurium infection model, where 
splenic T cell memory was absolutely dependent on B cells (figure 5.4).  One explanation, 
which may account for the differences between models, is that the antigens and route of 
administration differed vastly.  On the one hand, Salmonella bacteria are a complex 
pathogen consisting of many available antigens, which result in a systemic infection and 
colonisation of the spleen.  As seen in chapter 4, the spleen is the major site of the immune 
response, and becomes severely disrupted during this infection.  In the peptide immunisation 
system, on the other hand, the much simpler peptide antigen was administered s.c. together 
with an adjuvant, making the draining lymph nodes the primary site of immune activation.  
Therefore, it appears that the lymphoid organ in which initial priming occurred was the one 
in which T cell memory showed a dependence on B cells. 
 
It may be interesting to alter the method of peptide immunisation, by varying the route.  
Perhaps the reason for the differences in splenic versus lymph node T cell memory in the 
tetramer system is due to the peptide immunisation strategy used.  As mentioned above, 
splenic memory was impaired following systemic S. typhimurium infection in µMT mice, 
whereas this was not the case following antigen in CFA s.c. immunisation.  Notably, in 
addition to initially priming the draining lymph nodes, administration of CFA s.c. results in 
an antigen depot, which may result in chronic T cell stimulation in this region [328].  
Perhaps, if the peptide antigen became rapidly systemic, with the spleen, rather than the 
lymph nodes, as the major site of priming, the effects on splenic T cell memory generation 
may differ.  Additionally, the B cell response to protein versus peptide antigen is known to 
differ, and B cells have been shown to preferentially present protein rather than peptide 
antigen [147,148].  Thus, the use of a protein antigen, in addition to being more 
physiological, may alter B cell antigen presentation and impact upon the development of a 
memory T cell population.  Furthermore, tetramers could be used, here, to detect memory 
generation after priming with peptide-pulsed dendritic cells in µMT mice.  It would be 
intriguing to determine the effects of B cell deficiency on memory generation after this type 
of immunisation.  Clearly T cell memory was generated following priming with peptide-
pulsed dendritic cells (figure 6.2B), but it would be interesting to determine if this memory 
was dependent on the presence of B cells, as B cell antigen presentation is likely to be 
minimal. 
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A further alternative, which may explain the impairment in lymph node but not splenic 
memory in this system, is that the reduction in T cell responses in the lymph nodes may be 
due to an innate defect in lymph node architecture or function, as a result of their 
development without B cells being present.  However, the fact that lymph node boost 
responses were also reduced in B cell-depleted mice (figure 6.5), which developed normally 
in a B cell-sufficient host and possess B cells at the time of boosting due to B cell 
repopulation, this seems an unlikely explanation. 
 
Antigen-specific splenic T cells generated in µMT mice appear highly 
activated, in terms of surface marker expression, but function normally 
As mentioned above, the numbers of antigen-specific T cells found in the spleen of µMT 
mice after boosting were equivalent to those in wild type mice.  However, such T cells 
differed in phenotype from those generated in wild type mice in that they appeared to be in a 
more activated state.  Specifically, expression of CD44 was significantly higher on µMT 
tetramer+ T cells, while expression of CD62L was lower (figure 6.8).  This was also the case 
at the primary response, although to a lesser extent (figures 6.8B & C).  However, despite 
this activated phenotype of antigen-specific splenic T cells, their expression of Tbet and 
Ror!t, as well as their production of IFN! and IL-17, was normal at both the primary (figure 
6.9) and boost (figure 6.10) responses.  Thus, although the antigen-specific T cells generated 
in µMT mice differed in surface marker phenotype from those in wild type mice, they did 
not appear to differ in terms of Th1/Th17 effector cell generation or cytokine-producing 
capacity.  This leaves us with the question as to why antigen-specific T cells in µMT mice 
expressed higher levels of CD44 and lower levels of CD62L. 
 
The adhesion molecule CD44 has been implicated in the regulation of survival of antigen-
activated T helper cells of the Th1 phenotype into the memory phase [329].  The authors 
report that signalling through CD44 on Th1 effector cells regulates cell death by both 
limiting Fas-mediated apoptosis and promoting cell survival pathways [329].  In µMT mice, 
here, the Th1 effector cells may have upregulated expression of CD44 in an attempt to 
overcome the lack of the B cell-mediated signal required for memory development.  
However, this is purely speculative, and I can provide no evidence to support this theory.  
Indeed, this may not be correct, as the phenotype of increased CD44 expression seemed to 
not be restricted to Th1 cells, but IL-17-producing effector Th17 cells also had higher levels 
of surface CD44 (figure 6.10C).  Therefore, the reason for the increased expression of CD44, 
and reduced expression of CD62L, on tetramer+ T cells found in B cell-deficient mice 
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remains unknown.  A further possible explanation is that the lack of B cell-derived TGF" in 
regulating T cell function may result in this activated phenotype, a concept that is discussed 
more fully later.  Interestingly, the increased expression of CD44 on tetramer+ T cells was 
also apparent, to a lesser extent, on T cells from B cell-depleted mice (figure 6.8D), 
indicating that this phenomenon is not due to innate deficiencies in T cells generated in µMT 
mice. 
 
Peptide-specific antibody responses in B cell-depleted mice 
Despite the early depletion of B cells, the day 2 anti-CD20 treated group mounted 
unexpectedly large antigen-specific antibody responses, of the IgG1 isotype, following 
peptide immunisation (figure 6.7).  The development of antigen-specific antibody responses 
in mice depleted of B cells soon after (or before) immunisation was also seen after DNP-
KLH immunisation (figure 5.3C).  However, such antigen-specific antibody was not seen in 
the day 2 depleted group following S. typhimurium infection (figure 5.8A). 
 
The explanations for the presence of antigen-specific class switched antibody in B cell-
depleted mice were discussed in chapter 5 above.  To expand that discussion further, it 
appears that the production of antigen-specific class switched antibody was limited to 
peptide or protein immunisation and, in both cases, was predominantly of the IgG1 isotype.  
The time-course of antibody levels after peptide immunisation showed maximum serum 
IgG1 levels to be reached by day 9 post-immunisation in day 2-depleted, day 10-depleted, 
and non-depleted groups (figure 6.7B).  As B cells take ~3-5 days to be efficiently depleted, 
they will have reached baseline levels in the day 2-depleted group around 7 days after 
immunisation.  This presence of B cells for the initial 7 days appears enough for IgG1 
antibody levels to reach high levels (figure 6.7B). 
 
These data highlight two interesting points:  Firstly, the production of such large amounts of 
antigen-specific IgG1 in the initial ~7 days after immunisation raises the issue of T cell 
dependence.  T cell-independent IgG has been reported in a viral infection model [318], 
indicating that the IgG1 found here may occur in either a T cell-dependent or -independent 
manner.  T cell ablation would help in clarifying the requirement for T cells.  The second 
point raised by these data is that, at time of boosting 6 weeks post-immunisation, peptide-
specific IgG1 levels remained surprisingly high in the day 2-depleted group, although they 
did appear to decay more rapidly than in B cell-sufficient mice (figure 6.7).  If IgG1-
secreting plasma cells had been generated in the initial ~7 days, these cells would have 
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resisted depletion.  However, as early extrafollicular plasma cells are thought to only have a 
lifespan of 3-5 days [330], the longevity of the antibody seen here suggests the generation of 
long-lived plasma cells.  This raises the intriguing possibility of the early generation of long-
lived plasma cells that resist depletion by anti-CD20.  However, as long-lived plasma cells 
are thought to differentiate after the GC reaction [330], this would suggest the GC reaction to 
have occurred by day 9 post-immunisation (when antibody levels reached the plateau), 
which seems unlikely.  The analysis of the affinity of such IgG1 antibody, indicating affinity 
maturation, together with the timing of the GC reaction in this particular immunisation 
strategy, would help to clarify if the antibody was generated pre- or post-GC. 
 
Interestingly, recent data studying long-lived plasma cells following anti-CD20 treatment 
concludes that, during periods of B cell depletion when memory B cells are absent, long-
lived plasma cell numbers, together with serum antibody levels, remain constant, indicating 
that long-lived plasma cells are inherently long-lived and do not require the memory pool for 
replenishment [330].  Therefore, if long-lived plasma cells had been generated by day 9, they 
would have maintained serum antibody levels for the course of this experiment.  However, 
the possibility of long-lived plasma cell generation by day 9 post-immunisation is a topic 
which requires further investigation.  If true, this phenomenon has broader implications in 
both the vaccine field, and in the use of anti-CD20 in humans. 
 
The role of TGF"  in regulating CD4+ T cells in naïve mice 
One striking observation from the tetramer+ T cells isolated from µMT mice was that they 
appeared in a highly activated state in terms of surface markers, in that they expressed higher 
levels of CD44 and lower levels of CD62L in comparison to T cells isolated from wild type 
mice (figure 6.8).  One possible explanation for this higher state of activation may be the 
lack of B cell-derived TGF".  Indeed, such B cell-derived TGF" has been shown to 
induce/expand Treg cells in vivo [331].  Thus, T helper cell responses were measured in 
CD4-dnTGF"RII mice, which possess T cells that are unable to respond to TGF", using the 
peptide immunisation system.  Naïve CD4-dnTGF"RII mice have been shown in the past to 
spontaneously develop an autoimmune disease at around 3-4 months of age, characterised by 
the infiltration of inflammatory immune cells into multiple organs, and the presence of 
circulating autoimmune antibodies [43].  This observation alone points to a role of TGF" 
signalling in T cells in the control of anti-self immune reactions.  The onset of autoimmunity 
may explain the death of some animals in my own experiments by week 6 post-
immunisation, which is why group sizes after boosting were small (figure 6.16). 
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The data presented in figure 6.13 reveal the T helper cell phenotype in naïve CD4-
dnTGF"RII mice.  Such T cells displayed a more activated, effector phenotype (in terms of 
surface expression of activation and effector markers), with greater levels of division 
(measured by Ki67 staining).  The increase in CD44 expression and diminished CD62L 
expression resembled that seen in the B cell-deficient mice (figure 6.8), thus B cell-derived 
TGF" may be playing a role, although this was not assayed directly.  As these mice were 
unimmunised naïve mice that should not have underlying infection (although such mice 
could be undergoing a response to commensal bacteria), this suggests a role for TGF" 
signalling in T cells in homeostasis.  Indeed, previous reports suggest TGF" signalling in 
naïve T cells to regulate tolerance and promote survival [332].  Furthermore, T helper cells 
from naïve CD4-dnTGF"RII mice showed signs of Th1 activation, as characterised by their 
enhanced production of IFN!.  Both the Th1 bias, which regulates Th17 cells [37], and the 
lack of TGF" signalling, which is required in conjunction with IL-6 for Th17 cell 
differentiation [32], explain the complete loss of IL-17 production by T cells from the CD4-
dnTGF"RII mice (figures 6.14B, 6.15B & 6.16B).  The lack of Th17 cell differentiation is 
likely to impact on immune responses against extracellular bacteria and fungi, especially at 
mucosal sites [32], and thus may impact on survival rate if encountered with such pathogens. 
 
Interesting, despite evidence indicating TGF" involvement in the differentiation of inducible 
FoxP3+ Treg cells [32,49], the total numbers of FoxP3+ splenic T helper cells were 
equivalent in wild type and CD4-dnTGF"RII mice (figure 6.13E).  This evidence supports 
previous findings in these mice that Treg cell numbers are normal in the absence of TGF" 
signalling in T cells [52].  During an immune reaction, however, a proportion of antigen-
activated T cells are thought to differentiate into Treg cells in the periphery [32].  Therefore, 
although total splenic Treg cell numbers were unaffected in CD4-dnTGF"RII mice, these 
mice likely lack the ability to generate antigen-activated iTreg cells during infection.  This 
deficiency may impact on the control of antigen-specific effector T cells. 
 
The role of TGF"  in regulating CD4+ T cell responses following peptide 
immunisation 
TGF" has been shown to influence CD8+ T cell responses during viral infection, by limiting 
the peak effector response by the induction of apoptosis [324].  In this study, I used CD4-
dnTGF"RII mice to follow the antigen-specific T helper cell response using tetramers.  
Primary T cell expansion in the draining lymph nodes appeared enhanced, with tetramer+ T 
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cell numbers higher than in wild type mice (figure 6.14A, bottom).  This concurs with the 
data from the CD8+ T cell response, in that the peak of CD8+ T cell division was also 
enhanced in these mice.  However, the numbers of tetramer+ T helper cells in the spleen at 
the peak of the primary response appeared reduced in CD4-dnTGF"RII mice, following 
peptide immunisation (figure 6.14A, top).  Therefore, the unregulated effector response 
appeared localised to the draining lymph nodes.  The reason for the reduced numbers of 
antigen-specific T cells in the spleen is not obvious.  Perhaps, either the T cells themselves, 
or the initiating APC, are remaining in the lymph node as opposed to trafficking to the 
spleen.  However, the role of TGF" signalling in influencing the migration of these cells is 
unknown, and not investigated here. 
 
Six weeks post-immunisation, the numbers of tetramer-binding T cells in the draining lymph 
nodes were equivalent in wild type and CD4-dnTGF"RII mice.  However, in the spleen there 
appeared to be elevated numbers of tetramer+ T cells (figure 6.15), although statistical 
analysis was difficult due to small group sizes.  This increase in tetramer+ T cells in the 
spleen may be due, either to enhanced memory generation, or a lag in decline of the effector 
response.  Data on the CD8+ T cell responses indicate a lag in the decline of antigen-specific 
effector cells in the absence of TGF" signalling in T cells [324].  Therefore, a lag in decline 
of effector cell numbers due to the lack of TGF"-induced apoptosis seems a likely 
explanation for the elevated numbers of antigen-specific T helper cells seen at the memory 
time-point.  However, even if TGF" is involved in the control of the decline phase of CD4+ 
effector T cells, other mechanisms of control must exist, as antigen-specific T cell numbers 
in the spleen underwent a decline phase between day 9 and week 6 (compare figures 6.14A 
& 6.15A). 
 
Antigen-specific T cell numbers after boosting were normal in the CD4-dnTGF"RII mice 
(figure 6.16).  This therefore suggests that both memory generation and T cell re-activation 
are not dependent on TGF" signalling in T cells.  These data contrast to my original 
hypothesis that an enhanced primary effector response may be detrimental to memory 
development.  However, clear distinction between effector and memory T helper cells 
following immunisation was difficult.  Here, CD4+ T cell memory generation appeared 
normal in the absence of TGF" signalling in T cells, as the boost response was normal 
(figure 6.16).  Indeed, the normal development of T cell memory has previously been 
reported in the CD8+ T cell compartment in these CD4-dnTGF"RII mice [324], indicating 
that neither CD4+ not CD8+ T cell memory generation requires TGF" signalling in T cells.  
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Interestingly, here, although elevated numbers of antigen-specific T cells were seen in the 
draining lymph nodes after priming (figure 6.14A), excessive T cell expansion was not seen 
on day 5 post-boost (figure 6.16A).  It may be that boost responses do not require TGF"-
mediated control, or that the time-point analysed was earlier than the peak of the response.  
Alternatively, the lack of significant differences between groups at this time-point may 
simply be due to small group sizes, as a result of some mice dying before the completion of 
the experiment. 
 
Furthermore, it should be noted that the above data describes the effects of the lack of 
signalling through the TGF" receptor in all T cells, but does not distinguish between the role 
of TGF"-induced apoptosis of effector cells, and TGF"-induced differentiation of an 
inducible Treg cell population.  Additionally, one should bear in mind that the impairment in 
TGF" signalling also exists in the CD8+ T cell population of these mice. 
 
Lack of TGF"  signalling in T cells impacts on antibody production 
With the increased T helper cell activation and IFN! production in the spleen (figure 6.14B), 
I expected to find increased levels of the Th1-associated antibody isotypes, IgG2c/b [333].  
Instead, the CD4-dnTGF"RII mice had decreased levels of class switched IgG1 and IgG2b 
circulating antibody (figure 6.17A), and very low levels of IgG2c, which were at the limit of 
detection (data not shown).  The predominance of IgG1 production in response to peptide 
immunisation had been noted before by myself (figure 6.7B) and others [334], and occurred 
despite the Th1-biased environment.  This antibody response data indicates an impairment in 
T cell help for B cells in the CD4-dnTGF"RII mice.  Perhaps the highly activated state of T 
helper cells in these mice (or their Th1 bias) makes them less efficient at helping B cells, 
explaining the reduction in antigen-specific class switched antibody.  It would therefore be 
interesting to measure the numbers of TFH cells in these CD4-dnTGF"RII mice. 
 
The increase in IgM, capable of binding H19env peptide, seen at the memory and boost 
time-points in the CD4-dnTGF"RII mice, was not as a result of immunisation, as it was also 
present in naïve mice (figure 6.17B).  These naïve mice were, by this late stage in the 
experiment, around 13 weeks old (3+ months).  This is around the time of the onset of 
autoimmune disease, which leads to death of these animals [43].  It would be interesting 
therefore to determine whether this cross-reactive IgM, found in both naïve and immunised 
CD4-dnTGF"RII mice of this age, is also capable of binding self-antigens. 
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Spleen % Spleen numbers LN % LN numbers 
 P-value Summary P-value Summary P-value Summary P-value Summary 
Naïve 0.0000 *** 0.0000 *** 0.0000 *** 0.0000 *** 
WT primary 0.0000 *** 0.0000 *** 0.0000 *** 0.0000 *** 
µMT primary 0.0003 *** 0.0000 *** 0.0000 *** 0.0000 *** 
µMT 0.0000 *** 0.9222 NS 0.0462 * 0.0000 *** 
d-7 aCD20 0.9991 NS 0.9531 NS 0.0266 * 0.0396 * 
d2 aCD20 0.9987 NS 1.0000 NS 0.7953 NS 0.4106 NS 












Table 6.6:  Statistical analysis of data pooled from the three B cell depletion tetramer 
experiments.  Mice were immunised with peptide in CFA subcutaneously, and boosted with peptide-
pulsed dendritic cells 6 weeks later.  On day 5 post-boost, spleens and draining lymph nodes were 
removed and the percentages and absolute numbers of tetramer+ cells measured.  The data from 3 
identical experiments was pooled and analysed using a General Linear Model ANOVA (Tukey’s 
multiple comparison test) to adjust the means.  The p-values presented in the table above represent 
comparisons between each experimental group (e.g. day -7 anti-CD20) to the wild type group (positive 
control).  The p-value summaries given are as follows:  p=0.01 to 0.05 *, p= 0.001 to 0.01 **, p<0.001 
***, NS = not significant (p>0.05). 
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Clearly, the generation of immune responses against invading microorganisms is a vital 
phenomenon that continuously protects the host from pathogen-mediated damage.  These 
responses must be tightly regulated, to prevent both anti-self reactions and excessive 
immunopathology, whilst ensuring the removal of the infectious agent.  The early and rapid 
response of innate cells induces activation of the adaptive immune response, which is slower 
to develop.  Usually, the activation of both the innate and adaptive arms of the immune 
system are required for the clearance of infections and the generation of memory cells.  
These memory B and T lymphocytes, part of the adaptive immune response, are the 
fundamental mechanism of long-lasting immunity to future infection, and the reason for the 
efficacy of vaccines. 
 
In this study I focussed on the responses of a particular lymphocyte subset, the B cell, which 
was traditionally thought of as an adaptive cell, functioning mainly by secreting large 
amounts of antibody.  Here, however, I have demonstrated the important roles that B cells 
play in both the innate and adaptive arms of immune defence, and suggest that their position 
at the interface of innate and adaptive immunity ensures efficient adaptive immune cell 
activation and memory generation. 
 
Innate responses of B cells 
In this PhD, I have shown that B cells have the ability to respond rapidly to signals received 
directly from invading organisms, through TLRs.  Signalling through these innate receptors, 
expressed to varying degrees on all subsets of B cells [124], resulted in changes to whole 
populations of B cells, independent of their BCR specificity.  The effects of TLR stimulation 
of B cells were found to be many and varied, and are discussed, together with the knock-on 
effects on the adaptive immune response, in detail here. 
 
The marginal zone population of B cells, situated within the spleen adjacent to the marginal 
sinuses, is one of the first cell types to access systemic antigen [2].  In S. typhimurium 
infection, I identified significant and rapid changes to this population of B cells, which were 
partially dependent on their expression of the adaptor protein, MyD88, indicating a role for 
TLR signalling (chapter 4).  Specifically, marginal zone B cells were lost entirely by day 4 
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of infection in wild type mice, a phenotype also seen following injection with heat-killed 
bacteria and TLR ligands [294,295].  The likely fate of this population of marginal zone B 
cells is the differentiation into IgM-secreting plasma cells in the red pulp, and the generation 
of an early extrafollicular plasma cell response.  Interestingly, although the resulting IgM 
specificity likely reflects the variation in BCR specificities within the marginal zone B cell 
population, the differentiation of these plasma cells correlated with an increase in serum IgM 
that was capable of binding S. typhimurium antigens (chapter 4).  As IgM is a potent 
activator of the complement system, and such complement can lead to lysis of bacteria [281], 
this IgM production is likely to directly aid pathogen killing, as has been reported in Borrelia 
infection [303].  The early differentiation of effector B cells from the marginal zone 
population following TLR stimulation not only aids bacterial killing directly, but will also no 
doubt help stimulate adaptive immune cell activation, as is discussed further below. 
 
In addition to changes within the marginal zone population of B cells, follicular B cells, too, 
are directly affected by TLR stimulation.  The stimulation of all B cells by TLR ligands, 
specifically through TLR2, TLR3, and TLR9, resulted in the shedding of the cell surface 
adhesion molecule, CD62L (chapter 3).  During S. typhimurium infection, this TLR-
mediated alteration in CD62L expression led to changes in B cell migration within the host.  
B cell populations no longer localised to sites that require CD62L for entry, namely the 
lymph nodes and Peyer’s patches, and accumulated in the spleen during the first week of 
infection.  Altered trafficking of B cells, in a non-specific manner to the spleen, likely 
enhanced the exposure of B cells to bacterial antigen, increasing the potential for activation 
of cognate cells, which in turn have the ability to drive T helper cell activation.  Therefore, 
TLR-induced shedding of CD62L is likely to influence the activation of the CD4+ T cell 
subset of the adaptive immune response. 
 
B cells are positioned at the interface of innate and adaptive immunity 
The activation of B cells through innate receptors such as TLRs will likely influence the 
developing adaptive immune response.  The early production of cross-reactive IgM by TLR-
stimulated marginal zone B cells during S. typhimurium infection, for example, likely had 
several effects on the initiation of the adaptive immune response, in addition to the direct 
complement-mediated killing mechanism discussed above.  Firstly, as the resulting IgM was 
capable of binding S. typhimurium antigens (chapter 4), there was potential for the direct 
binding of bacteria, with the induction of phagocytosis by splenic macrophages, and possibly 
dendritic cells, expressing the high affinity Fc#/µ receptor [335].  The ongoing stimulation 
Chapter 7:  Final Discussion 
! "**!
of these cells by TLRs and other innate receptors will enhance antigen presentation of the 
phagocytosed bacterial antigen, allowing subsequent activation of CD4+ and CD8+ T cells.  
Secondly, as B cells themselves express the Fc#/µ receptor [335], uptake of IgM-coated 
bacteria will likely also enhance antigen presentation to T helper cells by B cells.  Thus the 
early activation of the CD4+ T cell response is likely influenced by the innate responses of B 
cells, a concept that has recently been reported in the S. typhimurium infection model [151], 
although my own data from day 7 of infection reported T cell cytokine responses to be 
normal in the absence of B cells (figure 5.6). 
 
The involvement of TLRs at the interface of innate and adaptive immunity has long been 
recognised [336,337].  In particular, stimulation of B cell TLRs has been shown to induce 
significant changes in B cells that result in increased antigen presenting capacity, which in 
turn impacts upon T helper cell activation.  These changes include the upregulation of 
surface MHC class II, which preferentially present cognate antigen taken up through the 
BCR [135], upregulation of co-stimulatory molecules, such as CD80, CD86 and CD40 
[124], and the secretion of cytokines capable of inducing T helper cell differentiation [124].  
Thus, the early innate activation of B cells by TLR ligands not only aids antibody 
production, which can impact upon the activation of other cell types, but also helps in the 
initiation of the adaptive immune response by focussing B cell migration to the spleen, 
inducing their activation, and increasing antigen presentation to T cells.  Thus, the early 
innate responses of B cells following TLR stimulation promote both B and T cell activation. 
 
Conflicting evidence on the innate roles of B cells in Salmonella infection 
Here, I have summarised the innate functions of B cells in S. typhimurium infection, which 
include the accumulation of B cells in the spleen, an early plasma cell IgM response, and a 
potential for antigen presentation to CD4+ T cells (chapters 3 & 4).  Despite these 
observations, the absence of B cells (by B cell depletion of wild type mice) did not have a 
significant impact on splenic bacterial load at the peak of infection, on day 7 (figure 5.6B).  
Thus, one could conclude that these innate responses of B cells are not influencing the 
control of bacterial growth.  However, I would argue that B cells might indeed be 
contributing to bacterial killing, be it directly or indirectly, but that the effects are either too 
small to detect by the assay used, or that there is a timing/kinetics issue, and perhaps looking 
only on day 7 of infection is not sufficient to detect such differences.  I favour the latter 
explanation, and would investigate further by performing a day-by-day analysis of bacterial 
loads in wild type and B cell-deficient (or -depleted) mice. 
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Cognate roles of B cells in T cell differentiation 
The TLR-induced changes to B cell phenotype significantly increases their antigen 
presenting ability.  However, the precise role of B cells in CD4+ T cell differentiation 
remains a topic of debate.  Here, I showed that initial T cell priming occurred independently 
of B cells, both in terms of numbers of antigen-specific T cells and their effector phenotype 
(chapters 5 & 6).  The efficient generation of T helper cell memory, however, was 
undoubtedly dependent on B cell presence (chapters 5 & 6).  Specifically, B cells were 
necessary in the first ~10 days of S. typhimurium infection (chapter 5), or even earlier in the 
peptide immunisation system (chapter 6), for the development of CD4+ T cell memory.  This 
early dependence on B cells was unexpected, as B cells were not thought to be efficient at 
antigen presentation and influencing T cell responses until late in the immune response, 
either due to their inability to prime naïve T cells [139], or due to the low numbers of 
antigen-specific B cells present before proliferation in the GC [133].  However, the early 
requirement for B cells, identified here, points to their role in influencing T cell memory 
generation well before the GC reaction develops, as is discussed below. 
 
Interestingly, I found another T helper cell population to be dependent on the presence of B 
cells, the T follicular helper cells.  In chapter 5, I showed the numbers of TFH cells to 
increase dramatically during the first week of S. typhimurium infection in B cell-sufficient 
mice, a phenomenon that was absent in µMT mice.  Furthermore, following B cell depletion, 
the TFH cell population was rapidly lost, within a few days, highlighting the role of B cells in 
the generation and/or maintenance of this population.  The exact mechanism of this influence 
of B cells on TFH cells remains unknown, but is perhaps a survival niche or signal.  Potential 
candidates might be B cell expression of ICOSL, or B cell-derived IL-6 production. 
 
Heterogeneity of the TFH cell population 
The population of CD4+ T cells with the TFH cell phenotype was found to expand rapidly 
during the early stages of Salmonella infection in wild type mice (chapter 5).  A large 
proportion of these cells had a Th1 effector cell phenotype, as determined by their 
expression of the Th1 master regulator, Tbet, and their secretion of IFN! (chapter 5).  This 
observation, together with the reports that antigen-activated T cells upregulate CXCR5 and 
migrate into the follicles soon after activation [75], suggests that such T cells with the TFH 
cell phenotype are antigen-specific T cells responding to the infection.  Indeed, reports in the 
Th2 setting of helminth infection, show that the IL-4-producing T cells are localised within 
Chapter 7:  Final Discussion 
! #+"!
the B cell follicles and express markers typical of TFH cells [73,74], supporting the notion 
that antigen-activated effector T cells may gain the TFH cell phenotype (or vice versa).  
Together, these data highlight the heterogeneity within the TFH cell subset. 
 
In the Salmonella infection model, it is known that the GC reaction, and the appearance of 
high affinity class-switched antibody, doesn’t occur until relatively late in infection, at 
around week 4-5 after onset [206].  Thus, the early TFH cells with a Th1 effector phenotype 
that appear during the first week of infection do not seem to be functioning as true helpers 
for the B cell response, in that they do not induce GC formation.  This observation leaves us 
with the interesting possibility that there might be two waves of TFH cells in this infection.  
Firstly, the early cells of the TFH cell phenotype may simply be antigen-activated Th1 cells 
acquiring a transient CXCR5+ phase and migrating through the follicles, whereas later, true 
TFH cells that are specialised in helping B cells, aid the GC reaction and the differentiation of 
high affinity class-switched plasma and memory cells. 
 
Clearly, the distinction between these two possible waves of TFH cells is a topic of ongoing 
research in our laboratory.  We aim to determine whether the ‘early’ and ‘late’ TFH cells 
differ in their localisation within the follicles/GCs, gene expression profiles, and helper 
function.  Using transcription factor identification, it may be possible to distinguish between 
these two potential populations of TFH cells.  In the helminth model, for example, it was 
shown that the Th2 effector cells located in the follicles expressed both the Th2-associated 
transcription factor GATA3, and the TFH cell-associated transcription factor Bcl-6 [74].  
Therefore, analysing the expression of the Th1-associated transcription factor, Tbet, as well 
as Bcl-6 in ‘early’ and ‘late’ TFH cells in the Salmonella infection model may allow 
distinction.  One might expect true ‘late’ TFH cells to express only Bcl-6, whereas the ‘early’ 
TFH cells, which were shown to express Tbet (chapter 5), may or may not also express Bcl-6. 
 
The correlation between TFH cells and memory generation 
The results showing a requirement for B cells in the initial ~10 days of S. typhimurium 
infection contradicts previous thinking that B cells were only efficient at antigen presentation 
late in infection, or in the activation of memory T cells.  However, the observation that the T 
cell-dependent GC response is slow to develop in the Salmonella model, with GCs and class 
switched antibody appearing around week 4-5 of infection [206], suggests that the B-T cell 
interaction necessary for T helper cell memory formation occurs well before the GC 
reaction. 
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Furthermore, the lack of the early expansion of the TFH cell population during S. 
typhimurium infection in B cell-deficient mice, and the rapid loss of this population soon 
after B cell depletion, showed that the presence or absence of TFH cells correlated well with 
the generation of T helper cell memory (chapter 5).  Here, I raise the possibility that, in the 
first ~10 days of infection, B and T cells interact in the follicles and such T cells with the TFH 
cell phenotype receive the signal(s) required for memory development.  In other words, soon 
after immunisation / onset of infection, activated antigen-specific T cells gain the CXCR5+ 
TFH cell phenotype and migrate to the follicle, interact with antigen-presenting B cells, and 
receive the signal(s) necessary for memory development.  Thus, in essence, such ‘early’ TFH 
cells might be memory precursors and the reason for the early increase in CXCR5 expression 
might be for the migration to the follicle to receive the vital signal(s) from B cells. 
 
The ‘Big Picture’ of T cell memory generation 
As discussed in the main introduction (figure 1.3), there are several theories as to the 
differentiation pathway of memory T helper cells [77,81].  Recent data provides evidence 
that in vitro-derived effector T cells are capable of differentiating into memory T cells in 
vivo [338,339], and that in vivo-generated IFN!+ effector cells can form long-lived memory 
cells [340], supporting the linear model of memory development.  Whereas data from our 
own laboratory shows memory cell development is capable in vivo without effector cell 
differentiation [215], suggesting a divergent model is likely.  The model of memory cell 
differentiation is further complicated by the discovery of ‘central’ and ‘effector’ memory 
subsets in the CD4+ T cell compartment [82].  How these subsets of memory cells fit into the 
pathway is unknown, and highlights the fact that many questions remain as to the 
differentiation processes that lead to memory development.  Furthermore, at what stage 
along the differentiation pathway B cells are required, also remains unknown.  However, the 
data presented in this thesis allow me to speculate on the likely model of the involvement of 
B cells in T cell memory differentiation. 
 
The illustration shown in figure 7.1 summarises some of what is known about the 
differentiation of effector and memory T helper cells.  Specifically it shows the B cell-
independent differentiation of short-lived effector cells, which requires the transcription 
factor Blimp-1 [92].  The generation of T cell memory, on the other hand, is B cell-
dependent.  For simplicity, I have omitted central and effector memory cell subsets, as little 
is known about the differentiation of these cells.  Importantly, figure 7.1 highlights the 
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requirement for a B-T cell interaction in memory T cell development, although the exact 
signal that B cells provide remains unidentified (represented by the question mark).  
Evidence from CD8+ T cell differentiation reveals that Blimp-1 expression promotes the 
generation of short-lived effector cells, whilst inhibiting Bcl-6 expression [89,341].  
Conversely, Bcl-6 has been implicated in both the differentiation and maintenance of 
memory CD8+ T cells [90].  It is, therefore, possible that Bcl-6 may also control the 
differentiation of the memory population of CD4+ T cells.  Published reports show this 
transcription factor to control the development of TFH cells in the T helper cell compartment 
[41,42].  Therefore, the involvement of the transcription factor, Bcl-6, in both CD8+ T cell 
memory formation, and CD4+ TFH cell differentiation, strengthens my proposal, here, that 
TFH cells may be memory cell precursors. 
 
Could TFH cells be memory precursors? 
The diagram presented in figure 7.2 shows an updated version of the CD4+ T cell memory 
generation model, incorporating my theory that TFH cells, or a proportion of them, are 
potentially memory precursors.  It is well documented that, soon after immunisation, 
antigen-activated T cells upregulate CXCR5 expression and migrate to the follicles [75,342].  
These cells with the TFH phenotype found in large numbers in the early stages of S. 
typhimurium infection have been found to express the Th1 transcription factor, Tbet, and 
secrete IFN! (chapter 5).  Due to the expansion of TFH cells during the early stages of 
infection and their effector cell phenotype, these cells are likely to be antigen-specific T cells 
responding to infection, undergoing a transient acquisition of TFH cell phenotype.  As 
mentioned above, the transcription factor, Bcl-6, is known to be responsible for driving cells 
of the TFH cell phenotype [41,42].  During this TFH cell phase, these antigen-activated cells, 
located in the follicle, have the potential to interact with B cells and receive the relevant 
signal(s) necessary for memory differentiation.  The observation that B cells are required 
during the first ~10 days of an immune response (chapters 5 & 6) certainly suggests that it is 
at this early stage that the B-T cell interaction required for memory generation occurs.  
However, the exact signal(s) that B cells are providing requires further investigation, and is 
discussed further below. 
 
Unanswered questions 
Despite my data going some way to identifying the timing of the involvement of B cells in T 
helper cell memory generation, there are many questions that remain.  In fact, as with most 
projects, many more questions have arisen from the results presented.  One of the questions 
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that is foremost in my mind is:  what is the signal(s) that B cells are providing to T helper 
cells for the generation of memory?  The fact that T helper cell memory is absent in µMT 
mice (chapters 5 & 6) suggests that B cells are providing a specific signal that other APCs, 
such as dendritic cells, cannot provide.  Previous members of our laboratory have shown that 
direct contact between cognate B and T cells, requiring MHC class II expression by B cells, 
is required for memory generation [142], showing that B cell antigen presentation is 
essential.  Additionally, IL-7 signalling is thought to be required for both the generation and 
maintenance of T helper cell memory [343], although the source of this IL-7 requires further 
investigation.  Meanwhile, an interaction between CD40 and CD40L, on B and T cells 
respectively, is not essential for memory formation, but is vital for the re-activation of 
memory cells [215]. 
 
Recent (provisional) data from our laboratory strengthens the observed correlation between 
TFH cells and memory.  For example, MD4 mice, in which all B cells recognise Hen Egg 
Lysozyme and thus cannot take up and present other antigens, lack TFH cells and do not 
generate T cell memory in the Salmonella infection model (T.A. Barr, S. Brown & D. Gray, 
unpublished data).  Furthermore, the most recent data from our laboratory indicates T helper 
cell memory to be impaired, although not absent, when B cells lack expression of ICOSL 
(T.A. Barr, S. Brown & D. Gray, unpublished data).  As ICOSL has also been shown to be 
involved in the generation of TFH cells [40], these data, again, highlight a correlation between 
TFH cell generation and memory cell development.  Together, these data reinforce the theory 
that the early migration of activated T cells into the follicle may be the time of the B-T cell 
interaction necessary for memory development.  Clearly, further investigation is required 




Understanding the fundamental principles of immune activation and memory generation is 
essential for the production of vaccines with the highest possible efficacy.  The data 
presented in this PhD thesis has expanded our knowledge of the roles that B lymphocytes 
play in such immune activation, and highlights the importance of an early interaction 
between B and T cells for efficient memory generation.  The varied functions of B cells 
should not be underestimated, and this requirement for B cell antigen presentation should be 
considered during vaccine development, to ensure that T cell memory generation is optimal. 
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Appendix 2 – Published paper 
 
 
TLR-Mediated Loss of CD62L Focuses B Cell Traffic to the Spleen during 
Salmonella typhimurium Infection 
Vicky L. Morrison, Tom A. Barr, Sheila Brown and David Gray 




Permission for printing in this thesis has been obtained from the publisher and co-authors. 
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